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Abstract
Chemical genetics is an approach to studying biological function through the use
of small molecules. An efficient way of accessing these small molecules is high
throughput synthesis on solid phase resins. The advantages of this technique include the
use of excess reagents to push reactions to completion and washing reagents and by¬
products before cleaving the specie of interest at the final step. The purity of the
compounds is good enough to perform biological screening without need of purification
provided the chemistry is well established.
The indazolinone core-structure has been selected for its small core and number
of functional groups available for diversity incorporation. However, selective
functionalisation of each position in the bicyclic system has not been reported yet.
Small molecules based on indazolinones have also been shown to exhibit biological
activity.
A reaction sequence allowing diversity incorporation on the indazolinone system
in a selective manner has been developed. This includes the use of an allyl group that
can be rearranged from the O position to the N2 position by an aza-Claisen
rearrangement. This sigmatropic rearrangement has been studied on the indazolinone
system with a range of allyl containing groups under different reaction conditions
including thermal (microwave based) and catalytic methods (Palladium (0) and (II)).
An indazolinone derivative that can be loaded onto a silicon-based resin has
been successfully synthesised. Two key steps in this synthesis involve a Suzuki
coupling and a copper-mediated cyclisation in the presence of hydrazine on an
iodobenzoic acid derivative. Initial studies using this derivative allowed us to design a
route for diversity incorporation in the solution phase by modelling the solid support by
a TIPS group. This strategy was then transferred onto a solid support. Comparison of
authentic compounds synthesised in solution with compounds made on the resin, by the
use of LC/MS technology, enabled us to confirm that the developed chemistry is of
relevance to library generation.
N2, O-substituted indazolinones contain two diene functional groups. Studies to
determine if these dienes are susceptible to the Diels-Alder reaction with reactive
electron deficient dienophile were carried out. A novel compound has been identified as
the product of a possible Diels-Alder reaction.
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The following abbreviations and symbols are used throughout this thesis.
9-BBN 9-borabicyclo [3,3,1 ]nonane
A angstrom, length unit (10"10m)
AcOH acetic acid
ADDP 1,1 -(Azodicarbonyl)dipiperidine
Bn benzyl radical, C6H5CH2-
BnCl benzyl chloride
Boc tert-butyloxycarbonyl radical, (CINbCOCO-
b.p. boiling point
Buli butyl lithium, strong base
ca. approximately
calcd calculated
CAN eerie ammonium nitrate
cGMP cyclic guanosine monophosphate, nucleotide metabolism
CI chemical ionisation
COSY correlation spectroscopy, 2D NMR technique
DCM dichloromethane






e.g. exempli gratia, latin, for instance
equiv. equivalents
ES electron impact, ionisation technique
ESI electrospray ionisation
Et ethyl radical, CH3CH2-
et al. "et alii", latin, for "and other"
Et3N triethylamine
EtOH ethanol
FT Fourier Transform, mathematical process
h hours, time unit
Hal halogen atom, either F, CL, Br, I usually
HMBC heteronuclear multiple bond connectivity, 2D NMR technique
HOMO highest occupied molecular orbital
HR high resolution, mass spectrometry
HSAB hard soft acid base concept
HSQC heteronuclear single quantum correlation, 2D NMR technique
Hunig's base jV,jV-diisopropylethylamine
Hz Hertz, frequency unit
i.e. id est, latin, that is
IR infrared
J coupling constant, Hz
LC/MS liquid chromatography coupled to mass spectrometry
LDA lithium diisopropylamide
LUMO lowest unoccupied molecular orbital




m/z mass over charge ratio
Me methyl radical, CH3-
MeOH methanol
Min minutes, time unit
m.p. melting point
MRSA methicillin resistant Staphylococcus Aureus
MS mass spectrometry
N/A non applicable
NaOMe sodium methoxide, CH3ONa
NMR nuclear magnetic resonance
Nu nucleophile
0 degrees, angle unit
°c degrees centigrade, temperature unit




PE petroleum ether 40-60°C
Ph phenyl radical, C6H5-
PIFA phenyliodine(III) bis(trifluoroacetate)
PPh3 triphenylphosphine
PPm part per million
PTAD 4-phenyl-l,2,4-triazoline-3,5-one, really reactive dienophile
Quant. quantitative










TIPS triisopropylsilyl radical, [(CH3)2CH]3Si-
TIPSOTf triisopropylsilyl trifluoromethanesulfonate
TLC thin layer chromatography
TMAD N,N,N ',N '-tetramethy lazodicarboxamide
TOS targeted-oriented synthesis
uv ultraviolet
z benzyloxycarbonyl radical, C6H5CH2OCO-




1.1. Discovery of Bioactive Compounds
1.1.1.Natural Product Extracts
1.1.1.1. Opportunities
Before the first cars were built, before written language was invented and even
before culturing of plants was developed for food purposes, our requirement to relieve
pain and prolong life drove us to search for medicines. It is not really clear what the
earliest humans did to treat their "aches" (e.g. headache, stomach ache) but they must
have used the natural resources around them (plants, animals and minerals).
Extracts of natural substances have been used for centuries to kill parasites,
neutralize venom and cure diseases, but no purification, analysis or separation
techniques were available at that time to determine specifically the compound(s)
responsible for the biological effect. It was believed that these extracts contained
mixtures that could act against the "infection".
During the 19th century, the concept of "pure" substances emerged from progress
in analytical chemistry and the development of isolation and separation techniques.
Indeed, in 1815, F. W. Serttirner, a German chemist/pharmacist,^'] isolated for the first
time in a pure form "morphium ", known as morphine (1), as the principal alkaloid in
opium (derived from Papaver somniferum L. or P. Album Mill, Papaveraceae).'2'
Morphine (1) and other alkaloids found in opium are used clinically as analgesics to
reduce pain without loss of consciousness.
(1)
Figure 1: Structure of Morphine (1) and the opium poppy, Papaver somniferum.
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Natural products were therefore the first source of biologically active molecules,
being present as mixtures in plant extracts, or as pure products when
identification/isolation was possible. Table 1 summarizes the timeline for isolation of
the first alkaloids and the investigators associated with their discovery.
Year Compound Investigator
1817 Narcotine Robiquet
1818 Strychnine Caventou & Pelletier
1818 Veratrine Meissner & Caventou
1819 Colchicine Meissner & Caventou
1820 Caffeine Runge; Caventou & Pellelier
1820 Quinine Caventou & Pelletier
1822 Emetine Pelletier & Magendie
1827 Coniine Giesecke; Geiger & Hess
1828 Nicotine Posselt & Reimann
1831 Aconitine Mein; Geiger & Hess
1832 Codeine Robiquet
1833 Atropine Geiger & Hess
1833 Thebaine Pelletier & Dumas
1842 Theobromine Woskresenky
1848 Papaverine Merck
1851 Choline Babo & Hirschbrunn
1860 Cocaine Niemann
1870 Muscarine Schmiedeberg & Koppe
Table 1: Isolation of alkaloids following the discovery ofmorphine (l).tl]
There is no doubt that our natural resources are extensive and can provide a
multitude of bioactive compounds, which are extremely diverse and structurally
innovative.
1.1.1.2. Limitations
Extraction from plants or microbes or insects allows the isolation ofmixtures of
compounds but raises difficulties such as identifying the active substance and
subsequently separating and isolating it. Isolation of the compound of interest is
sluggish, time-consuming, expensive and requires extensive resources. To follow the
example of morphine (1) cited previously, the production of 1.3 kg of this alkaloid
requires 13 kg of opium, which can be extracted from a one hectare field of opium
poppies.[2]
There are also other hurdles to be overcome in natural products extraction.
Environmental issues can increase the difficulties of isolating natural products. Taxol®
(2) (Scheme 1) is extracted from the bark of the Pacific yew tree (Taxus brevifolia) but
the plant is protected and is one of the slowest growing trees in the world. Six one




Scheme 1: Structure of Taxol® (2) [4] and Baccatin III (3).[3]
Extracting natural products from nature remains a difficult and low yielding
procedure. Isolating and identifying bioactive molecules from natural sources is time
consuming, limited technically and fraught from certain legal and ethical points of view
depending on the origin of the plant/microbe (e.g. the extraction of Taxol® (2) is not
only technically challenging but almost legally impossible).
Chemist can play an important role in overcoming the problems discussed
above. Semi synthetic routes can be developed. For example, Taxol® (2) is now
synthesised from Baccatin III (3) extracted from the renewable needles of the European
Yew, Taxus baccata L. (Taxaceae).[3] A second option is the total synthesis of the
natural product, which overcomes any problems relating to extractionJ6'
1.1.2.The Total Synthesis of Natural Products and
Medicinal Chemistry
1.1.2.1. Total Synthesis
The 19th century was the era of analytical science but also included a scientific
revolution. The power of chemistry was about to be discovered: the birth of total
synthesis. Indeed, in 1845, Kolbe synthesised acetic acid (4) from elemental carbon.
The word "synthesis" was used for the first time by this German chemist to describe the
process of assembling a chemical compound from other substances. Seventeen years
before, Wohler transformed an inorganic material (ammonium cyanate) into an organic
substance, urea (5). Fischer obtained in 1902 the Nobel Prize for chemistry [8] for his
work including the total synthesis of glucose (6). Dealing with the complexity of the
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target, including the stereochemistry (five stereogenic centres, four controllable and the








Scheme 2: Structures of acetic acid (4), urea (5) and glucose (6).
In the 20th century, scientists built on the success of the previous century. The
complexity of the synthesised molecules increased dramatically, due to the "genius" of
Fischer, Robinson [9], Woodward [10] and others.
This arguably culminated in 1959 when E.J. Corey (Nobel price in 1990 ^n'X
introduced and developed two distinctive elements: retrosynthetic analysis and new
synthetic methods. The concept of retrosynthesis was a new way of viewing and
analysing complex structures'13^ Breaking down the complexity of target structures
such as natural products by understanding the chemical functionality and planning their
synthesis from less complex molecules was the new way of synthesising natural
products. This revolutionary idea is now a standard approach to solve problems in
organic chemistry.
(J)
Scheme 3: Structure ofGinkgolide B (7).
For example, to synthesise a complex structure such as Ginkgolide B (7)'141
Corey started by looking at the final structure and broke it down into simpler starting
materials as described in Scheme 4.
13
The total synthesis of natural products is a great challenge and has proved to be a
difficult and interesting science but also an art as K. C. Nicolaou described.His
review highlights the astonishing achievements of organic chemists over the past
century in responding to nature's complexity by developing new methodologies and
creating new reactions. Nowadays, methodologies have been established, mechanisms
understood and when combined with retrosynthetic analysis, it is difficult to imagine a
problem that could not eventually be resolved in a natural product total synthesis.
However, copying nature to access complex natural products is long and
generally low yielding. For example, the synthesis of the alkaloid morphine (1) has
recently been achieved in 23 steps with an overall yield of 0.77%.[16]
1.1.2.2. Medicinal Chemistry [17"191
Importantly, less complex small molecules can also exhibit biological activity.
Indeed, acetyl salicylic acid (Scheme 5) better known as aspirin (8) proved to be of
interest. The realisation that rather simple chemical structures can also be of medical
importance calls into question the necessity of putting effort into the synthesis of
complex structures such as Taxol® (2) or morphine (1).
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o
Scheme 5: Structure ofAspirin (8).
Chemists can (and do) focus on developing compounds with relatively less
complex structures (compared to natural products) and work on them in order to find
and improve biological properties. Such an approach for generating small molecule lies
at the heart of medicinal chemistry. In this strategy, the first step is to identify a protein
target that is directly involved in the disease state. The second step and by no means the
simplest is to identify a bioactive compound. This is usually done by developing a
screen to select a chemical that will interact with this target. The third step is to optimise
the preliminary hit by making a large range of analogues. Compounds are made
individually, one by one, and optimised based on the results obtained in biological
testing. This process follows the concept described by Ehrlich, i.e., the core of the active
compound remains essentially unchanged and the chemist prepares analogues by
changing the groups attached to the core.
"The germicidal capability of a
molecule depended on its structure,
particularly its side-chains, which could
bind to the disease-causing organism."
P. Ehrlich ^
It is of interest to consider the efficiency of this approach. A medicinal chemist
using traditional synthesis methods can synthesise, on average, between one and five
compounds for biological testing per week. If a hit has been discovered, many
months/many years follow in which large numbers of analogues are prepared. This step-
by-step approach leads to important bioactive products but is arguably not the most
efficient method.
A recent example on a polycyclic structure supports this view. Rebeccamycin
(9), a potential anticancer compound, is a natural product extracted from fermentation.
Since 1985, when the structure was elucidated, the indolocarbazole core has been
extensively studied as a pharmacophore. To date, 300 analogues have been made and
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some of these have been studied in clinical trials. Thus, analogues of this polycyclic
structure are still generated using medicinal chemistry to find more potent molecules.1-211
The carbohydrate moiety of Rebeccamycin (9) seems to have an important role in its
activity. Indeed, common sugars have been added to the core and biological results
showed a variation in potency across the series. This observation led medicinal chemists
to synthesise new analogues by inserting less common sugars on the pharmacophore.
Scheme 6: Structure of Rebeccamycin (9) and analogues synthesised with uncommon sugars.1211
This example shows the strategy of medicinal chemistry. The first step of the
approach was the identification of the hit. Chemists then prepared analogues of the
primary hit, moving towards a potential anticancer agent. Further biological studies led
chemists to design and make new analogues, which gave further information about the
interactions of the small molecule and its target. Key positions on the aglycone moiety
were identified leading to additional sets of analogues for further studies. Therefore,
medicinal chemistry focuses on a rational stepwise approach. This strategy leads to
successful results, but can be slow depending on the available resources.
1.1.3.High Throughput Synthesis
Another, potentially more efficient, way of approaching the discovery of
bioactive compounds is to prepare a large collection (>200) of compounds up front and
then to screen them all using high throughput screening technology. By creating large
number of analogues, it is possible to perform rapidly structure-activity relationship
studies in order to optimise efficiently the side chains. There are two main approaches
to high throughput synthesis.
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1.1.31. Parallel Synthesis
1.1.3.1.1. Solution Phase High Throughput Synthesis
By definition, parallel synthesis is a strategy whereby sets of discrete
compounds are prepared simultaneously in arrays of physically separate reaction vessels
or micro compartments without interchange of intermediates during the assembly
process. This strategy allows the chemist to create a large range of individual
compounds usually with the aid of automation. This technique can also be used to
optimise reactions, because of the ease of changing several reaction parameters in
parallel (concentration, temperature, solvent etc.). The inconvenience of this approach is
that a purification step is needed, because the reactions arc performed in solution and
the products have to be separated from the reagents, starting material and/or catalyst etc.
The quantities created are in general 50-100 mg of compound and the number of
compounds is typically less than 1000.
Figure 2: Principle of solution phase high throughput synthesis, each reaction is performed in a
separate vessel; the last step of the procedure consists of a purification step to isolate the
product of interest from the reagents and by-products.
Scheme 7 summarises an example of this approach. A library of 240 members
was made in order to synthesise non-spiro analogues of spiperone (10), known to be an
antipsychotic agent.1" 1 Reductive amination of the aminoketone allowed the authors to
insert 5 different substitucnts at the R1 position. At this stage, reactions were pushed to
completion by the use of excess piperidone. A liquid/liquid extraction was then
performed to give the desired products in high purity and good yields (over 85% except
for one case). The acylation of the newly introduced nitrogen brought in 8 other groups
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at the R2 position. The last step was alkylation of the secondary nitrogen which had
been released previously by deprotection of the Boc group under acidic conditions.
Scheme 7: Structure of spiperone (10), general structure of libraries members (11) and starting
material for the library (12).[221
The library generation of spiperone (10) analogues of type 11 in solution phase
proved to be successful since two compounds with improved selectivity for the receptor
under study (5-HT2a) were identified. A clever combination of purification through
extractions and polymer-supported reagents allowed the isolation of products in
adequate purity.
Purification procedures have to be well planned in order to generate compounds
that are sufficiently pure for biological testing. This minimises the number of false
positives resulting from remaining reagents and by-products. Purification remains a
problem for parallel synthesis when a large number of analogues are prepared f23' and
generally involves preparative HPLC for final purification/24"271
Another example of biological importance is the targeted library based on
vancomycin. This glycopeptide is used often as the last resort for treatment of infections
by methicillin resistant Staphylococcus aureus (MRSA), a resistant strain of
Staphylococus aureus. However, vancomycin resistant strains of bacteria are
emerging/28"301 The need to overcome this problem led Nicolaou et al. to develop a
library based on the glycopeptide vancomycin by inserting diversity at the C terminal, N
terminal and carbohydrate positions. Several active compounds against vancomycin-
resistant bacteria were identified from the vancomycin-based library/311 proving that
this approach can lead to new hits.
Using a known bioactive molecule and inserting diversity onto it is the aim of




1.1.3.2.1. Solid Phase Chemistry
R.B. Merrifield[32] (Nobel Price in 1984) introduced the idea of solid phase
chemistry for the first time in 1963. The principle was to attach an amino acid by the C
terminal to a resin and to grow the peptidic chain using the N terminal. A suitable
protection and deprotection strategy was also required. Different protecting groups are
used on the side chain of the amino acids to avoid their deprotection during the amide
bond forming steps. These side chain protecting groups are removed at the end of the
synthesis to give, after cleavage from the resin, the peptide in solution (Figure 3). The
aim of this concept was to drive the amide bond forming reaction to completion by
addition of excess reagents and to avoid any purification step (by washing away the
excess reagents and cleaving the products in the final stage). Another advantage of this
technique was the potential for automation.
Figure 3: Principle of solid phase chemistry introduced for peptides by R.B. Merrifield.[32] The
peptidic chain is elongated by use of excess reagents (removed by washing) and the peptide was
cleaved off the resin at the final stage of the synthesis.
This technique has also become important in organic synthesis in general. In
particular, solid phase synthesis has increased dramatically in academia and to some
extent in industry due to the multiple advantages of the technique. The technique has
even improved over the years and new ideas have emerged from this concept: substrate




immobilised onto solid support to avoid bad odours,1to facilitate purification or
reduce risk ' or to allow the regeneration/recycling of reagents.136'37J These issues
have been described by Steven V. Ley in 2000 in a review entitled "Multi-step organic
synthesis using solid-supported reagents and scavengers: a new paradigm in chemical
library generation".Scheme 8 exemplifies the use of solid supported synthesis in
general organic chemistry for the synthesis of indoles on a Tenta-Gel S resin.
PPh3, DEAD, Tenta-Gel S resin, b-c) Pd(PPh3)2Cl2, Cul, TMG, alkyne, d) NaOH.
1.1.3.2.2. Split and Pool Synthesis 1321
The main concept in combinatorial synthesis is the generation of large
collections or "libraries" of compounds by synthesising all possible combinations of a
small set of chemical structures or "building blocks" on an insoluble polymer (resin).
The key technology for achieving this is split and pool synthesis.
Practically, the solid support is split into portions, each of which is subjected to
reaction with a single building block. Pooling these portions results in a single batch of
solid support in which each bead bears multiple copies of a single chemical entity
(Figure 4). Repetition of the split and pool processes results in a library where each
discrete bead of solid support carries a single library member. Split-pool synthesis is
often referred to as a "one bead-one compound" approach.
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Figure 4: Principle of split and pool synthesis.
The advantages of this technique are multiple:
1. The use of an excess of reagent is possible to push the reaction to completion.
2. No purification steps are needed (excess of reagent eliminated by washes).
Compounds are ready to be screened after cleavage from the resin or on bead.
3. Microgram quantities of compound produced hence reduction in reagent
costs.
4. Rapid synthesis (many fewer reaction steps than required to create an
analogous library using parallel synthesis).
5. Access to a very large number of compounds (more than 1000 structures):
29,400 discrete compounds were synthesised in 2002 using one solid phase library
synthesis in the ICCB at Boston ,l40J
6. Large data sets can be generated by screening leading to improved
interpretation of structure-activity relationships and therefore better guidelines for hit
and lead optimisation.
7. Possibility of automation for synthesis and analysis.
1.1.3.2.3. Unbiased libraries, DOS mm
In academia, split and pool synthesis has been used predominantly in the context
of diversity-oriented synthesis. When linked together, these two techniques provide
chemists with a very powerful method of preparing large unbiased compound libraries.
This means that the compounds that are selected for synthesis have no preexisting link
to a biological system or target. The chemist prepares the collection with two main
criteria in mind. First, the chemistry is compatible with the synthetic technology.
Second, as much structural diversity as possible is generated. The unbiased library is
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then screened in as many assays as possible in an attempt to identify a novel biological
activity.
The example given below is a library based on the core structure of a natural
product galanthaminc (13).'44' The core structure was not chosen because of the known
bioactivity of galanthamine (13) as an acetylcholine esterase inhibitor but because of its
interesting polycyclic structure, and the range of diversity-generating reactions that
could be applied. Indeed, different reactions have been performed on the oxygen carried
by C-7 (Mitsunobu reaction), then at C-l (conjugate addition), at the N-10 position
(acylation or alkylation) and finally at C-3 (formation of oxime and hydrzones).
Scheme 9: Structure of galanthamine (13) and the building blocks used for library generation.'441
As discussed above, galanthamine (13) itself is a potent acetylcholinesterase
inhibitor,'44' but screening of this unbiased library using an assay to detect compound
that perturb secretory pathways led to the identification of a potent inhibitor called
secramine (14) from this galanthamine-based library.
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Figure 5: Structure of secramine (14) and protein traffic perturbed by secramine (14).[44]
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The previous sections have highlighted how important small molecules are to the
study of biology processes and as drugs. They have also provided an overview of the
synthetic techniques that are applied in efforts to identify novel small molecule
modifiers of protein function. This research area is currently undergoing a resurgence in
interest and the systematic discovery of novel small molecule tools has recently been
referred to as "chemical genetics". The next section briefly outlines the key components
of this approach.
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1.2. Chemical Genetics t46_49]
1.2.1.The Origin of Chemical Genetics [50]
At the end of the 19th century, Paul Emil Fischer used the metaphor of a "lock
and key" to describe the interaction between a small molecule and an enzyme at the
molecular level. The "lock and key" concept was valid but Ehrlich updated the idea by
introducing the concept of a "RECEPTOR" as follows:
"... Designed for the purpose of
serving as toxic receptors for
substances ....
As these receptors, ..., become
occupied by the toxin, the relevant normal
function of this group is eliminated."
P. Ehrlich 1201
Therefore, as stated more than 100 years ago, small molecules were known to
have a powerful effect on biological systems by acting as the key. The key (or the toxin
according to Ehrlich's definition) was usually well characterised but the lock was not as
well identified. Ehrlich observed carefully that the small molecule could have an
important effect on biological system by eliminating the normal function associated
with the receptor. We know nowadays that these receptors are proteins, DNA or RNA.
Therefore, we can consider that chemical genetics was born from Fischer and Ehrlich's
ideas.
1.2.2.Definition of Chemical Genetics
The term "chemical genetics" symbolizes the idea of systematically using small
molecules to perturb, and thus determine, the function of proteins in the same way that
mutations are used in conventional genetics. As described in Figure 6, the genetic
approach consists of modifying the genetic information, which will ultimately be
processed to give a modified protein. Wild-type protein and modified protein may not
have the same function in a cellular context, in which case phenotypic differences are
24
likely to be observed. In the case of chemical genetics, a smail molecule is used in order









Figure 6: A comparison of chemical genetics and classical genetic approaches. In chemical
genetics, a small molecule is used at the protein level to induce (or not) changes in the
phenotype. In pure genetics, a mutation at the DNA level leads to the translation of a modified
protein which will induce (or not) a different phenotype.
1.2.3.Advantages of Chemical Genetics
The use of small molecules in chemical genetics differs from their traditional use
in the industrial area, for example as therapeutics. Chemical genetics involves
identification and use of research tools for enhancing our understanding of the detailed
mechanisms by which a biological system works. A recent example151J is the small
molecule monastrol (15) which binds the protein Eg5, a motor protein involved in
mitosis (a brief but essential event in the cell cycle during which the previously
replicated chromosomes are segregated into newly-forming daughter cells; this process
ensures that each daughter cell inherits a genome identical to the one of the parental
cell). The result of the action of monastrol (15) on a cell during mitosis and the structure
of this molecule are shown in Figure 7.1'° J Monastrol (15) was initially identified in a
whole-cell immunoassay designed to identify compounds that arrest cells in mitosis.[54]
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Figure 7: a) Immunofluorescence staining of a mitotic spindle in BSC-1 (green monkey) cells,
b) Monastrol treatment of mitotic cells replaces the normal bipolar spindle with a monastrol
microtubule array (green) surrounded by a ring of chromosomes (blue), c) Structure of
monastrol (15).[54'58i
Small molecule tools also provide the first step towards a therapeutic drug, in
two ways. First, they provide a means of testing whether the function of a given protein
is involved in a disease, and second, their chemical structure provides a starting point
for drug development.
Small molecules have several advantages over genetic technologies. They can
induce their biological effect rapidly and often reversibly. They can also be applied to
study a process of interest in a wide range of organisms, whereas the genetic approach,
demands that the desired genetic modification has to be regenerated every time the
experimental system is switched.'59' They also offer the capacity to study essential genes
at any stage in development.'60' They are versatile research tools that can be rapidly
adopted by many labs and used for the precise control of protein function in cells where
genetic manipulation is difficult.
In addition, washing out a small molecule from a biological system does not
present any difficulties, whereas removing a mutation in the genetic information is
impossible. Changing the genetic information by mutating the DNA induces the
expression of a unique alteration which cannot be turned on or off at will.'6'1
Even advanced techniques such as sRNAi which reduces the expression of a
protein from a gene by using a 21 bases sequence complementary to a portion of the
gene of interest arc not widely applicable, as it is difficult to apply these approaches to a
broad range of cells or in whole animals.'62'
26
1.2.4.Reverse and Forward Chemical Genetics
1.2.4.1. Forward Chemical Genetics'54'
Forward chemical genetics involves the screening of a library of small molecules
using a cell-based assay. The observation of an abnormal phenomenon, at the phenotype
level, is investigated further in order to identify the protcin(s) targeted by the small
molecule. In order to identify the possible effect of the small molecules at the
phenotypic level, several options are available. If a cell-based assay is performed,
automated microscopy will enable morphological observations (e.g. the discovery of
monastrol (15), Figure 7), whereas the use of reporter-gene assay will provide
information on the activity of the target protein (e.g. transcriptional regulation) through
an easily detectable enzymatic activity (e.g. the use of luciferase to process luciferin
with the linked production of light). Alternatively, cytotoxicity assays or "whole-cell
immunoassays" are described as broader methods but offer the potential to find
compounds which disrupt the activity of poorly characterized or even unknown
targets.'59'
Abnormal i \ Small I n ,t
Phenotype I Molecule 1 ^ Protein
Figure 8: Concept of luiwmd chemical genetics.
This concept is schematised in Figure 8. As illustrated in Figure 7, abnormal
mitosis observed by microscopy during the screening was caused by the presence of
monastrol (15). Further studies revealed that monastrol (15) binds to a motor protein
Eg5, which is responsible for the abnormal phenotypc. Such studies allow researchers to
discover and understand a protein's function by using small molecules.
1.2.4.1.1. Target Identification^
1.2.4.1.1.1. By isolation of the target
When the biological assay has been performed with a purified protein, the
protein target of the small molecule is obvious. When a forward chemical genetic
approach has been followed, using a cell-based assay, identifying the target protein of
the "hit" remains a difficult challenge.'fi4J However, it is not impossible and biochemical
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techniques allow the identification of the target proteins when a screen is performed.
Several approaches to target identification are reviewed here.
(a) Tracing the labelled compound bound to the target
Biochemical purification including the use of traceable derivatives (e.g.
radiolabelling of the bioactive compound and following it during fractionation of cell
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Figure 9: Principle of tracing a protein by binding covalently a small molecule (scheme adapted
from [65]).
(b) Affinity chromatography
Affinity chromatography is also a technique used for this purpose. It involves the
immobilisation of the small molecule of interest on a solid phase support (Figure 10).
Cell extracts are then passed over the solid support enabling the binding of the target
protein to its substrate. Washing away the excess of non-binding protein followed by
disrupting the specifically bound protein with a solution of the original small molecule
allows the isolation of the target protein(s).[66]
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1. Attachment of 2. Cell extracts onto resin 3- Target/small molecule
small molecule on resin Interaction (non covalent bonds)
4. Washing of 5. Elution of target protein
unbounded material with substrate in solution
Figure 10: Principle of affinity chromatography (Scheme adapted from 65]).
1.2.4.1.1.2. By identifying an interaction (or non-interaction) ^11
(a) Yeast two-hybrid system, disrupting a blown interaction
The yeast two-hybrid system is a technique allowing the study of protein-
protein interactions by the means of a reporter gene. One protein is built with two sub¬
structures: a DNA binding domain (DBD, in red) which will bind to the promoter of the
gene of interest and the protein of interest Y (green). The second protein is also
comprised of two sub-units: a protein of interest, X (blue) bound to a reporter gene
activation domain (AD, red).
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Figure 11: Principle of yeast two-hybrid system (Scheme adapted from [<,x|), DBD for DNA
Binding Domain, AD for Activation Domain.
The DBD domain and AD domain are known to be essential for the expression
of the reporter gene. However, the transcription of the reporter gene will be activated
only if the two proteins of interest Y (green) and X (blue) interact with each other. The
role of the small molecule in this system is to disrupt the protein-protein interaction. If a
small molecule binds Y as its target, the interaction X-Y will not take place, then, the
reporter gene will not be expressed.
A variant of this system called the reverse two hybrid system has been
developed. The same principle is used in a different manner: the reporter gene involves
a trigger for cell death. Uninterrupted interaction of X with Y will therefore induce the
death of the cell. However, if a small molecule disrupts the interaction, the cell does not
die.
The two-hybrid system is simple and inexpensive but has a tendency to produce
false positives.
(b) Yeast three-hybrid system, ^ by reading out an interaction
It is a further extension of this technology to the yeast three hybrid system that is
of particular relevance to target identification studies. This system involves the
construction of two sets of fusion proteins which arc different to those described in the
previous system in the sense that Y and X do not interact directly but through a third
element, a small molecule, often referred to as chemical inducer of dimerization (CID).
CIDs |64' are composed of two units: one (A, green circle) which is known to
interact with Y, the other one (B) which is derived from the hit compound. Y and A
will interact, bringing B close to the reporter gene. If B and X interact (i.e. if protein X
can bind to small molecule B), case 1, the activation domain will activate the reporter
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gene. If B and X do not interact, case 2, the hybrid X-AD will not activate the reporter
gene. A library of X-AD protein fusions are prepared and used to identify proteins that
bind to B.
Figure 12: Principle of yeast three-hybrid system, DBD for DNA Binding Domain, AD for
Activation Domain.[6S'
Reviews on the yeast forward and reverse "n"-hybrid systems have recently been
published 1 0| and highlight the details of the systems described here in outline.
1.2.4.2. Reverse chemical genetics
Reverse chemical genetics involves screening a small molecules library against a
purified protein of interest. This allows the identification of hits that bind to and/or
modify the activity of the protein of interest. Once a hit has been identified, it is
possible by looking at the phenotype to probe the role of the protein in cells. As
illustrated in Figure 13, the protein is the first element of the sequence. A small
molecule inducing changes at the phenotype level would be selected for further studies.
Protein Molecule [H^> PhenotyPe
Figure 13: Concept of reverse chemical genetics.
The small molecule (S)-(-)-blebbistatin (16) was discovered using the reverse
chemical genetics approach in a high throughput screening targeting non-muscle





Scheme 10: Structure of blebbistatin (16) and effect of blebbistatin (16), HeLa cells untreated
(control) or treated (blebbistatin) with 100 pM (±)-blebbistatin and stained for DNA (blue), a-
tubulin (green), and non-muscle myosin II (red).'7'1
1.3. The Project
1.3.1.Background
As mentioned previously, the starting point for chemical genetics is the
compound libraries. Libraries can be obtained commercially, by collecting together
individual compounds or by generating efficiently large numbers of compounds using
the techniques described in section 1.1.3. Commercial libraries provide few attractive
synthetic challenges from a chemist's point of view. Collecting compounds and
synthesising large numbers of compounds by using classical methods in organic
synthesis is time consuming. Therefore, designing strategies to create "efficiently"
libraries of large numbers of compounds are the main goals for a chemist involved in
chemical genetics. "Efficiently" is the term used by S. L. Schreiber to describe the
manner in which generating diversity must be achieved.l42J
However, this requires a significant change in the way chemists currently think.
Planning the synthesis of a defined target is well precedented and clear guidelines exist.
Driving chemical synthesis from the stand point of incorporating diversity is less well
prcccdented and the rules are only just emerging. Several of the factors that are
currently viewed as important in diversity oriented synthesis are discussed below.
1.3.1.1. Core Decoration
The way of accessing diversity described so far was to select a small molecule,
with or without biological precedents, and to decorate this core by incorporation of
building blocks (Figure 14). The galanthamine-inspired library described in section
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1.1.3.2.3 (page 21) illustrates the strategy of core decoration.'44' Indeed, the four
reactive sites on the core-structure are reacted orthogonally without a requirement for
the use of protecting groups. A library of 2527 members was synthesised and
successfully analysed by LC/MS after cleavage from the resin.'44'
Figure 14: Core decoration principle; diversity incorporation by use of building blocks.'72' The
core structure, unchanged along the synthesis, carries the functional groups which are reacted
orthogonally to insert the different building blocks.
By decorating the core, the central structure remains unchanged, i.e., the 3-
dimensional structure of the scaffold holding the building blocks is identical in all the
library members. In the library based on the galanthamine core, the 2527 members of
the library have the same inner skeleton.
1.3.1.2. Skeletal diversity
Diversity can also be generated by altering other factors in addition to building
block incorporation. Reactions involving the core structure would allow the introduction
of another degree of diversity in which the 3-dimensional structure is transformed and
starting from one core, another core can be generated by means of a single reaction
carried out on all members of a library. Creating one library of n members and
transforming it by a single reaction to another one would give a 2n member library. In
the past few years, the concept of generating diversity at the level of the core structure
rather than only through the use of building blocks has been described by S. L.
Schrciber as "skeletal diversity".'41'72'
Skeletal diversity generation can be achieved using two strategies (Scheme 11):
- by using different reagents on a common substrate to give different core
structures. This has also been termed reagent-based approach.
- by using a common reagent on different substrates (synthesised from a
common starting material in a previous step) called substrate-based approach.
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Scheme 11: Two general approaches for planning synthesis pathways to generate skeletal
diversity.
1.3.1.2.1. Reagent-based approach
In the reagent-based approach, the diversity is driven by the nature of the
common substrate which is reacted with a range of reagents. The nature of the reagents
induces diversity in the sense that the products are structurally different.
Scheme 12: Example of generation of skeleton diversity through a Diels-Alder reaction.l4(>1
In the example shown in Scheme 12 and Scheme 13, ten distinct polycyclic
skeletons have been prepared from the same starting material (Scheme 13). The authors
define compounds with different: (1) numbers or sizes of rings, (2) ring fusion
stereochemistry, and (3) degree of ring fusion saturation as having "different skeletons"
l40J. The structure of the reagents and their ability to induce stereoselective reactions on
the same substrate allow the creation of diversity/complexity.'7 ,1
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Scheme 13: Skeletons obtained through the Diels-Alder reaction.[401
1.3.1.2.2. Substrate-based approach
In the substrate-based approach, the starting point of the library involves a
unique starting material Al. The building blocks reacted at the desired site are chosen
for their ability to bring new functional groups to give A2, A3 and A4, for example.
Under the same reaction conditions, the new functional groups behave
differently in each case to give a particular skeleton.'721 In this example, the
Achmatowicz reaction, radical cyclisation, transformed A2, A3 and A4 to a bridged
product of type A5, A6 containing a six-membered ring and A7 a linear product,
respectively.
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Scheme 14: Example of substrate-based approach for skeleton diversity.[74]
1.3.2.Project goals
The main aim of this project was to establish a library design for an unbiased
collection of potentially bioactive small molecules. To achieve this it was necessary to
draw on many of the research areas discussed previously. In particular, we wanted to
incorporate skeletal diversity into our library design. The system we selected for study
was the indazolinone core structure (17) for two key reasons. First, indazolinone
derivatives have been previously reported to exhibit biological activity. Second, we felt
that there were some significant chemical challenges associated with diversity
incorporation using this system. As drug-like molecules are often expected to possess a
molecular weight of <500 Da (Lipinski's rules [75]), most library designs must start with
a small core structure (MW= 150-200 Da). In order to enable sufficient diversity
incorporation several functional groups are required in the core and the challenge
therefore becomes how to react each functional group in turn without the excessive use
of protecting groups. These challenges are particularly extreme with the indazolinone
core structure and the strategies we have developed to deal with this form the major part
of this thesis (for an overview, sec section 1.3.2.2)
1.3.2.1. Biological activity of indazolinone derivatives
Few substituted indazolinones are reported to have biological effect (Scheme
15). As far as the medical use is concerned, derivatives of l-benzyl-3-hydroxy-indazole
(bendazac (18) and benzydamine (19)) have a different pharmacological profile:
bendazac (18) showed a selective inhibition of protein denaturation,[76] while
benzydamine (19) is a strong anti-inflammatory agent, without any anti-spermatogenic
activity.[77]
36
Scheme 15: Structures of indazolinone (17), Bendazac (18) and Benzydamine (19).
Bruneau et al. 1781 have reported that substituted indazolinones were potent
inhibitors of the 5-Lipoxygenase enzyme (5-LPO), involved in the arachidonic acid
cascade for the synthesis of leukotrienes. This target represents a potential treatment for
disease in which elevated levels of leukotrienes are believed to play a role (rheumatoid
arthritis, asthma, inflammatory bowel disease)!79-8^
The reported bioactivity of indazolinone and its criterias that are in accordance
with Lipinski rules [75] make this molecule a relevant core structure for developing an
unbiased library in a chemical genetics project.
1.3.2.2. Diversity incorporation
The indazolinonc core structure is compact with various reactive sites. The first
goal of our project was to design a robust route to insert diversity in an efficient and
specific manner around the indazolinone core. Ideally, we would like to generate three
different skeletons from the indazolinone core. As illustrated in Scheme 16, for each of
the three isomers, the substituents arc in significantly different spatial arrangements.
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Scheme 16: Project of generating diversity from indazolinone core.
Maximising diversity incorporation around the indazolinone core involved the
optimisation of synthetic routes in solution phase. It was then necessary to transfer the
chemistry onto the solid phase in order to allow the synthesis of a library using the split
and pool technique. The scale used for the solution phase was sufficient to allow full
characterization of the products. The transfer from solution to solid phase involved the
use of LC/MS techniques to compare the authentic materials synthesised in solution
against the material made on and cleaved from the resin.
1.3.2.3. Claisen-type rearrangement as a method for core-switching
The Claisen rearrangement, one of the sigmatropic rearrangements, has been
extensively described in the literature!821 However, it has not been reported in the
context of indazolinones. In our library design, we planned to use a Claisen-type
rearrangement on the indazolinone core to convert, for example, 20 to 21 (or structures
of type C to type A, Scheme 16). A key aspect of the project was therefore to study the
possibility of rearranging an allyl group on the O position of the indazolinone to the N2
position of the indazolinone.
Scheme 17: Core switching reaction in the indazolinone series using the Claisen rearrangement.
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The aza-Claisen rearrangement presented in Scheme 17 would allow the
conversion of 20 to 21. If selected correctly, the group R could then be removed and our
strategy would be to identify a second reaction to functionalise 23 on the oxygen
position to generate structure of type 22 (Scheme 18, structure C in Scheme 16).
Scheme 18: Skeleton diversity, three skeletons from the indazolinone core using the aza-Claisen
rearrangement.
Scheme 18 summarises the initial design for our library, starting from one core
17 and by a carefully controlled and well-designed reaction sequence three different
cores 20, 21, 22 would be synthesised.
1.3.2.4. Plans for solid phase synthesis
Provided no purification is needed after the final step (the cleavage) and as the
compounds are ready for analysis and biological screening, solid phase synthesis
remains the technique of choice for combinatorial synthesis. Designing an indazolinone
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Scheme 19: Loading points on the 5-membered ring.
Several choices were available for loading the indazolinone core onto the resin.
However, the use of the 5-membered ring system (25, 26 and 27, Scheme 19) was
excluded because it was incompatible with the planned sequence (Scheme 17).
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Scheme 20: Loading points on the 6-membered ring.
Four possibilities involving the 6-membered ring were considered. Factors such
as the availability of starting material and the case of the synthesis were considered. 28
and 29 are acceptable but the position of attachment to the solid support is in close
proximity with the reactive sites N1 and O. It was therefore decided to focus initially on
structures 30 and 31 where the attachment to the solid support was such that it does not
interfere with the reactive sites. Successful synthesis of a compound corresponding to
an analogue of 30 was achieved and this core structure proved useful for library
synthesis on the solid support.
1.3.3. Potential Diels-Alder approaches
Structures of type 32 (Scheme 21) are one of the three skeletons aimed at in the
library generation. The di-diene feature of the molecule attracted our attention in
reacting it in the Diels-Alder reaction. Therefore, from a chemical point of view and in
the perspective of generating a new core for diversity purposes, we decided to
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Scheme 21: Idea of Diels-Alder reaction with 32 as a diene.
1.4. Literature review
1.4.1. Introduction to indazolinones
1.4.1.1. Nomenclature and structure [83]
Indazolinones are fused bicyclic structures (Scheme 22). This structure is








For the purposes of this review, O-substituted indazolinones will be referred to
as substituted indazoles rather than substituted indazolinones.
Several analytical studies have been carried out on indazolinones and are
described here in order to understand the key problem associated with the indazolinone
structure: the issue of tautomerism. The presence of three possible structures has been
determined by X-ray, NMR and UV analysis. The indazolinone may exist in the imidate
35 or the lactam tautomer form 17.
Scheme 22: Tautomeric structures of indazolinone.
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The existence of structure 36 is unlikely given the present knowledge of
indazolone tautomerism. Nevertheless, O'Sullivan used infrared techniques to study a
range of compounds consisting of a benzene ring fused to a five-membered ring, as in
indazolinone 17. According to his results,[84] the signals observed for indazolinone are
analogous to those obtained for isatin 39 and indigo 40; a strong band from 3100 to
2700 cm"1 and a very intense broad band at 1626 cm"1. He described the latter band as
too intense to be a C=C stretching frequency, and is probably due to a conjugated
carbonyl group involved in hydrogen bonding. This is evidence for the existence of
indazolinone in the tautomeric form 17.
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Scheme 23: Structures of indazolinone 37 and 38, isatin 39 and indigo 40.
In 1986, Ballesteros et al. used X-ray crystallography and NMR (15N, 13C) to
determine the structure of indazolinone in the solid state and in solution. They
concluded that indazolinone existed as 85% of the enol form 35 and 15% for the lactam
form 17 in the solid state structure.'85^
The indazolinone structures will be drawn throughout the document as they
appeared in the original papers.
1.4.1.2. Physical properties
The unsubstituted indazolinones are crystalline solids with melting points of ca.
200°C (with some decomposition).They dissolve readily in water and alcohols, but have
very poor solubility in apolar organic solvents. The UV spectrum of indazolinone in
ethanol shows absorption maxima at 220 nm (s=2200) and 310 nm (s=3700). The IR
spectrum (KBr disc) presents a very broad maximum between 3000 and 2700 cm"1 from
the N-H stretching and another broad maximum at 1630 cm"1, corresponding to the C=0
vibration, leading to assignment of the indazolinone in the tautomeric form 17 the solid
state (Scheme 22). X-ray analysis in 1986 by Ballesteros et al. concluded that in the
solid state indazolinone exists as such tautomeric form 17 (Scheme 24). 'H NMR
spectroscopy (d6-DMSO) shows that all the protons of indazolinone are in the aromatic
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region between 8 6.8-8.0 ppm. In solution (DMSO), tautomer 17 represents only 15%,
with the enol form 35 predominating (85%).
Scheme 24: (A) H-bonding pattern and (B) X-ray structure of indazolinone showing
intermolecular H-bonds.t85]
1.4.2.Reported routes to prepare indazolinones
Indazolinones can be synthesised via two distinct strategies. The first one
involves assembling either the 6-membered or the 5-membered ring using different
coupling methods. The different possibilities for disconnecting the indazolinone system
are presented in Scheme 25. The second involves the conversion of existing fused




1.4.2.1. Building the core
Scheme 25: The different ways to access the heterocycle.
As shown in Scheme 25, five disconnections to generate the indazolinone core
have been assessed to date. One route (A) involves the construction of the benzene ring,
whereas four routes (B, C, D and E) involve the construction of the 5-membered ring.
Routes B, C, D and E lead to the 5-membered ring by 4 different coupling reactions
involving C-C, C-N, N-N and N-C bond forming reactions respectively.
A literature survey of the main synthetic routes was carried out at the start of this
project to identify the best way to make the core-structure. A point of attachment to the
resin (for example an alcohol functionality if a silyl linker strategy was to be employed),
the possibility of inserting diversity at the O, N1 and/or N2 positions (the three positions
of the indazolinone need to be unsubstituted or protected in such a way that they can be
easily deprotected) and a short synthetic sequence are key requirements for the core
structure.
1.4.2.2. Method A
The Diels-Alder reaction is one of the methods of choice for building 6-
membered ring systems. This synthesis was a relatively new approach to indazolinone
discovered in 1999 by Roy et al. (Scheme 26).[86] It constructs the 6-membered ring
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system of the indazolinone using 41 as a precursor of the diene 42. 42 was generated
from 41 in presence of a strong base at low temperature. Coordination of the lithium
atom from LDA is proposed to stabilise the diene 42. Reaction with dienophiles of type
43 induces the Diels-Alder cycloaddition to give 44 which was not isolated but reacted
in benzene in the presence of pyridinium tosylate resulting in formation of the aromatic
derivative 45.
Scheme 26: Aromatisation of the 6-membered ring to give indazolinone 45; [86] a) LDA/THF, -
78°C, b) THF, -78°C, c) pyridinium tosylate, PhH, reflux, high yield, X=N02 or COPh.[86]
From the perspective of a library design, N1-methyl and AC-phenyl in 45
represent a hurdle for diversity incorporation. This sequence was considered as a
possible route to the library core-structure but was abandoned due to the difficulties
associated with the substituents at the N1 and N2 positions and the long sequence
required to generate structures of type 41.
1.4.2.3. Method B, Disconnection C3-C3a
1.4.2.3.1. From hydrazine derivatives and carbonic acid derivatives
This approach [87' 881 is the oldest method reported for the synthesis of
indazolinones, especially those having a substituent (alkyl or aryl) at the N1 position. It
involves a C-C bond forming reaction (C3-C3a) by direct synthesis (46 to 24) or by
synthesis of the intermediate 47 which is cyclised to give 24 on heating (Scheme 27).
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Scheme 27: Indazolinone synthesised by making the C3-C3a bond; a) i) NH2CONH2, 180°C, 3
h, ii) 280°C, 3 min, b) KOCN, H+, heat, c) Heat .[87>88]
The carbonyl system is incorporated either from urea or from potassium cyanate,
the intermediate semicarbazide 47 is not usually isolated. The cyclisation step is a
thermal process, occurring at ca. 200°C. Both approaches are generally low-yielding.[87'
881 Moreover, the first route (a) gives a mixture of several compounds because of the
high temperatures. This disconnection has been useful for obtaining label indazolinone
using 14C urea only (radio labelling) but does not seem appropriate for our library
design.
1.4.2.3.2. Carbonylation with CO and metal complexes
1.4.2.3.2.1. Using cobalt salts
This synthesis was reported by Murahashi and Horie in 1956. It converts
azobenzene of type 48 to 2-arylindazolones of type 49 in the presence of carbon
monoxide with octacarbonyldicobalt (Scheme 28).[91]
Scheme 28: Synthesis of indazolinone 49 from azobenzene 48 using cobalt complexes; a)
Co2(CO)8, CO, 190°C, 150 atm, 80%.[91]
Introducing a group containing an alcohol functionality for attachment onto the
resin could be possible as the azobenzene does not need to be symmetrical. However, as
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discussed previously for method A (page 44), the substituent at the N2 position is not
compatible with the planned diversity incorporation and increases the difficulty in
generating an indazolinone ready for diversity incorporation if the aryl group has to be
removed.
1.4.2.3.2.2. Using palladium complexes
Organometallic compounds containing palladium [91] can also be useful for the
synthesis of indazolinone. Indeed, azobenzene derivatives in the presence of palladium
dichloride induce the formation of intermediates of type 50. Under carbon monoxide
pressure in a protic solvent, this complex is transformed to structures of type 51.
Scheme 29: Carbonylation of azobenzene-palladium chloride complexes 50; EtOH or H20, CO,
150 atm, 100°C, 5h.[91]
The cyclisation of azobenzenes in the presence of palladium dichloride has been







Table 2: Summary of yields of carbonylation of azobenzene-palladium complexes.[91]
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This strategy, despite the high yielding reactions, again involves the synthesis of
^-substituted indazolinones, which is not ideal for our route, as diversity incorporation
would be limited for structures of type 51.
1.4.2.3.3. N-arylcarbamoyl azides and Curtius rearrangement
The elegant Curtius rearrangement from the carbamoyl structure 52 produces the
N1-substituted indazolol 54. Over a range of substituents, the yields vary from 15% to
70%.
Scheme 30: Synthesis of 54 from arylcarbamoyl azide 53 under thermal conditions; a) NaN3,
MeOH, 75°C, b) tetralin, 160-190°C, l-2h, 15-70% (R=Bn).
Unfortunately, in the majority of the studies, by-products of type 55 are usually
isolated with the desired product.
Scheme 31: By-product 55 obtained from the synthesis of 54.
The fact that a by-product is formed, the variable yields obtained in this
approach and the stable nature ofR at the N1 position make this sequence inappropriate
for our planned synthetic strategy.
1.4.2.4. Method C, Disconnection N2-C3
1.4.2.4.1. From hydrazine derivatives
The N2-C3 disconnection has been widely explored for the synthesis of
indazolinones. Unsubstituted, Nl- and ^-substituted indazolinones can be made using
this strategy.
For example, unsubstituted indazolinones of type 57 can be synthesised when











Scheme 32: Synthesis of 57 by cyclisation of 56; a) H2O, 100°C, 30 min, -H20, -HC1, 89%.[95]
This approach is useful because it results in an unsubstituted indazolinone.
Diversity incorporation would therefore be possible without any deprotection steps. The
nitro group present on the benzene ring is not required for the cyclisation and could be a
positive element for the introduction of the attachment to the resin.
^-substituted indazolinones of type 59 can be synthesised from hydrazine
derivatives of type 58 in acetic acid under reflux but the yield of the reaction is poor
(Scheme 33). The benzyl group at the N2 position is also incompatible with the






Scheme 33: Synthesis of indazolinone 59 from hydrazinobenzoic acid 58; a) AcOH, reflux, 30
min, 25% (R=Bn).[83'96]
The N2-C3 disconnection can also lead to anthranilic acids as starting materials.
jV-substituted anthranilic acids or esters of type 60 can be converted with nitrous acid to
the corresponding nitroso derivatives 61.[83] The reduction of the nitroso derivatives 61
gives the hydrazine which cyclises onto the carboxylate functionality to give 62.
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Scheme 34: Synthesis of indazolone 62 from anthranilic acid derivative 60; a) HNO2, h30+, b)
Raney-Nickel, Pd/C.[831
The formation of the nitroso derivatives is generally easy, but their reduction is
only possible with specific agents such as sodium hydrosulfide in an alkaline medium
when R1=H, Hal, Me, Bn, or by catalytic hydrogenation. The reduction of the nitroso
9 1 • 1 •
group could be a problem if the substituents R or R are sensitive to the reaction
conditions being used. The yields of this procedure vary from 45% to 85%.
I ^ R1 Reducing agent Yield




5-c1 4-Cl-C6H4 Lithium Aluminium
Hydride
46%
Table 3: Comparison of different reducing agents for the A-nitroso functionality.
As mentioned previously, synthetic routes resulting in A-substituted
indazolinones do not present any advantages for the development of our library design.
1.4.2.4.1.1. Reduction of diazonium salt IgAgsi
Anthranilic acids and derivatives can be reacted in another way to give
indazolinones. Indeed, unsubstituted indazolinones (Scheme 35) can be prepared by
diazotation of anthranilic acid derivatives to give the corresponding diazonium salt of
type 63. This salt is then reduced to the corresponding o-hydrazinobenzoic acid 64 by
sulfite or sulphur dioxide. 64 is then cyclised by action of phosphoryl chloride or in
boiling nitrobenzene, or aqueous solutions (acidic) to give indazolinone derivatives of
type 65.
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Scheme 35: Reduction of diazonium salt 63 to generate phenyl hydrazine derivatives 64 and
cyclisation to give 65; a) Na2S203, b) HC1, 80°C, 20 h, 86%.[83'
This approach is a straight forward synthesis leading to unsubstituted
indazolinones and presents potential advantages for the incorporation of the linker that
will be used to load the core-structure onto the solid phase. Indeed, indazolinones
presenting methyl groups (5 and 7 positions) or chloro (5 or 6 position) have been
reported in the literature.'83' This sequence has been explored for the synthesis of our
core-structure (see section 2.3.1.3.1).
1.4.2.4.1.2. From svdnone
Unsubstituted indazolinones can also be synthesised by the N2-C3 bond









Scheme 36: Synthesis of 17 from sydnone 66; a) HC1, 50 to 96% (X= NH2, NHMe, NHNH2, N3,
OMe).'97'98]
The synthesis of unsubstituted indazolinones from sydnone is an attractive point
for the synthesis of the library core-structure. Moreover, the yields of the transformation
are good to excellent. This approach is a potential sequence that can be used in the
synthesis of the core-structure we are interested in.
1.4.2.4.2. Approaches involving ring enlargement
The ring enlargement of four-membered heterocycles to the corresponding five-
membered pyrazole nucleus is interesting mechanistically, but has no practical
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importance. Indazolinone derivatives of type 68 have been synthesised in reasonable
yield from 67.
Scheme 37: Ring enlargement of 67 to give indazolinone derivative of type 68; a) AcOH, rt,
62%.[991
This synthesis has only been reported on substrate 67, but is interesting since an
unsubstituted indazolinone is generated. Even if it is reported that this synthesis has no
practical importance, this route is potentially of relevance for our library core structure.
1.4.2.5. Method D, Disconnection N1-N2 l10°l
To our knowledge, only two methods report N-N bond forming reactions as an
approach to indazolinones and their derivatives!78'100]
The first one is a method that has been applied for the synthesis of isoxazolo and
pyrazolo-pyridines and is interesting because the 5-membered ring system is not
substituted.
(69) (70)
Scheme 38: Creation of Nitrogen-Nitrogen bond; a) Phenyliodine(III) bis(trifluoroacetate)
(PIFA), DMF/H20 (1:1), pyridine, rt, R=alkyl, aryl and R'=CF3.[1001
However, the substituents R and R' in 69 are crucially important and must be
electron-withdrawing groups [I00] (yield ca. 70%). Indeed, in the intermediates 71-72
(Scheme 39) proposed to be formed en route to 70, the substituents on the aromatic
system are thought to stabilise the delocalisation as the X-N bond is formed. The










Scheme 39: Intermediates during the formation ofN1-N2 bond with PIFA.[1001
The synthesis has not been reported for the generation of indazolinones, raising
the question of whether the nitrogen is essential for the cyclisation or not.
The second method involves the formation of N-N bond by the use of metallic
zinc. The 2-nitrobenzamide derivative 73 is reduced and cyclised to give 74 in alkaline
medium in modest yields.[78]




Scheme 40: Creation ofNitrogen-Nitrogen bond; a) Zn, NaOH, MeOH, reflux, 10-40%.[781
iV2-substituted indazolinones of type 74 presents problems for the synthesis of
the library core structure that have already been discussed. This synthesis was therefore
not part of the different strategies attempted for core structure generation.
1.4.2.6. Method E, Disconnection Nl-C7a
1.4.2.6.1. Barton's route
The synthesis of unsubstituted indazolinone 35 from benzhydrazides of type 75
has been reported by Sir D. Barton. The presence of a strong base, such as «-butyl
lithium used by Barton,[l 01 ] is claimed to lead to the formation of a polyanionic species
(see page 143, Scheme 151) which, when the temperature rises to room temperature,





Scheme 41: Synthesis of 35 by cyclisation of 75; a) n-BuLi, THF, -78°C to rt, 80%.[10I]
Barton's route in the context of library generation appears to be an easy and
flexible synthesis because of the availability of benzoic acid derivatives as starting
materials. This approach was therefore the focus of our early efforts for the synthesis of
the library core structure. The results of these studies are shown in section 2.3.1.4.
1.4.2.6.2. From 2-halogenobenzoic acid derivative
The cyclisation of the N1 onto the C7a in the indazolinone system can be
achieved by the displacement of a leaving groups102^ This leaving group is typically a
halogen atom. For example, the fluorine atom can be displaced by the terminal nitrogen
of the hydrazide functionality in 76 to give 77 (Scheme 42).
Scheme 42: Synthesis of ^-substituted indazolinone 77 from 2-fluoro-5-nitrobenzhydrazide
derivative 76; a) 20% TFA/CH2C12, 4 h, b) PS-morpholine, DMF, 36 h, 5O%.[102]
The halogen atom can also be chlorine. In this synthesis, the cyclisation
conditions involve the use of copper metal for the formation of indazolol of type 54
(Scheme 43). The metal helps in the displacement of the chlorine atom a of the
carbonyl group.
Scheme 43: Synthesis of indazolinone 54 from 2-chlorobenzhydrazide 78; a) K2C03, Cu,
pentanol, reflux, 17 h, 44% (R=Ph).'831
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As stated previously, synthesis of A-substituted indazolinones are not useful in
the context of library generation. However, A-substitution can be avoided in this
procedure. For example, when the 2-fluorobenzoic acid derivative 79 was subjected to
the copper mediated reaction in the presence of hydrazine, the unsubstituted
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Scheme 44: Formation of unsubstitued indazolinone from 2-fluorobenzoic acid derivative 79
used in the synthesis of SE063.[I031
The cyclisation to the unsubstituted indazolinone is straight forward and is
compatible with the possibility of diversity incorporation. This reaction has been the
main reaction used by us to make the library core-structure in this project. The reaction
has also been optimised in our system (section 2.3.1.3.3).
1.4.2.7. Approaches involving Ring Contraction
1.4.2.7.1. From two fused six-membered rings
Indazolinones can be synthesised easily and in good yield by thermolysis of
benzotriazin-4(3A)-one 81 (Scheme 45). The problem with this approach is the
substituent at the N2 position that can reduce the diversity incorporation.
Scheme 45: A2-phenyl indazolinone 49 synthesis by ring contraction of 3-amino-1,2,3-
benzotriazin-4(3//)-one 81; a) 1-methylnaphthalene, reflux, 88%.[l04'105]
Indazolinones can also be made by oxidative treatment of 1A-2,1,3-








Scheme 46: Synthesis of indazolinone from l//-2,l,3-benzothiadiazin-4(3//)-one 2-oxide 82; a)
H202, AcOH, 100°C, 2h, 52%.[106]
The final example of the use of a ring contraction reaction to access
indazolinones involves an alkali-induced Lossen rearrangement of l-methyl-3-
[(phenylsulfonyl)oxy]-2,4(1//, 3Z/)-quinazolinedione 83. The intermediate 84 generated
by action of the base undergoes a ring closure to give 1-methyl-l//-indazol-3-ol 85 in a
good yield of 78%. Only the synthesis of unsubstituted indazolinones is useful for our
project, this approach will therefore not be considered further.






Scheme 47: Synthesis of 1-methyl-l//-indazol-3-ol 85 from l-methyl-3-[(phenylsulfonyl)oxy]-
2,4(1 H, 3/f)-quinazolinedione 83; a) NaOMe, DMF, reflux, b) H20, 78%.[I07]
1.4.2.7.2. From benzotriazepinones
The indazolinone structure can be accessed via a ring contraction reaction
starting from benzotriazepinone of type 86. The acidic conditions give indazolinones in
a rather low yield.
Scheme 48: Synthesis of indazolol 35 from benzotriazepinone 86; a) HC1, EtOH, H20, reflux,
2h, 20%.11081
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The sequence of ring contraction from benzotriazepinone is interesting as it
leads to unsubstituted indazolinone. Due to the low yielding reaction, this approach
would be considered as potentially valuable if the previous prioritised routes failed.
1.4.2.8. By ringmodification
l//-indole-2,3-diones (isatins) 87 react in alkaline media undergoing a ring
opening reaction to give (2-aminophenyl)(oxo)acetic acids, which cyclise on
diazotation, followed by reduction with sodium hydrogen sulfite, to give indazolinones
of type 54. The yield of 26% shows that this route is inefficient (R=Ph). The other
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Scheme 49: Conversion of isatin 87 to indazolinone 54; a) i) NaOH, ii) NaNCb, H2SO4, iii)
NaHSCh or SnCh/HCl (R= Ph).[83]
Interestingly, when R in 87 is a hydrogen, the product of the reaction sequence is
88 (l//-indazole-3-carboxylic acid).
Scheme 50: By-product isolated during the synthesis of 88.
1.4.3.Reported routes to functionalise indazolinones
As the central goal of this project is to create a library design for use on solid
phase based on the indazolinone core structure, it is also necessary to develop a
synthetic sequence that involves selective and very high yielding reactions using the
indazolinone heteroatoms. This section will focus on the reported routes to insert
substituents at the different positions of the indazolinone core. Reactions leading to
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mixtures of compounds are not considered useful in the context of solid supported
synthesis.
1.4.3.1. Selective functionalisation at the N1 position
1.4.3.1.1. From unsubstituted indazolinone
Malamas et al. [109] reported two sequences for the synthesis of Nl, N2-
substituted indazolinones (Scheme 51). The authors proposed that using different
electrophones they could influence the selectivity for the N1 over the N2 position and
vice-versa. However, the selectivity was poor in both cases and AT-functionalised
products 89 and 92 were isolated in only ca. 30% from 91. Such low yields can be
explained by two factors: incomplete reaction or the formation of undesired product
(positional isomers). The authors do not comment in sufficient detail however, the
second case seems very feasible in the case of indazolinones as the N2 and O positions
can also react with the electrophile.
Scheme 51: Reaction on the nitrogens using two kinds of base; a) K2C03, DMF, 4-bromo-2-
fluorobenzylbromide, 31% b) NaH, DMF, methylbromoacetate, 90% c) K2C03, DMF,
methylbromoacetate, 31% d) NaH, DMF, 4-bromo-2-fluorobenzylbromide, 89%.[1101
Incomplete reaction is a problem that can be solved by the use of large excesses
of reagents to push the reaction to completion in solid supported synthesis. However,
the problem of generating isomers is more complex.
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One approach to solving the isomer issue is to protect the indazolinone using
carbamate groups. Bruneau et al. [78] described the synthesis of 95 in 78% yield by
reacting unsubstitued indazolinone 94 with ethyl chloroformate in the presence of
pyridine at reflux (Scheme 52). 95 was subsequently converted to 96 and 97. The
selectivity of these reactions is discussed in section 1.4.3.1.2.
Scheme 52: Substitution on nitrogen with other reagents; a) EtOCOCl, pyridine, reflux, 78%, b)
NaH, DMF, Mel, 70%, c) 3-pyridylcarbinol, PPh3, DEAD, 20%. [78]
An analogous approach was used by Patel et al. in their synthesis of the
indazolinone core of the unsymmetrical cyclic urea SE063J1031 They selectively
protected the N1 position in 79% yield using a Boc group. This was achieved in a two
step protocol involving an excess of Boc anhydride to over-protect the indazolinone
giving a mixture of the N1,N2 and N1,0 di-protected isomers. The mixture of isomers
was then reacted in presence of methanol and ammonia to deprotect the O and N2
positions giving the Nl-Boc protected indazolinone. This selective protection can be
incorporated in our sequence as it leaves the N2 and O position available for further
substitution.
Gordon et al. reported that unsubstituted indazolinone (17) was selectively
functionalised at the N1 position in 99% yield (Scheme 53) using sodium hydroxide,
benzyl chloride and ethanol.[Ill]
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Scheme 53: Quantitative alkylation at the N1 position of 17; a) BnCl, EtOH, NaOH, 99%.[1U]
This synthesis has been carried out with furopyrazole derivatives in Pfizer
Central Research in Kent, UK, for the synthesis of YC-1 (99) (Scheme 54).[1U]
Scheme 54: Structure of YC-1 (99).
This route is also of interest for our planned strategy. However, whilst it is
clearly useful in solution, it is less useful for solid phase chemistry as the resin needs to
swell properly to allow the reagent to go in the deepest cavities. From a practical point
of view, polystyrene beads do not swell in ethanol. Moreover, from a chemistry
perspective, the selective reaction might be possible with benzyl chloride derivatives
only, reducing the possibility of diversity incorporation.
1.4.3.1.2. From substituted indazolinone
To our knowledge, O- and ^-substituted indazolinones react selectively at the





Scheme 55: N1-substitution of O- and 7V2-substituted indazolinones.'831
Accessing selectively 0-substituted indazolinone (when the substituent R is
allyl) therefore enables us to direct diversity incorporation at the N1 position.
Subsequently, rearrangement of the allyl moiety from the O to the N position would
then be possible. Inserting an allyl substituent at the O position is therefore a crucial
detail in the plan.
1.4.3.2. Selective functionalisation at the N2 or O position
Inserting substituents at the O or N2 position of N1 -substituted indazolinones
has been reported. Selective reactions at the N2 position can be achieved (ca. 90%) [109]
but this is not our main interest. We need to selectively functionalise the O position with
an allyl group.
In Scheme 52, however, the 20% reaction yield at the N2 position suggests that
the reaction is incomplete or the rest of the material is the O-alkylated isomer. In this
case, the Mitsunobu reaction seems to be a method to insert substituents at the O
position.
Steric effects could also direct the selectivity 0/N2 substitution. The difference
between a bulky group and a small group has been studied with the Nl-
methylindazolinone and the A7-benzylindazolinone under alkylation (Scheme 56).
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Scheme 56: Difference between the bulkiness of groups in the TV-alkylation step; a) BnCl, Et3N,
67% N-isomer 101, b) CH2N2, 21% TV-methyl 102, 64% O-methyl isomer 103.[78]
Bruneau et al. report obtaining only 101 in the reaction between 100 and benzyl
chloride in presence of triethylamine.[78] However, the yield is only 67%, 33% of the
material based on the starting material is missing. It is possible that a mixture of O and
N2 benzylated products was obtained or the reaction did not go to completion.
By reacting 98 with diazomethane, a mixture of 102 and 103 was obtained; the
majority of the product was the O-methylated product 103.
1.4.4.Summary
Reviewing the different possibities to synthesise the indazolinone core structure
was the first essential step in this project. It allowed us to choose a synthetic way that
leads to an unsubstituted indazolinone which was subjected to diversity incorporation.
This route must allow us to insert a linker unit that was used for the loading of the small
molecule onto the resin.
Different possibilities for inserting the linker on the indazolinone core structure
were presented; only two of them were selected. One has been optimised in our studies
and led us to an indazolinone that we loaded successfully onto the resin.
From the perspective of diversity incorporation, the literature provided some
interesting guidelines but in general indicated that selective reactions on the
indazolinone system are not yet available.
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2. Results and Discussion
2.1. Project Overview
The central goal of this thesis was to develop an efficient library design that had
as its key step a rearrangement reaction that allows additional diversity incorporation.
Subsequently, the chemical route needed to be validated on a solid support, enabling the
potential synthesis of hundreds of analogues.
In order to address the goals of the project, three main issues had to be dealt with
separately. Investigating the rearrangement of an allyl moiety from the oxygen to the
nitrogen atom of the indazolinone core was the first priority (Scheme 78, page 82). This
was an unprecedented rearrangement for indazolinones prior to our work. Additional
questions included whether this sigmatropic rearrangement could be used on solid
support and whether the chemical method used for the rearrangement allowed for the
use of a suitably large diversity ofbuilding blocks.
The second objective of the project was to access a molecule containing the
indazolinone core that was both compatible with incorporation of building blocks and
contained a linker for attachment to a solid support. This linker must not interfere with
the key functionality in the indazolinone core. Section 1.4 reviews the literature
surrounding the synthesis of indazolinones. It was clear from this review that structures
of this type are not easy to manipulate due to the comparable nucleophilicity of the 3
heteroatoms.
The final goal was to prove that the chemistry carried out in solution phase could
be transferred to the solid phase. This involved the comparison of authentic compounds
prepared in solution with material cleaved from the solid support. This is best achieved
by using the technique of liquid chromatography coupled with mass spectrometry
(LC/MS). Arguably, this is the only method of analysis as the fact that tens of
milligrams of resin carrying only nanomolar quantities of compound makes it difficult
to use other spectroscopic methods. Importantly, this technique can be easily automated
for the analysis of large compound libraries.
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2.2. The Aza-Claisen Rearrangement
2.2.1. Introduction
The following section is organised into four main sections. In the first, the
synthesis of the required compounds containing an allyl functionality is described using
procedures from the literature and exploring new methods of accessing the required
compounds in improved yields. The second section explores different methods of
rearranging the allyl group from the O position to the N2 position in the indazolinone
system. Palladium-catalysed mechanisms and microwave-assisted approaches were
studied for this rearrangement reaction. In the third section, the chemical technology
was transferred to the solid phase to prove that the rearrangement reaction was
applicable to library generation. Finally, mechanistic questions associated with the
aza-Claisen rearrangement were addressed.
It is important to note that a significant effort was required to assign the
structures of many of the indazolinones prepared during this project. This is not a new
problem. Indeed, in 1960, O' Sullivan reported a detailed study using infrared methods
to assign indazolinone structure.'841 In 1982, Professor Sir Derek Barton characterised
indazolinones by both 'H NMR analysis and by chemical methods. He reduced the
indazolinones in the presence of zinc and hydrochloric acid to the corresponding ortho-
amino carboxylic acid and compared the melting points of these compound with
literature values.'1011 This technique was also used by Ruiz et al. ,'1121 X-ray and NMR
(including 15N NMR) studies were performed by Ballesteros et al. on indazolinone
derivatives.'851 In 1993, Aran et al. introduced 13C NMR to characterise the resulting
products.'1131 In 1995, Aran et al. used 13C NMR and conformational analysis (AMI
semi-empirical method) to probe the structure of indazolinones in more detail.'114'
Bruneau et al. subsequently published a paper entitled "The tautomerism of
indazolinones in aqueous solution. A note on the principle of vinylogy" in which they
report a study of unsubstituted, monosubstituted and disubstituted indazolinones and
their preferred tautomeric forms.'1151
In this programme, we will use extensively 2D NMR techniques including
COSY ('H-'H correlation experiments), HSQC and HMBC ('H-^C correlation
experiments) to confirm the proposed structures. X-ray crystallographic analysis also
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proved a useful tool to compare related structures (e.g. compounds 104 and 23, Scheme
66).
2.2.2. Synthesis of 3-allyloxyindazole 104
2.2.2.1. Synthesis of 104 from indazolinone 17
(104)
Scheme 57: Structure of 3-allyloxyindazole 104.
In order to prepare 104, the use of a Mitsunobu reaction described in the
literature'1161 appeared to be an appropriate route as it was reported to give the ()-
alkylated species in 30% yield. Different alcohols were used in the literature. Our target
required the use of allyl alcohol as the Mitsunobu partner combined with commercially
available indazolinone (17) in the presence of diethylazodicarboxylate (DEAD) and
triphenylphosphine in toluene. The *H NMR analysis of the crude Mitsunobu reaction
revealed a complex mixture, with at least three different compounds containing allyl
groups. These corresponded to the three mono-substituted indazolinones, 104 isolated in
38% and 23 and 105, which were difficult to isolate in pure form from the reaction
mixture (Scheme 58). Two other di-substituted products were also present in the crude
reaction mixture, 106 and 107, but were not isolated. Evidence to support the presence
of 106 and 107 came from comparison of the 'll NMR spectra of authentic materials
prepared in solution (Section 2.2.7.2.4) and the crude reaction mixture.
Scheme 58: Products of allylation obtained by Mitsunobu reaction of 17 with allyl alcohol in the
presence of DEAD and triphenylphosphine in toluene.
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A third possibility for a di-substituted product is 108 (Scheme 59). Indeed,
structures of type 23 are known to exist in two tautomeric forms.[85] Because of these
two tautomeric forms, reagents can be inserted on either position, depending on the
nature of the electrophile (see section 1.4.3). However, the formation of 108 in this
reaction did not occur. This became evident when the 'H NMR spectrum of the crude
reaction mixture was compared with an authentic sample of 107 prepared whilst
studying the alkylation of the AT-substituted indazolinone 23 (Section 2.2.7).
Scheme 59: Tautomeric forms of N2-allyl indazolinones and possible products from allylation
of 23.
2.2.2.2. An improved synthesis of 104:
Due to isolation problems associated with this approach, it was decided to
identify an improved method of preparing 104. Ballesteros et al. showed that AT-methyl
indazolinone exists in 2 tautomeric forms.[85] Whilst it is less applicable when a methyl
group is present at the N1 position, the idea of protecting one position to reduce the
possibilities of tautomerism is of importance. Indeed, thirty years after Ballesteros, Patel
et al. [103] described the synthesis of an A7-Boc protected indazolinone derivative by
treating the indazolinone with an excess of Boc anhydride and using ammonia and
methanol to selectively deprotect one of the two Boc groups. The reported overall yield
for this transformation was 61%.
Based on these two literature precedents, it was decided to react an excess of
benzyl chloroformate with indazolinone (17) to protect fully the heterocyclic core,
yielding 109 and 110 (Scheme 60). These two compounds were not isolated but treated
with one equivalent of a nucleophilic amine, for example morpholine. This resulted in
the selective deprotection of the Z group present in the O and N2 positions, leaving 111
in which the N1 position is protected. The overall yield of the reaction was similar to
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Scheme 60: Selective protection via selective deprotection for the synthesis of iV7-protected
indazolinone 111; a) Et3N, BnOCOCl, THF, rt, o/n, b) morpholine, THF, rt, 2 h, 70%.
N1 -protected indazolinone 111 was then submitted to the Mitsunobu-mediated
allylation step. Literature precedent in an analogous system indicated that it would be
necessary to warm the solution overnight at 80°C.''161 When this was attempted using
111, it resulted in a complicated TLC containing multiple spots. However, the reaction
improved when it was run at room temperature. After optimisation, the Mitsunobu
reaction to couple the indazolinone 111 with allyl alcohol proved to be an efficient
process with the yield of the reaction being essentially quantitative. 'H NMR studies of
the crude reaction showed the presence of the two isomers 112 and 113 (Scheme 61) in
a ratio O/N isomer of 0.74:1 (112:113). Isolation followed by characterisation of both
compounds revealed a ratio O/N isomer of 0.62:1 (112:113).






















Figure 15: A section (6.5 to 4.5 ppm) of the 'H NMR spectra obtained on the Mitsunobu
reaction of 111 to give 112 and 113, 1H NMR spectrum of a) crude reaction, b) 112, and c) 113.
Figure 15 represents an expansion between 6.5 and 4.5 ppm of the *H NMR
spectra associated with this Mitsunobu reaction. Spectrum (a) is of the crude reaction
mixture, spectra (b) and (c) correspond to purified 112 and 113 respectively. Full
spectroscopic analysis using isolated material (112 and 113) allowed the assignment of
all the signals. Special focus on the allyl moiety showed the difference between the
signals for each isomer. As a general comment, the 1H NMR signals for the allyl moiety
are shifted to higher field when the allyl group is on the N2 nitrogen (Xo>/(n) as
expected. The terminal alkenc protons in 112 appear at two different p.p.m positions as
a doublet of doublets whereas in the N2 isomer 113 both protons come on top of each
other as an apparent multiplet.
The two isomers were easily separated using flash chromatography.
Rfin 0.37 in 10% ethyl acetate/hexane
Rfm 0.1 in 10% ethyl acetate/hexane
2.2.2.3. Unsuccessful approaches to 112 and 113
During the course of this study, other procedures to prepare 112 were attempted.
Indeed, deprotonation of 111 with sodium hydride and allylation with allyl bromide was
attempted, but the carbamate protecting group did not survive the reaction conditions.
This procedure was used by another group to benzylate the N2 position of 114 (88%
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yield reported).1'091 The N1 substituent in 114 was stable to the reaction conditions used
(Scheme 62). The reaction involving the treatment of 111 with sodium hydride as base
and allyl bromide as the electrophile yielded a diallylated compound, which has been
characterised as 107 (Scheme 58).
Scheme 62: Substrate used in the sodium hydride/benzyl bromide reaction.'10"'
A procedure involving allyl bromide in refluxing chloroform was also ruled out
because the transformation did not go to completion. In addition, the ratio between
OIN2-allylated compounds 112 and 113 was comparable to that observed under the
Mitsunobu conditions.
2.2.2.4. Mitsunobu reaction mechanism l117-120l
H Nu Et02CN ,C02Et
,C02Et ( (^N-NH ©
,N-N ► Et02C 0 C02Et ► Ph3P©
B02C i VN-N'
PPh 3 Ph3F© VHP R




EtQ2C h R Nu + 0=PPh3
Scheme 63: Mechanism of Mitsunobu reaction using triphenyl phosphine and DEAD with a
primary alcohol and a NuH as the nucleophile.
New reagents used in the Mitsunobu reagent are available including the use of
ADDP (115), TMAD (116) or TIPA (117) coupled with PBu3. [119'120] An attempt was
made to use ADDP (116) with PBu3 in an attempt to improve the observed ratio of
112:113. The yield of the compound of interest 112 was not increased using this system.
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Scheme 64: Structure of ADDP 115, TMAD 116 and TIPA 117.[1201
As the pKa of indazolinones such as 111 is in the appropriate range for the use of
DEAD, it was decided that there was no reason to use these new reagents. We therefore
carried out the synthesis with the conventional reagents, i.e. diethylazodicarboxylate
(DEAD) and triphenylphosphine.
2.2.2.5. Deprotection of 112 and 113
Scheme 65: Synthesis of 104 and 23 by lithium hydroxide; a) LiOH aq. in THF, rt, 2 days,
quant.
Both isomers 112 and 113 were deprotected using aqueous lithium hydroxide
solution in THF.[14] The solvent used for this reaction was a mixture of THF/water, 10/1
with vigorous stirring as the reaction was biphasic. The reaction went to completion in
48 hours although the time was found to be dependent on the substrate:
112 to 104: 72 hours
113 to 23: 48 hours
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2.2.2.6. Structural assignments using X-ray crystallography
The assignment of the structures 104 and 23 was facilitated by X-ray techniques.
The products 104 and 23 obtained after chromatography were both recrystallised from
dichloromethane (m.p. 81-82°C for 104, m.p. 113-114°C for 23). The crystal structures
are presented below and crystallographic data is shown in appendices A and B.
Scheme 66: Crystal structures of N2-ally 1 indazolinone 23 and 3-allyloxyindazole 104.
A detailed study of the bond lengths in the crystals shown above allows the
comparison of the C-0 bond in the two different isomers:
C-0 bond length in N2-allyl indazolinone 23: 1.2514 (19)A
C-O bond length in 3-allyloxyindazole 104: 1.355 (5)A
C-0 bond length in indazolinone 17 [85]: 1.264 (2)A
The value of the C-0 bond in the A^-allyl indazolinone 23 shows that, in the
solid state, the preferred tautomeric form is the keto form rather than the enol form
(Scheme 67).
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Scheme 67: Extreme tautomeric forms based on the C-0 bond length.
2.2.3.N2-substitution of 104
As presented previously (section 2.2.2.2), an alternative method to access 3-
allyloxyindazole 104 in reasonable overall yield from indazolinone 17 has been
developed. Relatively few examples of A7,0-protected indazolinones have been
reported in the literature but examples exist where the R group in 20 is acyl, alkyl,
benzyl, phenyl or a sulfonyl group.1-109'1U' 121"123] Only one example of a urea moiety on
the N1 position has been reported.11161 Diversity incorporation at the N1 position of the
indazolinone core was a factor we wanted to investigate. A general route from 112,
through 104, leading to new indazolinones of general type 20 is presented below
(Scheme 68).









Scheme 68: Sequence of deprotection and substitution at the N1 position; a) LiOH, H20/THF.
These reactions include epoxide opening as a method of bringing new diversity



















( 118) ( 119) ( 120) ( 121) (106) ( 122)
99% 40% 89% 99% 89% 65%
Table 4: R groups introduced on the Nl position in the 3-allyloxyindazole system.
As presented in Table 4, the yields of the reaction designed to insert diversity at
the Nl position are good (122) to excellent (106, 118, 120, 121). The range of
commercially available reagents that can be introduced at the N1 position is very broad.
2.2.4.Rearrangement in solution phase
Whilst the terminal alkcne of the allyl moiety in 20 could be useful as a means
of incorporating diversity, the diversity within this library design would then come
exclusively from the use of different building blocks, as in section 2.2.3. The presence
of an allyl group in 20 allows for a second type of diversity to be incorporated using a
core switching reaction (section 1.3.1). The potential of the allyl moiety in the designed
system can be seen by comparison with the related imidate structure (Scheme 69) in
which the aza-Claisen rearrangement reaction can be used to convert the 0-allyl system
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Scheme 69: Similarity between the aza-Claisen rearrangement of imidate 123 to amide 124 and
3-allyloxyindazole 20 to indazolinone 21.
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2.2.4.1. Applications of Aza-Claisen rearrangement in organic
synthesis
The Claisen rearrangement was discovered almost 100 years ago and has been
studied and used extensively in organic chemistry. In a comprehensive review of the
Claisen rearrangement, A.M.M. Castro summarised the Claisen type rearrangement
over the past nine decades [82]. In this brief review, the focus will be on selected
applications of the aza-Claisen rearrangement. The aza-Claisen rearrangement is
described as a sigmatropic rearrangement when X=0 and Y=N (Scheme 70). The aza-
Claisen rearrangement, in contrast to the other sigmatropic rearrangement, is
characterized by non-reversibility due to the exothermic transformation from the
imidate to the amide, measured at ca. 14 kcal mol"1!1241 This unique transformation is
involved in many different strategies in organic synthesis. Some examples are presented
below.
Scheme 70: General Claisen rearrangement by metal catalysis.[125]
2.2.4.1.1. Making 1,2-diamines by diastereoselective synthesis
In 1993, Bellus et al. published an article proving that the aza-Claisen
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Scheme 71: Preparation of 131 from a chiral source 125 to prepare 1,2-diamines; a) (Boc)20,
DCM, Et3N, b) DIBAL-H, THF, c) (COCl)2, DMSO, DCM, Et3N, d) Ph3P=CHC02Me, DCM,
e) DIBAL-H, DCM, BF3.OEt2, f) CC13CN, NaH, Et20.
Starting from a-amino acids of general structure 125 as a chiral source, it is
possible to access 1,2-diamine 134 in a high stereoselective way. According to Scheme
71, the amino acid 125 is transformed to the corresponding ally lie alcohol 130 by chain
elongation developed by T. Moriwake et al. ,[127] The terminal alcohol was transformed
to the corresponding trichloroacetimidate 131. The trichloroacetamide 131 was then
rearranged immediately due to its relative instability (Scheme 72).
Scheme 72: Rearrangement of 131 for synthesis of diamines 132 and 133.[1261
Thermal conditions for the rearrangement using xylene (140°C) gave good yields
but low diastereoselectivity and the deprotection of the protecting group (Boc) was also
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observed. However, metal-catalysed rearrangement using PdCl2(MeCN)2, a source of
Pd(II), induced the formation of 132 in a high diastereomeric excess (de > 99:1).
Figure 16: Proposed transition state for the sigmatropic rearrangement of 131.[126]
This high diastereoselectivity is explained by the fact that the two faces of the
chiral olefin are diastereotopic. The coordination of the palladium is guided in by the










Scheme 73: Deprotection and oxidation of 132 (when R=H) to give 134; a) i) Cat. RuClg.FhO,
NaI04, CC14/CH3CN/H20, rt, 2h, 81%, ii) NaBFL), MeOH, rt, lh, 3 M aq. HC1, 100°C, 15 min,
iii) propene oxide, EtOH, 62%.
Oxidation of the terminal alkene followed by deprotection of the Boc group and
the trichloroacetamide yielded 134, (2S,3S)-diaminobutanoic acid (Scheme 73), which
occurs in amphomycin antibiotics.'128"13^
2.2.4.1.2. Making chiral amines from imidates
The aza-Claisen rearrangement is also used in the stereoselective synthesis of
chiral amines from prochiral allylic alcohols. As described by L.E. Overman, the
transformation of structures of type A to type B was achieved in good yields (58-99%)
with an excellent enantioselectivity (73-97%) depending on the catalyst.
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Type A Type B
R1=Ph R1=Ph
R2=CF3 R2=CF3
Scheme 74: Rearrangement of prochiral allylic imidates.'1321
This rearrangement was then followed by two deprotection steps: treatment with
sodium ethoxide to hydrolyse the amide moiety and the use of eerie ammonium nitrate
(CAN) to deprotect the 4-methoxyphenyl protecting group.
Scheme 75: Deprotection of allylic amides; a) NaOEt, EtOH, 54°C, 12 h, b) i) CAN, 0°C, 3 h, ii)
maleic acid.[132]
The combination of catalyst, suitable protecting groups and well designed
substrates allowed the synthesis of enantiomerically pure allyl amines.
2.2.4.2. Thermal rearrangement of 3-allyloxyindazoles
2.2.4.2.1. The use of standard thermal methods:
The rearrangement of 112 was attempted under thermal conditions under
atmospheric pressure. Different solvents were used including rr-hexane, toluene and
THF. No rearrangement was observed due to the limited temperature that is accessible
using these solvents.
Scheme 76: Attempt of rearrangement of 112 to 113 under thermal conditions.
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High boiling-point solvents including decaline (b.p. = 189-191°C) were also
used. A small amount of the rearranged product 113 could be detected by *H NMR
analysis of the crude reaction mixture. However, the difficulty in removing the solvent
was a further barrier to the use of this approach. In summary, the use of thermal
conditions was not applicable to the conversion of the 3-allyloxyindazoles 112 to the N-
substituted indazolinones 113.
r-n r r 13312.2.4.2.2. The use ofmicrowave techniques
Microwaves have wavelengths of between 1mm and lm, corresponding to
frequencies between 0.3 and 300 GHz. Heating foods with microwaves was introduced
over 50 years ago. In the late 1970s, the use of microwaves in inorganic chemistry was
reported and about 10 years later, this technique became standard in organic chemistry.
The difference between normal heating and microwave heating is that, in the first
technique (oil bath, sand baths, heating jackets), the heating is slow and temperature
gradients can develop within the sample. Local overheating can also lead to product,
solvent, substrate, and/or catalyst decomposition. In the microwave approach, the
energy is directly transferred to the reaction component without heating the reaction
vessel.
(i) The theory:
All magnetic irradiations can be divided into two components:
- an electric field and
- a magnetic field.
When microwaves are applied to a system, both fields (electric and magnetic)
interact with the solvent. The magnetic field does not have any effect on the solvent.
However, the electric field produces two kinds of interaction:
-the dipolar polarization mechanism
-the conduction mechanism
The dipolar polarization mechanism is described as the sensitivity of a dipole
to external electric fields. This dipole will attempt to align itself with the field by
rotation, as shown in Figure 17. The energy contained in the applied field is transformed
into rotational energy. For low frequency irradiation, the molecules of a liquid will
rotate in phase generating only a small heating effect. However, when high frequencies
are applied, the dipole is unable to respond and rotate in phase, consequently, heat is not
produced. This is why microwave frequencies are useful, because the effect is in
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between these two extremes. Indeed, the frequency is low enough to allow the dipole to
rotate and not high enough for the rotation to be out of phase. This is the origin of
constant rotation of the dipole, inducing molecular collisions that give rise to dielectric
heating.
The conduction mechanism is due to the interaction of the electric field and
another factor: charged particles. Indeed, charged particles are sensitive to electric field.
In solution, a charged particle will move through the solution under the influence of the
electric field. Because of the viscosity of the liquid, the kinetic energy of the particles
will be lost by heat generation due to the collision effect as shown in Figure 18.
A A / tV V I
Figure 18: Charged particles in a solution will follow the applied electric field.
(ii) The equipment:
The machine used in our laboratory was the CEM Discover. The system was
equipped with a temperature detector and a pressure device to report on certain
parameters from the reaction. The circular cavity directs the microwave energy into a
defined area, resulting in a homogenous field pattern surrounding the sample.
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Figure 19: CEM Discover microwave and homogenous irradiation around the sample.'134'
(iii) Results
Due to the unsatisfactory results obtained using standard thermal heating
techniques, microwave-based approaches were used to attempt the rearrangement of the
3-allyloxyindazole 112 to the corresponding TV-allyl indazolinonc 113.
Scheme 77: Attempt to rearrange Nl-Z 3-allyloxyindazole 113 using microwave techniques.
112 was irradiated under microwave conditions in dry DMF. The reaction was
successful, however, the yield of the isolated product 113 was very low (10%).
Moreover, the TLC of the crude reaction revealed the presence of multiple other
products. Careful study of the 'H NMR spectrum of the crude reaction mixture revealed
the presence of the deprotcctcd compounds 104 and 23.
This experiment suggests that the Z group is not stable under the reaction
conditions used in the microwave.
The experiment described above was run under microwave conditions at 200°C,
for 5 min in DMF as solvent. Several parameters of this initial experiment were
changed in an attempt to optimise this reaction (Table 5).
80
A standard run time of 5 minutes was used and the substrate 112 was irradiated
in different solvents at different temperatures. As Table 5 indicates, the only experiment
where 112 was transformed was using DMF at 200°C (pressure of 60 psi).
50°C 100°C 150°C 200°C
DCM X X x (120 psi) N/A
THF X X X x (110 psi)
Decalin X X * * (30 psi)
Toluene X X X * (45 psi)
DMF X X X ■S (60 psi)
Table 5: Attempts to rearrange 112 in different solvents at different temperatures. :change, *:
no change by TLC)
Unfortunately, the results were not satisfactory. None of the conditions
attempted gave the desired rearrangement product 113 in good yield.
The rearrangement can occur under microwave conditions but the AT-substituent
needs to be less labile (see section 2.2.6.2). Meanwhile, catalysts were applied in an
attempt to carry out the rearrangement of the allyl moiety under milder conditions.
2.2.4.3. Rearrangement of 112 using Palladium catalysts:
Canadian researchers reported studies on transition metal-catalysed aza-Claisen
rearrangements of allyl imidate substrates.[135] Rhodium(I), iridium(I) and palladium
were the different transition metals used. Palladium at either the (0) or (II) oxidation
level was the transition metal studied most extensively in order to understand
mechanistic and stereoselectivity issues (for a further discussion of mechanistic issues,
see Section 2.2.6). We therefore decided to investigate if the desired rearrangement
would occur under palladium catalysis.
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2.2.4.3.1. The rearrangement on Nl-Z protected indazolinone:
Scheme 78: Rearrangement of 112 using tetrakis(triphenylphosphine)palladium(0); Pd(PPh3)4
(10% mol.), rt, 16 h, quant.
112 was therefore reacted in the presence of a palladium (0) catalyst in THF at
room temperature under an inert atmosphere. After 16 hours, the reaction was stopped
purified and the products of the reaction analysed. 'H NMR analysis of the crude
reaction mixture showed that traces of the starting material 112 were present but the
major product was 113. A sample of 113 prepared as described in section 2.2.2.2 aided
product assignment. To visualise in detail the differences and similarities of 112 and
113, the region of the 'H NMR spectra containing the alkene protons (6.50-4.50 ppm)
has been expanded (Figure 20).
Figure 20: Comparison by 'H NMR (6.50 to 4.50 ppm) of the a) Nl-Z 3-allyloxyindazole 112,
b) Nl-Z AC?-allyl indazolinone 113 and c) product of the reaction of 112 under palladium (0)
catalysis.
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The first two spectra are from analysis of 112 and 113 prepared via the
Mitsunobu reaction. It is clear from the signals that each set of protons from the allyl
moiety appears in a specific window. The bottom spectrum in Figure 20 represents the
purified product of the reaction of 112 under Pd(0) catalysis. The fact that the signals
corresponding to 113 and this product overlap provides good evidence that 113 and the
rearranged product are the same. The Pd (0) rearrangement is therefore an efficient way
of converting Nl-Z 3-allyloxyindazole 112 to 113.
2.2.4.3.2. The rearrangement on AT-substituted indazolinone
Applying the aza-Claisen rearrangement on structure of type 20 would allow us
to generate structures of type 21 in a single step. In terms of library generation, skeletal
diversity would therefore be generated.
Scheme 79: Rearrangement of N1-substituted 3-allyloxyindazoles of type 20 to AT-substituted
N2-&\\y\ indazolinones of type 21.
The results from the rearrangement carried out with the N1-substituted 3-







(118) (121) (119) w
(120)






Table 6: Rearrangement of 118, 119, 120, 121 under palladium (0) catalysis.
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The rearrangement of 118 and 121 yielded the corresponding N2-a\\y\
indazolinone of type 21 in excellent yields. Tetrakis(triphenylphosphine)palladium(0)
induced the rearrangement of the allyl group of 118 to give 135 in 90% yield and 121 to
136 in 91%.
Scheme 80: Synthesis of 135 by rearrangement of 118 under palladium (0) catalysis; a)
Pd(PPh3)4, THF, 90%.
In the infrared spectrum, the band characteristic of the C=N bond at 1527 cm"1 in
118 disappeared after the reaction to give a new product with an IR band at 1661 cm"1
characteristic of a C=0 bond (expected in 135). In the 'H NMR spectrum, the doublet of
triplets corresponding to the allylic CH2 shifted from 4.83 ppm in 118 to 4.52 ppm in
135 as expected due to the difference in electronegativity between the oxygen and the
nitrogen atoms.
Scheme 81: Synthesis of 136 by rearrangement of 121 under palladium (0) catalysis; a)
Pd(PPh3)4, THF, 91%.
The positive outcome of the rearrangement of 121 by
tetrakis(triphenylphosphine)palladium(0) was confirmed by infrared as the band at 1543
cm"1 in 121 characteristic of the imidate functionality disappeared and a new band at
1704 cm"1 characteristic of an amide functionality appeared in the product 136. In the
13C NMR spectrum, the signal of the carbon of the allylic CH2 shifted from 70.2 ppm in
121 to 49.9 ppm in 136, a chemical shift which is consistent with the structural
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assignment of 136 due to the greater electronegativity of the oxygen compared to
nitrogen.
However, the rearrangement of 119 and 120 gave mainly an undesired product
and the desired product only in low yield or not at all. The main product from both of
these reactions was identical as judged by TLC. Further investigation and comparison
with material already characterised proved that the main product isolated from the
rearrangement of 119 and 120 was 107.
Scheme 82: Rearrangement of 119 by tetrakis(triphenylphosphine)palladium(0); a) Pd(PPh3)4.
The rearrangement of 119 under tetrakis(triphenylphosphine)palladium(0)
catalysis also yielded 137 as a minor product of the reaction. The 13C NMR spectrum
confirmed the rearrangement to 137 due to the chemical shift change in the allylic CH2
carbon from 70.2 ppm in 119 to 47.8 ppm in 137, (%o>%n)-
Scheme 83: Rearrangement of 120 by tetrakis(triphenylphosphine)palladium(0); a) Pd(PPh3)4.
The rearrangement of 120 did not yield the desired product (138) but only gave
107 as judged by 'll NMR of the crude reaction mixture.
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Figure 21: Expansion of jH NMR spectrum (6.00 to 4.00 ppm) of AT,./V2-diallyl indazolinone
107.
The 'H NMR spectrum of 107 showed that signals corresponding to the presence
of 6 proton environments in the 4.00-6.00 ppm range.
Figure 22: Expansion of COSY spectrum (6.00 to 4.00 ppm) of AT,7V2-diallyl indazolinone 107,
and identification of two allyl groups.
The COSY spectrum for 107 allows us to determine which protons couple with
each other. Analysis of this spectrum leads to the conclusion that two allyl groups are
present in 107.
A structural clement that has not been elucidated at this point is the position of
the two allyl groups. It was assumed that both the allyl groups were on the nitrogens
(position of the two X-CFC signals between 4.00 and 4.50 ppm). However further
evidence in support of this was required. The chosen method for doing this was another
2D NMR experiment which measures the connectivity between the carbon skeleton and
the protons. Two types ofmeasurement are possible: a short distance coupling, where a
proton couples to the carbon that it is directly bonded to (HSQC); a long distance
coupling where a proton couples to carbons in the p, y or 5 position (HMBC).
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Figure 23: HSQC spectrum (x scale: 8-4.2 ppm, y scale: 150-30 ppm) of 107.
From the HSQC spectrum (Figure 23), 10 carbons could be assigned as
expected.
Figure 24: HMBC spectrum (x scale: 8-4.2 ppm, y scale: 170-30 ppm) of 107.
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Analysing the HMBC spectrum led to the conclusion that the compound was the
A7,iV2-diallyl substituted indazolinonc 107. The red rectangle would have been
expected to contain two cross-peaks in the case of an alternative isomer AC-allyl 3-
allyloxyindazole 108 (two CH2 coupling with the C from C=0, two signals). Figure 25
provides a more detailed view of this argument. In the case of 106 and 107, only one set
of X-CH2 protons is coupled to the carbon atom of the carbonyl group. This interaction
will be visible in the HSQC spectrum as a single cross peak (case 1, Figure 25).
However, N2-ally 1 3-allyloxyindazole of type 108 would show two sets of protons X-
CH2 that couple to the carbon of the carbonyl. These couplings will be seen as two cross
peaks in the HSQC spectrum (this remark is valid only if the chemical shifts of the two
sets of protons X-CH2 are different, case 2, Figure 25).
Case 1 Case 2
(107) (106) (108)
Figure 25: Prediction ofHMBC spectra for diallylated indazolinones.
A possible explanation for the formation of 107 comes from the labile C-N bond
at the N1 position in the product of the rearrangement as the electrons of this bond can
be delocalised and stabilised by the oxygen atom. This stabilisation of the negative
charge helps the C-N bond to break and enables allylation at the N1 position (Scheme
84).
Scheme 84: Possible mechanism explaining the fonnation of 107.
This study on N1 -substituted indazolinone defines the scope of substituents that
are compatible with the palladium rearrangement (benzyl and sulfonyl groups).
Importantly, this chemistry is also compatible with an N1-carbamate group (see section
2.2.4.3.1). Acylating agents or isocyanate building blocks do not survive under
palladium catalysis both yielding the same by-product 107.
2.2.5.Rearrangement on solid phase
Using the methodology described in section 2.2.4.3, it was decided to synthesise
a substrate which could be loaded onto a resin in order to attempt the rearrangement
reaction in the solid phase. 122 contains a secondary alcohol functional group that could
be used to load 122 onto a silicon based resinl136'137^
Model studies were initially carried out using a TIPS protecting group (solution
phase) to mimic the solid phase. The reaction sequence involved the use of the
palladium (0) catalysed rearrangement reaction. Removing the TIPS protecting group in
solution phase is equivalent to cleaving the material from the resin (solid phase).
Scheme 85: Synthesis of 141 from 122; a) TIPSOTf, NEt3, THF, rt, 85%, b) Pd(PPh3)4, 60%, c)
TBAF, THF; 60%.
The protection of the secondary alcohol in 122 was achieved in 85% yield using
triisopropylsilyl trifluoromethanesulfonate in the presence of triethylamine in THF at
room temperature. Evidence in support of the formation of 139 came from mass
spectroscopy in CI+ mode (m/z increased from 233 for 122 to m/z: 389, mass increase of
156, characteristic of the insertion of the triisopropylsilyl (TIPS) group [(CH3)2CH]3Si
(157) and the abstraction of the proton of the secondary alcohol).
The rearrangement of 139 to 140 was confirmed by the change in the chemical
shift of the allylic CH2 carbon from 69.6 ppm in 139 to 45.0 ppm in 140, indicating the
rearrangement of the allyl group from the oxygen to the nitrogen position and no change
in the molecular mass (m/z: 389 in CI+) was observed as expected.
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The cleavage of the TIPS group from 140 to 141 was achieved by using a source
of fluoride, tetrabutylammonium fluoride, in THF. The loss of 156 in mass between 141
and 140 supported the fact that the TIPS group had been removed. Furthermore, the
infrared spectrum indicates a band at 3332 cm"1 characteristic of a free alcohol (OH
stretch). This reaction sequence enabled the synthesis and full characterisation of an
authentic sample of 141. Comparison of 141 prepared in this way with material cleaved
from the resin would allow validation of the solid phase chemistry. Scheme 86 shows
the reaction sequence that was carried out on the solid phase.
Scheme 86: Example of the aza-Claisen rearrangement on the solid phase, synthesis of 141 in
the solid phase; a) loading, b) Pd(PPh3)4, c) HF/pyridine then methoxytrimethylsilane (Q
silicon-based resin).
2.2.5.1. Using catalyst
After 122 was loaded onto the alkylsilyl tethered resin following the literature
procedure/136] the rearrangement was induced using
tctrakis(triphenylphosphine)palladium(0) in THF at room temperature. After 2 days
under a nitrogen atmosphere, the insoluble polymer was washed as described in the
literature j6'. The reaction time was extended to 2 days from 16 hours in solution phase
due to expected differences in reaction kinetics for solid phase versions of solution
phase reactions. Despite the black appearance of the beads (presumably residues of
palladium black), the beads were exposed to HF/pyridine in order to cleave the
product(s) from the resin. The solvent was evaporated and the non-volatile compounds
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Figure 26: Comparison of solution and solid phase rearrangement induced by transition metal
catalyst (Pd(PPh3)4) by 1H NMR (6.3 to 4.3 ppm).
The three spectra shown in Figure 26 are the 'H NMR traces of authentic 122
and 141 prepared as described in Scheme 85 and the crude product obtained from the
solid phase sequence. The similarities in the 'H NMR spectra obtained from 141 and the
crude product from the resin allowed us to conclude that both products were the same.
However, the expected product is also contaminated by the presence of an unidentified
by-product as seen in the 'H NMR spectrum of the crude reaction mixture. Attempts to
isolate by-products from this reaction were unsuccessful. The rearrangement on the
solid phase was therefore viewed as successful as the crude reaction mixture contains
predominantly 141 after cleavage from the resin.
2.2.5.2. Using thermal approaches
2.2.5.2.1. Microwave conditions
The rearrangement on the solid phase with 142 was not carried out under
microwave conditions due to time constraints. Because the system using the alcohol
connected onto the N1 position docs not allow diversity incorporation at the N1




As a result of the poor results obtained in solution (section 2.2.5.2.2), attempts to
carry out this transformation under standard thermal conditions were not pursued.
2.2.6.Mechanistic issues relating to the aza-Claisen
rearrangement
2.2.6.1. Introduction
The Claisen rearrangement is an important and useful process in organic
synthesis (see section 2.2.4). This chemical transformation leads to the creation of a C-
C bond. This sigmatropic rearrangement is also interesting mechanistically.
Detailed studies reported in the literature [138] on 144 lead to the conclusion that
the thermal rearrangement is concerted. This experiment relied on the use of a 14C label
at the terminal alkene carbon to prove the reaction mechanism 'l3S|.
Scheme 87: Claisen rearrangement under thermal conditions of 14C labelled allyl phenyl ether
144.
A second experiment was used to provide further evidence that the allyl moiety
was transferred in an intramolecular manner rather than intermolecularly. This
experiment (Scheme 88) was designed by Hurd in 1937 and proved that the allyl moiety
rearranged intramolecularly.[139] Indeed, when 147 and 148 were heated simultaneously,
the products that are formed are the same (149 and 150) as when 147 and 148 are heated
separately. No evidence for the formation of the cross-over products (151 and 152) was
obtained.
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Scheme 89: Additional products expected if an intermolecular process was taking place
(Scheme 88).
The rest of this section focuses on our studies on the mechanism of the aza-
Claisen rearrangement in the indazolinone system. As discussed previously (section
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Scheme 90: [3',3] and [l',3] sigmatropic rearrangements terminology and general understanding.
The mechanism of the rearrangement has been studied for allyl groups carrying
substituents on the terminal alkene carbon to determine which of the two different
reaction pathways shown in Scheme 90 and known as [3',3] and [l',3] rearrangement
occurs. Obviously, an allyl imidate carrying R"=H cannot provide any useful
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information regarding the mechanism as the product of the rearrangement will be the
same whatever the mechanism.
2.2.6.2. Synthesis of precursors for aza-Claisen rearrangement:
The precursors for the aza-Claisen rearrangement 158 (Scheme 91) and 160
(Scheme 92) were synthesised from 112 using the Mitsunobu procedure described in
Section 2.2.2.2. As expected from the result obtained in the Mitsunobu reaction between
112 and allyl alcohol (Scheme 61), the N2 isomers 159 and 161 were also obtained
from the Mitsunobu reaction between 112 and crotyl alcohol (Scheme 91) and cinnamyl
alcohol (Scheme 92) respectively.












Scheme 91: Synthesis of 157 and 158 by Mitsunobu reaction with crotyl alcohol; a) DEAD,
crotyl alcohol, triphenylphosphine, toluene, 44% of 157 and 54% of 158.
157 was obtained in an isolated yield of 44% and 158 in 54% yield (a ratio of














Scheme 92: Synthesis of 159 and 160 by Mitsunobu reaction with cinnamyl alcohol; a) DEAD,
cinnamyl alcohol, PPh3, PhCH3, 45% of 159 and 40% of 160.
159 and 160 were isolated in pure form in 45% and 40% yields respectively,
corresponding to a ratio of 159:160 of 1.1:1. The ratio calculated from the 'H NMR
spectrum of the crude reaction mixture indicates a ratio of 159:160 1.10:1. Scheme 93
summarises the results of this study.
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Scheme 93: Comparison of 0/N2 isomers ratios obtained in the Mitsunobu reaction with 111
and allyl, crotyl and cinnamyl alcohols measured by 'H NMR of the crude reation and isolated
yield of the products.
In summary, we observed a slight variation in the ratio of O and N2 alkylation as
a function of the elcctrophile. One possible explanation for these subtle differences may
be steric. At first glance, this appears counter-intuitive as the bulky Z group would be
expected to reduce the amount of reaction at the N2 position. However, the pcri-H may
also introduce significant steric interactions disfavouring O-alkylation hence explaining
the trend that as the alcohol increases in steric bulk the reaction is more N2 selective.
2.2.6.3. Aza-Claisen rearrangement studies
2.2.6.3.1. Transition metal catalysed aza-Claisen rearrangement
2.2.6.3.1.1. With tetrakis(triphenylphosphine)palladium(Q) as Pd (0)
source
2.2.6.3.1.1.1. Effect of tetrakis(triphenylphosphine)palladium(0) on 157
In initial studies, wc attempted to rearrange 157 using palladium (0) catalysis.
The 'H NMR spectrum of the crude reaction mixture showed several signals
corresponding to three different crotyl groups. Unreacted starting material 157 was
present, but two other sets of signals corresponding to a crotyl group could also be
identified. After purification, 'H NMR analysis of the two new products led to their
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assignment as 158 (37%) resulting from a [1 \3] rearrangement and 161 (63%) resulting
from a [3',3] rearrangement.
The structure of 161 was elucidated using ID 'H NMR and 2D experiments
(HSQC and HMBC). Evidence in support of the structure assignment of 161 is
presented in Figure 27.
8 0 7 0 6.0
... i .... i












13 o - C-18
O
(161)
Figure 27: Structure of 161 and 2D spectrum (HMBC), C-3 and H-17 are coupling to each
other, so are H-20 and C-17/C-18, which are the characteristic coupling expected in 161.
2.2.6.3.1.1.2. Effect of tetrakis(triphenylphosphine)palladium(0) on 159
The tetrakis(triphenylphosphine)palladium(0) catalysed reaction of 159 yielded a
single product 160. This product was compared by 'H NMR with authentic 160
obtained from the Mitsunobu reaction of 111 with cinnamyl alcohol. This comparison
concluded that 159 had been cleanly converted to 160. This result proved that, for this
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Figure 28: Comparison of a) 'H NMR spectra from 159, b) the product obtained on the
rearrangment of 159 with Pd(PPli3)4 and c) authentic 160 (7.00-4.50 ppm).
2.2.6.3.1.2. With dichlorobis(acetonitrile) palladium (II) as Pd (II) source
2.2.6.3.1.2.1. Effect of dichlorobis(acetonitrile) palladium (II) on 157:
To a solution of 157 in THF was added dichlorobis(acetonitrile) palladium (II)
(mol. 10%). The reaction was stirred under an inert atmosphere at room temperature for
16 hours. The 'H NMR spectrum of the crude reaction showed that the starting material
157 disappeared completely, and a new product was formed. The product was compared
with 158, to see if a [l',3] rearrangement occurred, but the 'H NMR spectra were
different (Figure 29). It was then compared with 161 by 'H NMR (data not shown).
Both spectra matched perfectly and we therefore concluded that the rearrangement of
157 using dichlorobis(acetonitrilc) palladium (II) gave a [3',3] rearrangement product as
the unique product of the reaction as judged by the 'H NMR of the crude reaction
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Figure 29: Comparison of 'H NMR spectra from a) 157, b) the product obtained on
rearrangement of 157 with Pd(PPh3)4 and c) authentic 158 (6.7 to 1 ppm).
2.2.6.3.1.2.2. Effect of dichlorobis(acetonitrile) palladium (II) on 159:
When a solution of 159 in THF was treated with dichlorobis(acetonitrile)
palladium (II) no reaction was observed even when the reaction time was extended to 48
hours. In order to rearrange the allyl moiety, the palladium catalyst needs to undergo an
oxidative addition onto the alkene of the allyl moiety. This step is necessary to initiate
the rearrangement. A possible reason not to observe the rearrangement in the case of
159 could be that the addition of Pd(II) on the cinnamyl moiety does not occur as
required (Scheme 94, page 100) due to steric hindrance.
2.2.6.3.2. Summary of Transition metal catalysed aza-Claisen
rearrangement
The results from the catalysed Claisen rearrangement studies on 159 and 157 are
shown below in Table 7. These results are in accordance with the literature for aza-







Pd (0) yield 92% 93%
[1\3] 100% 37%
[3',3] 0% 63%
Pd (II) yield No reaction after 48 97%
[1\3] hours 0%
[3 ,3] 100%
Table 7: Percentage of [l',3] and [3',3] sigmatropic rearrangement with different Nl-Z 3-
allyloxyindazoles using different catalysts, Pd(0) and Pd(II) (Percentage determined by 'H
NMR analysis of the crude reaction mixture).
The Pd(0) catalysis induced the expected rearrangement of the allyl moiety from
the O position to the N position in both cases (crotyl and cinnamyl). When 159 was
rearranged with Pd(0), only one product assigned as 160 was obtained from a non-
concerted mechanism of type [1 ,3], When 157 was rearranged under the same reaction
conditions previously used for 159, 158 and 161 were isolated in 37% and 63%
respectively. These observations are in accordance with the literature [135] since the same
results have been reported from rearrangement studies on various allyl imidates. Indeed,
the cinnamyl derivative was rearranged to give only the product of the [3 ,3]
rearrangement whilst the crotyl derivative gave a 50:50 mixture of products resulting
from [1 ,3] and [3',3] mechanism.
Our results reinforced the mechanism due to the fact that the Pd(0) mechanism
occurs via the 7i-allyl intermediate (Scheme 94) and the nucleophilic attack on the
alkene depends on the substituents; a small substituent such as methyl allows the attack
at CI and C3 on the p-allyl cation, whereas the phenyl group blocks the attack at the C3
to induce the attack only at the CI position.
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These studies have proved that the Pd(II) can insert into the crotyl moiety and
induce rearrangement via a concerted [3',3] mechanism creating a new stereogenic
centre CI7 in 161 which is raccmic. These observations are in accordance with the
literature 'l35^ since the same results have been reported from rearrangement studies on
various allyl imidates. However, the Pd(II) catalyst was inactive on the cinnamyl
containing compound 159. The lack of reactivity of 159 is presumably connected with
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the difficulty of forming the complex or the sterically hindered six-membered ring
system with the phenyl group a to the C-Pd bond.
The concerted mechanism induced by Pd(II) is explained by the fact the
transition metal coordinates to the alkene. This intermediate undergoes a six-membered
ring formation and by loss of palladium, the ketone is formed whereas the allyl group
ends up on the nitrogen atom (Scheme 94).
2.2.6.4. Thermal aza-Claisen rearrangement
As described previously in section 2.2.4.2.2 (page 78), the rearrangement can
also be carried out under microwave irradiation. The main problem faced in our initial
studies was that the Z group did not survive under the reaction conditions. We therefore
decided to incorporate a less labile group on N1 to enable us to study the mechanism
and the products obtained. A benzyl group was selected.
2.2.6.4.1. The synthesis of the starting materials:
The reaction sequence described previously (section 2.2.3, page 72) was applied
to compounds 157 and 159. The carbamate group was removed and a benzyl group
inserted at the N1 position (Scheme 95 and Scheme 96). The deprotection step was
carried out in the presence of lithium hydroxide and gave 162 and 164 respectively,
which were subsequently benzylated in presence of potassium /-butoxide and benzyl
bromide in THF at room temperature to yield to 163 and 165 respectively in good yields
for the 2 step procedure.
Scheme 95: Synthesis of 163 from 157; a) LiOH aq., THF, rt, 99%, b) BnBr, 'BuOK, THF, rt,
66%.
The deprotection of 157 was judged to have been successful by infrared
spectroscopic analysis of 162 as the new band at 3154 cm"1, characteristic of the NH
bond, was observed, while the band of the carbonyl of the carbamate (at 1727 cm"1 in
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157) disappeared. The loss of 134 Da observed by mass spectroscopy also supported the
formation of 162.
The benzylation of 162 appeared to occur specifically at the N1 position as in
the *H NMR spectrum of the crude reaction a unique singlet appeared in the 5-5.5 ppm
region of the spectrum. By infrared, the characteristic band for the NH also disappeared.
The high resolution mass spectroscopy indicated a m/z of 301.1316 characteristic of the
formula CigHi8N2ONa (calcd m/z: 301.1317), which corresponds to the sodium adduct
of our target compound 163.
The same sequence was reproduced starting with 159 (Scheme 96). The
deprotection of 159 was achieved using an aqueous solution of lithium hydroxide in
THF and afforded 164 as the only product. Indeed, the TLC of the crude reaction
mixture showed a single spot (Rfi64 = 0.45 in 20% ethyl acetate/petroleum ether 40-
60°C).
Scheme 96: Synthesis of 165 from 159; a) LiOH aq., THF, rt, 96%, b) BnBr, 'BuOK, THF, rt,
91%.
High resolution mass spectroscopic analysis gave m/z: 273.1003 corresponding
to a formula of Ci6Hi4N20Na which was in accordance with the formula of the sodium
adduct of our target 164 (calcd m/z: 273.1004). X-ray crystallographic data were
consistent with the proposed structure 164 (Appendix D).
164 was then submitted to the benzylation reaction. The *H NMR spectrum and
the TLC of the crude reaction mixture revealed the presence of one new product as a
single spot different from the starting materials and a unique singlet in the benzylic
region was observed. The mass spectroscopic analysis gave a m/z of 363 (low
resolution), corresponding to the sodium adduct and in high resolution in a m/z of
363.1479, in accordance with the molecular formula of C23H2oN2ONa (calcd 363.1473)
which fits with the sodium adduct of 165.
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2.2.6.4.2. Rearrangement of 163 and 165:
The rearrangement conditions were selected based on our previously described
optimisation studies (Table 5, page 81), i.e., dimethylformamide as solvent (1 mL),
200°C, for 10 minutes (time was extended to push the reaction to completion). The
pressure in the sealed tube increased to 100 psi. The work up with DMF is standard and
consists of adding water which is miscible with DMF, extracting with diethyl ether
(twice) and washing the organic extracts with water to remove the traces of DMF
extracted into the diethyl ether. We believe that this work up procedure does result in
the loss of some of the product into the aqueous phase explaining the moderate yields
obtained (66% and 50% for 166 and 167 respectively). We have not been able to obtain
any evidence in support of the formation of additional products as the TLC of the crude
reaction showed only one product.
163 was irradiated under microwave conditions in DMF for 10 minutes at
200°C. The reaction was cooled down to room temperature and the reaction worked up
as previously mentioned. The organic extracts were concentrated in vacuo and purified
by flash column chromatography. A single product was isolated.
Scheme 97: Synthesis of 166 by rearrangement of 163 by microwave irradiations; a) DMF,
200°C, 10 minutes, 66%.
This product was compared with the starting material 163 using 'H NMR
analysis but was different (Figure 30). The mass spectroscopic analysis is in accordance
with the proposed formula of 166 as m/z: 301 was obtained (sodium adduct of 166). The
structure was also assigned using NMR techniques.
It is clear from the ]H NMR spectra of 163 and 166 that there has been a





Figure 30: 'H NMR (6.35-4.30 ppm) comparison of a) 163 and b) 166, product of microwave
rearrangement.
Moreover, the benzylic protons that appeared as a singlet in 163 are completely
different in 166. They appear as an ABX system consistent with the CH2 hydrogens
being diastercotopic. This indicates that a stereogenic centre is present in the product.
The formation of a stereogenic centre can be explained by a concerted mechanism to
give the product of a [3',3] mechanism. The 2D NMR experiments allowed us to
confirm the proposed structure of 166 as the CH proton couples to the carbon a to the
N2 in the HSQC and couples with the carbon of the CH and CH2 in the HMBC.
165 was also irradiated using microwave conditions in DMF as described for the
rearrangement of 163. After work up and purification, a single product was isolated in
50% yield.
Scheme 98: Synthesis of 167 by rearrangement of 165 under microwave conditions; a) DMF,
200HC, 10 minutes, 50%.
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The 'H NMR of the product 167 was compared to that of 165 as shown in Figure
31. Despite the fact that the chemical shifts of the different signals between 6.90 and
4.50 ppm have moved to higher field, the pattern of each signal remained the same.
Figure 31: 1H NMR (6.90-4.50 ppm) comparison of a) 165 and b) 167, product from microwave
rearrangement.
This difference indicates that the cinnanryl moiety of 165 has moved from the ex¬
position to the N2-position via a [1 ',3J mechanism, yielding 167 as the only product of
the reaction. TLC of the crude reaction mixture showed a single spot.
2.2.7.Reactivity of A/2-allyl indazolinones
2.2.7.1. Overview
As described in Section 1.3.2, the main goal of this project was to develop a
library blueprint based on the indazolinone core. Section 2.2.3 focused on methods of
incorporating diversity at the N1 position to access structures of type 20 (page 72). The
aza-Claiscn rearrangement applied on 20 allowed us to generate structures of general
type 21 (page 83). The ability to generate a third structural class of type 22 from 21 was
the final step in our library design (Scheme 99).
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Scheme 99: Generating structural diversity from indazolinone.
The aza-Claisen rearrangement transforms structures of type 20 into type 21.
Simple deprotection of 21, when R group is a carbamate yields compound 23 (Scheme
100). To our knowledge, little has been reported about the reactivity of 23 or analogous
structures. Indazolinone 23 can exist in two tautomeric forms (Scheme 59), however, all
our experimental evidence suggests that 23 exists in the keto form as the major tautomer
in both solution and in the solid state. X-ray crystallographic data indicates a C-O bond
length of 1.2514(19) A. This bond length is characteristic of a C=0 bond corresponding
to a carbonyl group (see Appendix). In solution, the 13C NMR contains a signal
assigned as C-3 at 162.0 ppm corresponding to a carbonyl carbon as expected for
tautomer 23.
2.2.7.2. Is diversity incorporation possible?
Due to the fact that little is known about the reactivity of compounds of type 23
with electrophiles [140J, we decided to investigate this issue by reacting 23 with a series
of elcctrophiles previously used in Section 2.2.3 (Table 4).
2.2.7.2.1. Reaction with benzoyl chloride
Benzoyl chloride was reacted with 23 (Scheme 100). The crude reaction mixture
was analysed by TLC and showed two new spots that were really close to each other.
Scheme 100: Reaction of 23 with benzoyl chloride; a) PhCOCl, Et3N, THF, rt.
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'li NMR analysis of the crude reaction mixture was studied in detail and
compared with that for the previously prepared 137 (page 83). Integration of the allyl
signals revealed the presence of a mixture of two products 168:137 in a ratio 1:1.5,
indicating a non-selective functionalisation of the indazolinone core. The two isomers
could not be separated by flash chromatography. This initial result persuaded us not to
investigate further the use of acid chlorides because library generation on solid phase
requires the development of efficient selective methods of generating pure compounds.
2.2.7.2.2. Reaction with phenyl isocyanate
Phenyl isocyanate was reacted with 23 in the presence of potassium /-butoxide
in THF at room temperature.
(23) (138) (169)
Scheme 101: Reaction of 23 with phenyl isocyanate; a) PhNCO, 'BuOK, THF, rt, 0% i.e. no
reaction.
No reaction was observed under these conditions, as judged by *H NMR and
TLC of the crude reaction mixture. Only unreacted starting material was present.We
believe the deprotonation of 23 occurred as the colour changed from colourless to
yellow, however, after work up the 'H NMR spectrum of the crude reaction mixture
showed only signals corresponding to the unreacted starting material.
2.2.7.2.3. Reaction with benzyl chloroformate
23 was reacted with benzyl chloroformate in the presence of triethylamine in
THF. Analysis of the crude reaction by TLC indicated the apparent formation of a
single new compound. Analysis of the *H NMR spectrum of the crude reaction mixture
showed a set of signals corresponding to a single allyl group.
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Scheme 102: Synthesis of 170 from 23; a) Et3N, PhOCOCl, THF, 97%.
Further analysis of the 'H NMR spectrum confirmed that the product also
contained the indazolinone core and a benzyloxycarbonyl group. Comparison with 113
(prepared as described in Scheme 61, page 67) showed that the two compounds were
different as judged by 'H NMR spectroscopy. The product was therefore assigned
structure 170. HSQC and HMBC data are consistent with this assignment.
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Figure 32: 'H NMR (8.00-4.50 ppm) comparison of a) 113 and b) 170.
Moreover, the 13C NMR spectra led to the same conclusion, as the chemical shift
of C-3 in the indazolinone ring in 113 is 164.7 ppm, corresponding to the carbon of the
carbonyl (C=0) group whereas the C-3 of the indazole 170 appeared at 136.8 ppm.
2.2.7.2.4. Reaction with ally! and benzyl bromide
23 was reacted with allyl bromide in the presence of potassium /-butoxide and
benzyl bromide in the presence of the same base ('BuOK) with THF as the solvent in
both cases. The analysis of the crude reactions by TLC revealed a single spot in both
reactions.
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Scheme 103: Synthesis of 107 by allylation of 23; a) allyl bromide, lBuOK, THF, 96%.
The *H NMR spectrum of the crude reaction mixture showed the presence of
only two different allyl moieties, indicating that a single product was produced when 23
was reacting with allyl bromide. We had previously prepared diallyl substituted
indazolinones 106 and 107 (section 2.2.2.1, page 65) and comparison with the analytical
data for these compounds led to the conclusion that the Nl, AT-diallyl substituted
indazolinone 107 was formed in this reaction. The allylation therefore occurred
exclusively on the Nl position (Scheme 103).
Scheme 104: Synthesis of 135 by benzylation of 23; a) BnBr, (BuOK, THF, 99%.
The reaction involving benzyl bromide showed by *H NMR analysis the
presence of a single allyl moiety and a unique singlet corresponding to the benzylic CH2
protons. This result proved the presence of one isomer. The 'H NMR spectrum of the
newly formed product was then compared with that of a sample of 135 (!H, HSQC,
HMBC) that had previously been prepared as described in section 2.2.4.3.2 (page 83).
The identical spectra led us to the conclusion that benzylation of 23 gives 135 in
excellent yield through fiinctionalisation of the Nl position (Scheme 104).
2.2.7.3. Conclusion
Different parameters, described below, govern nucleophilic attack of an
electrophile by an ambident nucleophile. The concept of hard soft acid base (HSAB)
allows chemists to rationalise the observed product ratio.[141~144]
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Previous examples of the use of the concept of HSAB include the reported
reaction of enolate 172 with two separate electrophiles to give two different products.
As the oxygen atom is the more electronegative atom in the enolate, it bears the
majority of the negative charge. It would therefore be easy to think that the oxygen atom










Scheme 105: Difference between hard and soft electrophile on an enolate.11421
However, as illustrated in Scheme 105, the outcome of the reaction depends also
on the clcctrophile. As methyl iodide is a "softer" reagent than acetyl chloride, the
iodine atom will be displaced by the "softer" nucleophilic centre of the enolate, which is
in this case the C-3 carbon atom. The product of this attack is 173. The acetyl chloride
is a "harder" electrophile and will therefore be attacked by the "harder" nucleophile of
the enolate, the oxygen atom, to give 171.
As the chemical reactivity results from the interplay of "charge control" and
"orbital control", external parameters can influence this concept. Indeed, the leaving
group of the electrophile, the use of a solvent which is capable of stabilising any
developing charges and the base all have an important practical role in the HSAB
concept. 1I4M441
This general concept can be applied to the anion of indazolinone 23. When
structures of type 23 are deprotonated, the resulting anion is stabilised by the two
heteroatoms, nitrogen at the N1 position and oxygen. The nucleophilic substitution can
occur cither by attack of the nitrogen or the oxygen on the clcctrophilic centre.
The oxygen atom can be considered as the "hard" center because of its greater
electronegativity and the nitrogen atom as the "soft center" (Scheme 106). This is of














Scheme 106: "Hard" and "soft" nucleophile centres in indazolinone after deprotonation.
Benzyl chloride and allyl bromide are classified as "soft" electrophiles because
the carbon bearing the halogen atom is not highly polarised. The isolation of N1
functionaliscd products (Scheme 103 and Scheme 104) is in accordance with the attack
of the "soft" donor, the N1 atom, onto the "soft" acceptor.
The isolation of 170 (page 108) when 23 was reacted with benzyl chloroformate
is also in accordance with the HSAB concept. The carbonyl of the chloroformate is
highly polarised because of the other groups attached to it (the two electron-
withdrawing oxygen atoms make the carbon atom electron deficient). This carbon is
therefore considered as a "hard" centre which reacts with "hard" nucleophiles. The
indazolinone therefore reacts through the "hard" centre, the oxygen atom.
The hardness (softness) of the carbon in the case of benzoyl chloride is in
between the two extremes discussed above and therefore leads to a mixture of products.
Investigating the reactivity of structures of type 23 led us to the conclusion that
it is possible to access selectively compounds of general type 22 (Scheme 99, page 106)
as described in the goals of the project. Indeed, benzyl chloroformate reacted
specifically on the O position of 23 to give a unique product.
However, specific O-functionalisation only occurred with benzyl chloroformate.
The isocyanate, acid chloride and alkyl halides tried did not react in the same manner.
The carbonate moiety in 170 is unfortunately relatively labile and therefore
functionalisation through the oxygen atom with chloroformates is not a useful route to
incorporate into a library design.
Using methyl triflate in the presence of potassium hexamethyl disilylazidc could
have been a possibility to alkylate on the oxygen but this was not investigated due to
time constraints.
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From a chemical perspective, however, we remained interested in structures of
type 22, as exemplified by 170. One interesting feature of 170 (Scheme 102) was the
presence of two dienes in the same molecule.
We proposed that this chemical feature could be relevant to our library design as
shown in Scheme 107. We therefore decided to investigate the reactivity of 170 in the
Dicls-Alder reaction in solution. The reactivity of this diene was expected to occur
through the azo-diene moiety considering that the product of the reaction would keep
the aromaticity in the benzene ring to give 191 (Scheme 113) after reaction of one
equivalent of dienc with one equivalent of dicnophilc.
2.2.7.4. Attempted aza-Diels-Alder reactions of 170
2.2.7.4.1. Overview
The Diels-Alder reaction is a pcricyclic [714,5+712.5] cycloaddition reaction
involving a diene 174 (in the s-cis conformation) and a dicnophilc 175 (Scheme 108).
The formation of two ct bonds and the disappearance of 2 n bonds in the transition
state (176) results in a six-mcmbered ring system 177 containing one unsaturated C=C
112
bond, if the dienophile 175 is alkene-based, or two unsaturated C=C bonds when the
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Scheme 108: Principle of Diels-Alder reaction.
In a real situation, substituents are present on the reaction partners and
depending on the electronic properties of these substituents, Diels-Alder reactions can
be classified into three main types: (I) Normal (HOMOdiene-controlled) and (III) inverse
electron demand (LUMOdiene-controlled) compared to (II) neutral Diels-Alder reactions
(Scheme 109).[145]
As shown in Scheme 109, a neutral Diels-Alder reaction occurs when the
partners are not perturbed by electronic factors (very rare). The efficiency of the
interaction of the two relevant molecular orbitals is increased if their energy separation
The reaction can be activated by controlling the energy level of the HOMO of
the diene. In the normal electron demand Diels-Alder reaction, activation of this
HOMO by electron-donating substituents will tend to increase its energy and
consequently, decrease the energy separation between the HOMOdiene and
LUMOdienophiie molecular orbitals, while electron-withdrawing substituents on the
dienophile will decrease the energy level of the LUMOdienophiie-
In the inverse electron demand Diels-Alder reaction, decreasing the energy
separation between the molecular orbitals is helped by a decrease in energy of the
LUMOdiene and an increase in energy of the HOMOdienophiie orbital. This is achieved by
inserting electron-withdrawing substituents on the diene and electron-donating
substituents on the dienophile.
is decreased.1146,147]
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Scheme 109: Diagram showing the three different types ofDiels-Alder reactions.11461
Indazolinone 170 contains an aza-diene system (Scheme 107). This section
therefore focuses on a brief review of the aza-Diels-Alder reaction.11481
Simple aza-dienes, due to their intrinsically electron-deficient nature favor
participation in "inverse electron demand" LUMOdiene-controlled Diels-Alder reactions
but by modifying the substituents on the diene and the dienophile, "normal" aza-Diels-
Alder reactions can also be observed.[149] For example, the 1-azabutadiene system 178
was shown to react with an electron-deficient dienophile such as maleic anhydride 179
to give the corresponding six-membered ring product 180 (Scheme 110).
Scheme 110: Early reports of successful Diels-Alder reaction with 1-azadienes derivatives; a)
neat, 125-130°C, 1 h.[148]
When the nitrogen atom is substituted with an electron-donating group, the diene
behaves in the normal pattern and reacts as an electron rich diene (Scheme 109). Indeed,
electron-rich dienes substituted with an oxygen at the C-4 position of the diene, similar
to 170, have been reported to react with TV-phenylmaleimide (synthesis of 182, Scheme
111) or dichloro/chlorophenyl ketene to give structures of type 184 (Scheme 111).
114
Scheme 111: Diels-Alder reactions of aza-dienes; a) 125°C, neat , 17%, b) Et3N, PhH, reflux,
21-85%.[150'151]
170 can also be seen as containing an "internal" hydrazone as the N1 nitrogen is
bonded to another nitrogen. This type of substrate, a,(3-unsaturated hydrazones, has also
been reported by L. Ghosez to undergo cycloaddition reactions with electron-deficient
dienophiles such as maleic anhydride (Scheme 112).[152]
Scheme 112: a,p-unsaturated hydrazones in aza-Diels-Alder reactions with electron deficient
dienophiles ; a) DCM, 30 minutes, 20°C, b) MeOH, CH2N2, 56%.[1521
To our knowledge, Diels-Alder reactions on systems like 170 have not been
reported. We therefore decided to attempt aza-Diels-Alder reactions using 170.
2.2.7.4.2. Initial studies
170 could react along two different pathways in the Diels-Alder reaction
(Scheme 113) to give either 191 through the reaction with the aza-diene or 190 via the
cyclohexadiene. The formation of 190 was considered unlikely as the formation of the
fully aromatic benzene ring was considered a strong thermodynamic driving force for
formation of 191.
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Scheme 113: Possible Diels-Alder adducts by reacting 170 with N-methyl maleimide 189.
The reaction shown in Scheme 113 was tried under microwave irradiation
(100°C, neat, 10 minutes). The reaction was stopped when TLC analysis indicated that
there was no starting material present. None of the desired product was detected by *H
NMR.
Scheme 114: Rearrangement of 170 to 113; a) N-methyl maleimide 189, microwave, 10
minutes, 100°C, solvent free.
The isolated product was analysed and the structure assigned as 113 by
comparison with authentic material prepared as described in Scheme 58. Under these
conditions, the Z group rearranges from the oxygen to the N1 position presumably in an
intermolecular process. Similar examples have also been described for rearrangement of
a substituent from the N2 to the O-position (Scheme 115) [153] and from N2 to N1
position. In both cases the kinetic product was transformed to the thermodynamic
product on heating.[83]
116
Scheme 115: Rearrangement of 192 to 193 and 194 to 195; a) CHC13, 70°C, reflux, [1531 b) 50-
100°C.[83]
This result reinforces the fact that the original synthesis of 170 is under kinetic
control and 113 is the thermodynamic product as described in the literature [83]. This
hypothesis was validated by taking 170 and heating in the microwave at 100°C for 10
minutes in solvent free conditions. The purified product was found to be identical to 113
formed in the Diels-Alder reaction attempt. As the carbonate group in 170 is labile
under thermal reaction conditions, carrying out the Diels-Alder reaction with 170 is not
a viable strategy.
In order to study further the behaviour of indazolinone derivatives in the Diels-
Alder reaction, a substrate of type 22 containing a non labile R group (alkyl) on the
oxygen needed to be synthesised.
Scheme 116: Target compound for the Diels-Alder reaction.
As described in section 2.2.7.2 (page 106), functionalising the oxygen of 23 in a
specific manner to obtain a stable compound proved to be difficult by direct alkylation.
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We therefore decided to adopt an alternative approach to synthesise structures of type
22.
2.2.7.4.3. An alternative synthesis of substrates for Diels-Alder reaction
A previous literature report describes a procedure to transform ^-substituted
indazolinones of type 59 to 196 in refluxing phosphorus oxychloride (Scheme 117).[154]
The reaction was therefore performed on 23 and the desired product 197 was isolated by
flash column chromatography (Scheme 117). 197 was isolated in 54% and assigned
using mass spectroscopy (molecular weight increased by 18 (from 175 to 193),
corresponding to the lost of OH (m/z: 17) and the gain of chlorine). A characteristic
band at 1504 cm"1 in the infrared spectrum of 197 appeared corresponding to the C-Cl
stretching frequency. The bands at 1628 cm"1 (C=0) and 3069 cm"1 (NH) in 23 were not
present in 197.
Scheme 117: Synthesis of 197 from 23; a) POCl3, reflux, o/n, 54%.[1541
In the second step, 197 was treated with sodium methoxide. The displacement of
the chlorine by a nucleophile is reported on systems of type 196 when R substituents are
aromatic rings such as phenyl groups. 197 was treated with sodium methoxide in
methanol under microwave heating for 10 minutes at 100°C. The *H NMR spectrum of
the crude reaction mixture showed no starting material, but also no signals
corresponding to the methoxy group in the expected material. We therefore concluded
that the nucleophilic displacement of the chlorine atom by the methoxy group did not
occur. Evidence to support isomerisation of the double bond in 197 to give 199 instead
of 198 was found in the lH NMR spectrum of the crude reaction. This unexpected result
has not been the subject of further investigation due to time constraints.
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Scheme 118: Synthesis of 199 during attempts to prepare 198 from 197; a) NaOMe, MeOH,
microwaves, 100°C, 10 minutes, 100 psi, 95%.
Our interest in reacting an analogue of 170 containing a non-labile group on the
oxygen in the Diels-Alder reaction next led us to a reaction sequence that had already
been reported in the literature. The route involved conversion of nitrobenzoic acid 200
to the corresponding amide 201, which was subsequently cyclised by the action of zinc
under basic conditions in methanol to afford 202 (Scheme 119).[78] Aromatic (and
aliphatic) nitro compounds can be reduced to amines in acidic conditions. However,
aromatic nitro compounds are reduced with zinc in water under neutral conditions to
give the corresponding hydroxylamine derivative [155]. This reaction therefore involves
initial hydroxylamine formation followed by conversion to 202 by attack of the nitrogen
of the amide (presumably aided by deprotonation of the amide by sodium hydroxide).
Scheme 119: Synthesis of 203 and 204; a) (COCl)2, DMF (cat.), DCM, 3 h, rt, then Et3N and
PhCH2NH2, o/n, rt, 99%, b) Zn, NaOH, MeOH, 71%,[78] c) POCl3, reflux, o/n, 33%,[156'1571 d)
MeONa, THF, 0%, e) Zn, AcOH, 78%."57'1581
202 was transformed to 203 using phosphorus oxychloride, according to the
procedure described by Ardakani et al.. [156' 1571 The transformation was successful as
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judged by the fact that the signals corresponding to the benzylic protons appeared as a
singlet that was shifted from 5.06 ppm in 202 to 5.55 ppm in 203.
Previous reports in the literature suggested that alkoxides cannot displace the
chlorine in 203.[157J However, we attempted the displacement with sodium methoxide
anyway but replaced the conventional heating with microwave irradiation.
Unfortunately, this did not give any of the desired compound 204. Reduction of 203
using zinc metal in acetic acid under reflux yielded 204 in good yield ^157' 158^.
Comparing spectroscopic data for 204 with that reported in the literature confirmed that
the product of this reaction was 204, as expected. These two new compounds 203 and
204 were selected for further study.
In a second route, the starting anthranilic acid 205 was transformed to the
corresponding azide compound 206,[157] Spectroscopic evidence in support of 206
included the observation of a characteristic band for the azide functional group at 2101
cm"1 in the infrared spectrum [156]. Activation of the carboxylic acid 206 through
formation of the acid chloride (not isolated) enabled the synthesis of 207 on reaction
with aniline in dichloromethane. 207 was then cyclised in boiling thionyl chloride to
give 208 in 91% yield (m.p. = 36-37°C; literature m.p. = 34°C).[156' The infrared
spectrum of 208 also showed the disappearance of the band at 2127 cm"1, characteristic
of the azide functional group in 207.
(205) (206) (207) (208)
Scheme 120: Synthesis of 208; a) i) HC1, NaN02, ii) NaN3, AcONa, 54%, b) i) (COCl)2, DMF
(cat.), DCM, 3 h, rt, ii) Et3N, PhNH2, 2 h, rt, 84%, c) SOCl2, reflux, 2 h, 84% (lit. 91% [156]).
208 was then submitted to reaction with sodium methoxide (Scheme 121) to
give 209 in 11% yield along with 81% of the starting material 208. A singlet at 4.17
ppm in the 'H NMR spectrum of 209 integrated for 3 protons and therefore provided
evidence in support of the fact that a methoxy group had displaced the chlorine atom.
The reduction of 208 using zinc metal in acetic acid under reflux occurred
according to literature procedures [78'157] to give the desired product 210 in 76% [158]
(Scheme 121). The mass spectral data showed a difference of 34 (35-1) between 210
and 208, corresponding to the loss of chlorine (35) and the gain of a proton (1).
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[157, 158]
Substrates 203, 204, 208, 209 and 210 were selected for studies on the reactivity
of the indazole/indazolinone core in the presence of a dienophile (the Diels-Alder
reaction).
2.2.7.4.4. Attempt to carry out a Diels-Alder reaction:
To increase the chances of performing the Diels-Alder reaction successfully, we
decided to use 4-phenyl-l,2,4-triazoline-3,5-dione (PTAD) 212. PTAD 212 is known to
be a highly reactive dienophile.[159] This class of reagent is more reactive than common
dienophiles such as maleic anhydride, JV-phenylmaleimide, diethylazodicarboxylate and
dimethyl acetylenedicarboxylate. For example, 212 reacts rapidly with cyclopentadiene





Scheme 122: Reaction of cyclopentadiene 211 with PTAD 212; a) acetone, -78°C.[160]
In initial studies, the different substrates 203, 204, 208, 209 and 210 were
submitted to the Diels-Alder reaction in the presence of 212. The results of the reactions

























No No reaction No reaction No starting No starting
reaction material material
present present
Table 8: Summary of the outcome of the Diels-Alder reaction with 212.
As presented in Table 8, at room temperature, the indazolinone 209 did not react
with dienophile 212. This reaction was refluxed in chloroform for four hours under an
inert atmosphere but the bright red colour of the dienophile did not fade. TLC and 'H
NMR analysis of the crude reaction showed only the presence of unreacted starting
materials. The same observations were made with the 2-phenyl-3-chloro-2//-indazole
208 and 2-benzyl-3-chloro-2//-indazole 203 under analogous reaction conditions.
However, 204 and 210 did react with 212 in refluxing chloroform. In both cases,
the bright red colour of the dienophile faded to give a colourless solution, indicating the
consumption of 212.
The crude mixture obtained on reaction of 204 with 212 was purified by flash
column chromatography and a single product was isolated. Mass spectroscopic analysis
of the product in chemical ionisation mode showed a m/z ratio of 384 in positive mode,
corresponding to an adduct of 204:212 in the ratio 1:1. In the infrared spectrum of the
product, a broad signal at 3494 cm"1 characteristic of an NH group and a strong signal at
1726 cm"1 characteristic of a carbonyl group were observed. Moreover, in the 'H NMR
spectrum, signals corresponding to a benzylic CH2 were shifted from 5.52 ppm in the
starting material 204 to 5.49 ppm in the product suggesting relatively little change in the
core structure. Based on these and other pieces of spectroscopic evidence, the product of
this reaction was assigned as 214 (Scheme 123).
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Scheme 123: Synthesis of 214 by reaction of 204 with 212; a) 70°C, CHCI3, 6 h, 82%.
As described in Table 8, the reaction between 210 and 212 also showed the
consumption of the starting material (TLC indicated that the starting materials were
both absent from the reaction mixture).
Scheme 124: Synthesis of 215 by reaction of 210 on 212; a) 70°C, CHCI3, 6 h, 75%.
The product 215 of the reaction between 210 and 212 was isolated in 75% yield
(Scheme 124). Mass spectroscopic analysis of 215 was consistent with a 1:1 ratio of 210
and 212 (m/z: 368 in negative electrospray mode). A broad band in the infrared
spectrum at 3468 cm"1 characteristic of the presence of the NH bond and a strong signal
at 1725 cm"1 characteristic of a carbonyl group were both observed for 215.
Scheme 125: Possible side-products from the reaction between 212 and 210.
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However, a side product was also obtained and isolated in 5% yield. The 'H
NMR spectrum shows only aromatic protons and the infrared spectrum is similar to the
main product 215, except for the absence of a signal corresponding to NH. According to
the mass spectroscopic analysis (m/z: 584 in positive mode), this side product could
correspond to the sodium adduct of a molecule containing a ratio 1:2 of 212: 210. Two
possible structures 216 and 217 could be assigned to the isolated product (Scheme 125).
X-ray crystallographic analysis solved the assignment problem showing that the
structure was in fact 216 (Scheme 126).
Scheme 126: Structure of 216 confirmed by X-ray analysis.
2.2.7.4.5. Mechanistic considerations:
The formation of products 214 and 215 could have occurred via a Diels-Alder
mechanism. If the first step of the reaction is a Diels-Alder reaction, the general
intermediate 219 can be drawn as the result of the [4+2] cycloaddition. Subsequent
cleavage of one of the N-N bonds in 219 would lead to 221 by either of the two
mechanisms shown in Scheme 127 and Scheme 128.
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Scheme 127: Possible mechanism explaining the formation of structure of type 221 by proton
transfer.
Our current view is that the mechanism shown in Scheme 127 is more likely
based on stereoelectronic arguments.
Scheme 128: Possible mechanism for the formation of 221 with participation of the lone pair of
the bridged nitrogen inducing ring fragmentation (R= Ph or Bn).
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However, another (perhaps more likely) option for explaining the formation of
the two new compounds 214 and 215 (Scheme 123 and Scheme 124) is nuclcophilic
attack involving the lone pair on the N2 nitrogen of the indazole core 218 (Scheme
128). The initially formed adduct of type 222 could then undergo a proton transfer to
give the structure 222 (Scheme 129).
Scheme 129: Alternative mechanism for the formation of 214 and 215 (R=Ph or Rn
respectively).
This mechanism is quite appealing because it involves the formation of an
intermediate of type 222. The intermediate 222 can also be invoked as an intermediate
en route to the side product 216 of type 227 as shown in Scheme 130.
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Scheme 130: Possible mechanism for the formation of 227.
One possible explanation as to why the product 216 is observed but an
analogous product from the reaction of 210 is not is that the intermediate 222 is
sufficiently long lived due to the increased stability arising from extended conjugation
in 222 (R=Ph) to enable a competing reaction (Scheme 130).
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An alternative mechanism for formation of 227 is shown in Scheme 131. This
mechanism seems unlikely due to the requirement for hydride (H") to act as a leaving
group (Scheme 131).
(220) (227)
Scheme 131: A possible mechanism for formation of 227 involving hydride as a leaving group.
2.2.8.Conclusions
From the studies presented in this section, we are able to draw the following
conclusions.
1) A synthetic route to 3-allyloxyindazole 104 in a good yield was established
(Scheme 60).
2) 104 was shown to react exclusively at the N1 position, whatever the
electrophilic character of the reagent (soft or hard).
3) In the analogous system of type 20, conditions to carry out a aza-Claisen
rearrangement were investigated (Scheme 69, page 73). This was attempted under
conventional thermal and microwave approaches and in the presence of a catalyst in
solution phase. In addition, the Claisen rearrangement of 142 was achieved on solid
phase under palladium catalysis.
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The rearrangement did not work under standard thermal conditions. The required
energy delivered through this technique was presumably not sufficient to induce
rearrangement prior to degradation. However, the microwave irradiation proved to be an
excellent alternative. 10 minutes at 200°C in DMF resulted in complete conversion of
compounds of type 20 to the corresponding N-isomer 21, provided that the N1 position
was substituted by a non labile group, i.e. benzyl group. Transition metal catalysed
rearrangement was also very efficient and supported results in the literature for aza-
Claisen rearrangements in unrelated core structures [135l In addition, when applied on
the solid phase, the palladium (O)-catalysed rearrangement was successful in inducing
the desired sigmatropic rearrangement (page 81).
4) The results described in 3) are also very interesting from a mechanistic
prespective. Depending on the method and the terminal substituent of the allyl group,
different mechanisms are observed. Indeed, as the literature described from an unrelated
core [162], microwave irradiation induces a [3 ;3] mechanism. This is confirmed in our
experiment by the use of a crotyl moiety, where we obtained a racemic product which is
readily assigned using 'H NMR (ABX system). However, a [1 ;3] mechanism is
observed with the cinnamyl moiety (159, 165, Scheme 133). A possible explanation for
this result presumably involves a steric interaction that does not allow the phenyl ring a
to the N2 position but also electronic factors might be involved in the stabilisation of the
rc-allyl cation.
Under palladium catalysis, the use of palladium (0) is required for bulky groups
such as the cinnamyl group and induces a [1 ;3] mechanism. The palladium (0) method
is less useful for less bulky substituents such as crotyl moiety where a mixture of
compounds resulting from [1 ;3] and [3 ;3] rearrangement were formed.
In contrast, the use of a palladium (II) catalyst led to highly selective reaction
when the crotyl group was present (157), inducing a [3 ;3] rearrangement. However, no
rearrangement of the cinnamyl group (159) was observed. This can be rationalised by
the fact that addition of the metal to a sterically hindered alkene is difficult, stopping the


















Scheme 133: Summary structures.
5) The reactivity of A2-allyl indazolinones of type 23 (21 when R=H) was also
studied with different electrophiles and the results were rationalised based on the HSAB
(hard soft acid base) concept. "Soft" electrophiles reacted at the soft centre of the
indazolinone, the nitrogen position; hard electrophones at the hard centre, the oxygen.
We proved by reacting benzyl chloroformate with 23 that a single product 170
was obtained. This product was shown to be the kinetic product of this reaction since
rearrangement of the Z group from the O position to the N1 position was induced
thermally. Identifying a method of preparing exclusively O, N2-substituted
indazolinone was one of the key goals of the project as it would enable us to access all
the three isomers in the library. However, due to the instability of carbonates of this
type under assay conditions, the use of chloroformate reagents does not represent an
attractive building block for the creation of the library.[163,1641
Scheme 134: Summary structures.
6) Analogues were synthesised in which the O to N1 shift was not possible.
Structures of type 22 (Scheme 116) were prepared and when R=methyl proved not to
react under standard Diels-Alder reaction. When the C-3 of the indazole was substituted
with a chlorine, no reaction was observed under standard Diels-Alder conditions.
However, when the chlorine was reduced to give 204 and 210, reaction with 212 gave
the adduct of type 221 as the main product. The formation of this product can be
explained by a possible Diels-Alder mechanism (Scheme 128) although an alternative
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mechanism seems more likely. The formation of 216 supports this alternative
mechanism (Scheme 130).
Scheme 135: Summary structures.
2.3. The Library Design
2.3.1.Synthesis of the Library Core Structure
2.3.1.1. Overview
In order to develop the solid phase route, a target molecule that could be loaded
onto a resin needed to be synthesised. This molecule must contain, as previously
described, the indazolinone core and a functional group that is compatible with the
selected linker methodology. The mode of attachment to the resin must be orthogonal to
the heteroatoms already present in the indazolinone core and must contain an alcohol
functionality to load the oxygen on to the resin through formation of a Si-0 linkage.
The following section will focus on the synthetic path we developed to access a
compound of this type. Alternative and less successful approaches for reaching the same
type of target are also briefly described later in this section.
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2.3.1.2. Suzuki coupling
Allylbenzyl ether 229 was reacted with 9-borabicyclo[3.3.1]nonane (9-BBN) to
give the corresponding boron derivative 233 (Scheme 137) which was coupled via
Suzuki methodology to the anthranilate 228. The reduction of the alkene with 9-BBN
occurs via anti-Markovnikov addition, giving 233 (Scheme 137) with the boron atom
attached to the terminal carbon atom. An important step that must occur before the
transmetallation takes place is the formation of the boronate 235 (Scheme 137). Sodium
hydroxide is used in order to form 235.
Scheme 136: Synthesis of 231; a) i) allylbenzyl ether 229 and 9-BBN, THF, 3h, rt, ii) 228,
Pd(PPh3)4, NaOH aq., reflux, THF, 24h, quantitative; b) NaOH, MeOH, reflux, lh, quantitative.
The coupling reaction was successful as analysis of the oil that was isolated after
purification showed a singlet at 3.75 ppm in the 'H NMR spectrum, corresponding to
the methyl ester, but also three signals at 3.37, 2.51 and 1.79 ppm each integrating for
two protons. We assigned these signals as the three methylenes present in the aliphatic
chain formed in the coupling reaction. The two bands in the infrared spectrum at 3481





























Scheme 137: Mechanism of Suzuki coupling [165-167]
The presence of sodium hydroxide in the reaction mixture also leads to a side
reaction which is an advantage in our synthesis. It converts the methyl ester 230 to the
corresponding carboxylic acid 231 (Scheme 136). In practice, the hydrolysis of the ester
230 was driven to completion by addition of a further aliquot of sodium hydroxide after
the coupling reaction was complete and the reaction was refluxed for a further 24 hours.
The one-pot reaction (coupling-hydrolysis) yielded the acid 231. The new signal at 1670
cm"1 present in the infrared spectrum of 231 supported the fact that the ester, appearing
at 1691 cm"1 in 230, had been transformed to the acid 231. High resolution mass
spectroscopic data also supported the assignment (m/z: 284.1279, negative electrospray
mode corresponding to the formula C17H18NO3 (calculated m/z: 284.1287) of 231 [M-
H]").
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The purification step of 231, however, provided major difficulties. Indeed, by¬
products believed to result from the 9-BBN were not separable by flash chromatography
and contaminated the desired product 231. An attempt to destroy these by-products
using sodium hydroxide followed by hydrogen peroxide [168] was made, but
unfortunately 231 degraded under these reaction conditions yielding unindentified
products and considerably decreasing the yield.
An alternative approach involving the extraction of acid 231 into a solution of
sodium hydroxide, followed by washing with DCM, neutralisation and re-extraction
with an organic solvent was attempted but the by-products were also carried through
this procedure.
A solution was found when the oily crude reaction mixture was triturated with
hot petroleum ether 40-60°. This enabled the separation of the oily 9-BBN by-products
and the 5-[3(benzyloxy)propyl] anthranilic acid 231. The oily residues were not soluble
in hot petroleum ether and were separated from the product 231 which was partially
soluble in hot petroleum ether. Further time consuming trituration eventually yielded
231 as a white solid after evaporation of the solvent.
2.3.1.3. Cyclisation of 231
2.3.1.3.1. A complicated procedure
Due to the difficulties in purification, 231 (page 132) was a relatively precious
material, so initial cyclisation studies to form the indazolinone were carried out on the
commercially available anthranilic acid 205 according to a procedure reported by
Baiocchi [83]. The sequence consisted of diazotisation followed by reduction with
sodium thiosulfate and finally acid-catalysed cyclisation of the corresponding hydrazine
derivative 238 to afford indazolinone 17 (Scheme 138). This procedure was successful












(205) (206) (238) (17)
Scheme 138: Synthesis of indazolinone 17 via diazotation, reduction of the diazonium salt, and
cyclisation; a) NaN02, HC1, b) Na2S203, c) HC1, 80°C, 20 h, 82% [83].
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Having shown that this one-pot reaction worked in our hands, the next step was
to attempt the reaction with anthranilic acid derivative 231. Unfortunately, none of the
desired indazolinone 232 was produced. In the synthesis of 17, the product precipitates
when the pH of the solution was adjusted to pH=5. No precipitate was observed when
the pH was adjusted to pH=5 in the reaction using 231. Extraction of the aqueous media
with organic solvent and subsequent analysis of the organic extracts by 'H NMR did not
show the presence of the expected product 232. This three step-one pot reaction was
acceptable for the synthesis of 17, but the problem with a one pot-multistep reaction of
this kind is that when it does not work, it is often difficult to determine the weak step.
We therefore studied this reaction in more detail.
2.3.1.3.2. Is the first step failing?
The diazotation step in this method of making the desired indazolinone 232 is
the first crucial step that had to be checked. Diazotisation of anthranilic acid 205 was
performed according to a procedure published by Vogel ^1691 and was followed by
conversion of the diazonium salt 206 to the aryl iodide 239. The success of the
diazotisation was measured by monitoring the amount of iodobenzoic acid 239 that
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(205) (206) (239)
Scheme 139: Synthesis of 239 by diazotisation of anthranilic acid 205; a) HC1, NaN02, b) KI,
heating. [169]
To optimise the reaction different conditions were used, especially changing the
solvent. The standard conditions were diazotisation/iodination of benzoic acid 205 (200
mg) in 2 mL of solvent (variable), 300 pL of hydrochloric acid and 100 mg of sodium
nitrite. The sodium nitrite was added as an aqueous solution dropwise at 0°C and the
solution was stirred for 30 minutes.[169] The displacement of the diazonium salt 206 by
iodide was carried out by adding solid potassium iodide and refluxing the dark solution
for 10 minutes. The iodobenzoic acid 239 was expected to precipitate out of the
solution.
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Solvent H20 10% 25% 50% 75% 10% 25% 50% 75%
MeCN MeCN MeCN MeCN THF THF THF THF
Precipitate ✓ V V V >/ X X X
2 2 2
phases phases phases
Yield 15% 70% 75% 45% 40% 66% X X X
Table 9: Optimisation of diazotisation of anthranilic acid 205 by variation of solvent.
Table 9 details the results of this study. In summary, the use of 100% water and
the use of a solvent mixture that resulted in a biphasic system led to poor yields of 239.
Helping the reagents and substrate to be in a homogeneous media was the key in this
reaction and seemed to improve the yield dramatically. Over a defined range (10-75%
CH3CN/H2O) acetonitrile and water are miscible. The best ratio of acetonitrile/water to
run the diazotisation reaction in was found to be 25% acetonitrile/water. These
conditions were selected as the standard conditions for any further diazotisation
reactions. These conditions were then applied to the desired substrate anthranilic acid
231 in order to convert it into the corresponding iodobenzoic acid 241.
(T° CVCOzH a)^NH2 "~cC™ r°^c^co2H
(231) (240) (241)
Scheme 140: Synthesis of 241 from 231; a) NaNCh, HC1, b) KI, heating, 86%.
The conditions developed using anthranilic acid 205 proved to be reliable with
substrate 231. Indeed, the yield of the reaction reached 86% conversion. Knowing that
the diazotisation was working in 25% acetonitrile/water, we next attempted to repeat the
multistep procedure to synthesise 17 with this solvent combination. From analysis of the
'H NMR of the crude reaction, we observed that the signals of the indazolinone 17 were
not present, whereas the reaction carried out in water alone was successful. We
therefore decided to abandon this multistep procedure as a route to 232 due to the
limited amount of 231 that was available.
2.3.1.3.3. An improved protocol for the cyclisation
There are several literature reports on the preparation of indazolinones starting
from 2-halogen substituted benzoic acids.[83' 1031 This approach consists of reacting
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hydrazine and the 2-halogen substituted benzoic acid in isopropanol in the presence of
copper metal. This cyclization reaction has been described with 2-chloro and 2-fluoro
benzoic acid but not with 2-iodobenzoic acid 239. We therefore investigated and
subsequently optimised the cyclisation of 239 to form 17.
0 0
(10H a) rvV► NSJ^N
H
(239) (17)
Scheme 141: Cyclisation of iodobenzoic acid 239 to indazolinone 17; a) Cul, NH2NH2.H2O,
IPA, reflux, o/n, >90% (judged by 'H NMR, as purification was difficult).
For cyclisation of 2-fluoro benzoic acid, [83] the literature procedure involves the
use of metallic copper (0.9 equiv.) and 2 equivalents of hydrazine hydrate. The reaction
is then refluxed for 4 hours in isopropanol. When we repeated this procedure with 239,
throughout the reaction what was assumed to be a copper residue was present as a
suspension. The copper was activated by removing any copper oxide coating with dilute
sulfuric acid as described in the literature. 11691 The copper was then washed with water
and acetone and dried in vacuo.
The reaction of 239 under these conditions was monitored by analysis of the
crude reaction mixture by 'H NMR. This avoided the need for work up and hence
eliminated any error resulting from the fact that indazolinone 17 may dissolve in
aqueous solution.
Following the literature conditions, the 'H NMR of the crude reaction mixture
after 4 hours showed the presence of predominantly starting material 239 (Scheme
142b). When the reaction was repeated using 7 equiv. of hydrazine, the major product is
not the starting material 239 or the desired product 17 (Scheme 142c). Traces of 17
were observed, however, and the reaction was further improved by extending the time
of reflux to 16 hours (rather than 4 hours, Scheme 142d).
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Scheme 142: ]H NMR comparison of cyclisation optimisation; a) 'H NMR of 2-iodobenzoic
acid 239, b) 'H NMR of cyclisation of 239 with 2 equiv. of hydrazine, reflux 4 h, c) cyclisation
of 239 with 7 equiv. of hydrazine, reflux 4 h, d) cyclisation of 239 with 7 equiv. of hydrazine,
reflux 16 h, e) 'HNMR of indazolinone 17.
From these model studies, we had identified optimised conditions for the
formation of 17 from 239. We therefore applied these optimised conditions to 241 in





Scheme 143: Synthesis of 232 by cyclisation of 241; a) NH2NH2.H20, Cu metal, IPA, reflux, 16
h, 51%.
Diazotisation of 231 followed by treatment with iodine using the conditions
described previously afforded 241 as an oil in 85% yield. The presence of the aliphatic
chain helped to solubilise the product in organic solvents by decreasing the polarity so
that flash column chromatography was used to purify 241. The cyclisation of 241 in
isopropanol in the presence of hydrazine hydrate (7 equiv.) and copper metal allowed
the isolation of 232 in 51% after 16 hours under reflux. Figure 34 shows the "H NMR
spectrum of 232 along with the corresponding assignments.
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Figure 33: 'H NMR spectrum of 232 (CDC13, 300 MHz).
2.3.1.4. Unsuccessful approaches to a library core structure
2.3.1.4.1. Methods involving attachment of the linker to the indazolinone
core structure
2.3.1.4.1.1. Derivatising the indazolinone
2.3.1.4.1.1.1. Starting from indazolinone
Indazolinone 17 is known to react with bromine leading to incorporation of
bromine at position 5. Using this bromo derivative in a Suzuki coupling reaction with
the boronate derived from allyl benzyl ether 229 by reaction with 9-BBN was proposed
as an alternative route to 232.
Scheme 144: Synthesis of 232, attempt to react under Suzuki reaction conditions; a) Br2, AcOH,
rt, 2h, 30%, [S51 b) attempt of Suzuki coupling, allylbenzyl ether reacted with 9-BBN, THF, 3h,
rt, assumed to be quantitative, then bromoindazolinone, Pd(PPh3)4, NaOH, reflux, 24h, 0%.
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No problems in repeating the synthesis of 242 were encountered. Unfortunately,
we were unable to improve the previously reported difficult separation ofmono- and di-
brominated products in chloroform as stated in the publication. Attempts to carry out a
Suzuki coupling using 5-bromoindazolinone 242 failed due to the fact that 242 was not
soluble in THF. This approach could have been significantly shorter than our successful
approach to 232 but due to time restriction and because of the low yielding reaction to
prepare 242 (30%), no further optimisation studies were attempted.
2.3.1.4.1.1.2. Starting from anthranilic acid derivatives
a) The model
As discussed previously, indazolinone 17 can be synthesised from anthranilic
acid 205 through diazotation, reduction of the formed diazonium salt to the hydrazine








Scheme 145: Synthesis of 17 from 205; a) i) NaN02, H20, HC1, under 5°C, 4h, ii) Na2S203, o/n,
rt, iii) reflux, o/n, 85% [83].
This route is also applicable to starting materials containing a side chain that
could be used to insert a point of attachment for loading onto a resin.
b) Substrates containing a methyl group
It was proposed that having a methyl group on the aromatic ring may prove
useful due to the possibility of subsequently oxidising the methyl group and ultimately
accessing a benzylic alcohol functionality. Following the same procedure, 5-methyl








Scheme 146: Synthesis of 5-methyl indazolinone 244 from 243; a) i) NaN02, H20, HC1, under
5°C, 4h, ii) Na2S203, o/n, rt, iii) reflux, o/n, 86%.
Using oxidising agents to transform the methyl to the carboxylic acid
functionality would have provided an alternative strategy of linking the indazolinone









Scheme 147: Strategy for derivatising 244 to load through an alcohol moiety to the silicon-
based resin.
Attempts to react 244 with IBX according to the procedure ofNicolaou 11701 did
not give any of the desired product and was therefore abandoned. However, the strategy
of cyclising a suitably substituted anthranilic acid was still valid and it was proposed
that other substituents on the aromatic ring such as a halogen atom could be
incorporated to carry out a palladium coupling reaction.
c) Substrate containing an iodine group
An attempt was made to convert the commercially available 5-iodo-anthranilic
acid 247 (Scheme 148) to 248 under the previously described diazotisation/reduction-
cyclisation conditions. Unfortunately, the expected final product 248 did not precipitate
from the reaction mixture after adjusting the pH to 5-5.5. Different pHs were tried but
no precipitation was observed. This approach was therefore abandoned.
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Scheme 148: Attempt of cyclising 247 to give 248; a) i) NaNCT. FfO, HC1, under 5°C, 4h, ii)
Na2S203, o/n, rt, iii) reflux, o/n, 0%.
2.3.1.4.1.2. Making the indazolinone with the chain already in place
2.3.1.4.1.2.1. Barton's route
Our first route to generate indazolinones for this project was inspired by the
work of Sir Derek Barton. In a paper published in 1982, he reported a versatile method
to access indazolinones containing electron-donating substituents in the aromatic
ring.[10IJ This strategy was first attempted due to the availability of starting materials
253 and 256. The key feature in 253 and 256 was the presence of the methoxy
functionality (249), which could potentially be transformed later on to a phenol moiety
(250). This phenol could then be used to link the indazolinone core onto an insoluble
polymer through the formation of a Si-0 linkage (251)(Scheme 149).
(249) (250) (251)
Scheme 149: Strategy of linkage through a phenol moiety.
The commercially available esters 252, 253 and 256 were converted to the
corresponding hydrazides 75, 254 and 257 respectively. These hydrazides were
subsequently treated with three equivalents of a strong base, /?-butyl lithium at -78°C
according to Barton's protocol.
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Scheme 150: Attempted formation of indazolinones from 252, 253 and 256 following Barton's
method; a) NH2NH2.H20, THF, 99%, b) w-BuLi, THF, -78°C.
Scheme 151 shows the mechanism for the formation of the indazolinones as
published by Barton in 1982.1'0IJ This involved the generation of a polyanionic species,
which was then described to cyclise as shown. In our hands, none of these reactions
were successful despite us taking great care to exclude water and air from the reaction.
Scheme 151: Barton's proposed mechanism for indazolinone synthesis published in 1982.'101
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2.3.1.4.1.2.2. With nitro benzoic acid derivatives
In another approach, we decided to explore the possibility that a derivative of
type 259 containing a linker unit (R) could be transformed to the corresponding amide
260 and then cyclised to ^-substituted indazolinone 261 (Scheme 152). Different
derivatives of 2-nitro benzoic acid are commercially available and could have been of
interest to cyclise to a suitable indazolinone system. This strategy relied on our ability to
remove the group present at the N2 position (e.g. use of p-methoxybenzyl followed by
CAN deprotection).
Scheme 152: Synthesis of AT-allyl /V2-benzyl indazolinone 262 from nitrobenzoic acid 259; a)
(COCl)2, DMF cat., THF, rt, 5 hours, b) BnNH2, THF, o/n, rt, 99%, c) Zn, NaOH, EtOH, 80°C,
o/n, 71%, d) i) Flunig's base, THF, 2h, rt, ii) allyl bromide, o/n, rt, 99%.
As stated in section 2.2.7.1, the alkylation (allylation) of 262 (R=H) occurs
specifically at the N1 position. Whilst it proved possible to prepare 269 (R^H) by this
route, it was reasoned that even if the required deprotection of the N2 substituent
occurred, the product would still be a AT-substituted indazolinone. Analogues of 261
would have been functionalised at the N1 position. Structures of type 262 could not be
subjected to the Claisen rearrangement, a crucial step of our library design.
Consequently, this strategy was rapidly abandoned.
2.3.2.Substrate(s) for loading onto the resin
As presented in section 2.3.1.3.3 (page 136), an indazolinone core containing a
handle for linking to a resin was synthesised, but there was still a benzyl group present
that protects the oxygen on the chain. This benzyl group must be removed to enable
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loading onto the resin. Moreover, because of the isomer issues known to be associated
with the indazolinone core structure, care had to be taken in order to avoid low yielding
reactions.
We decided that only one strategy could meet all of our requirements based on
the following criteria:
1. If benzyl deprotection was the first step of the sequence, a primary alcohol
would be generated, making the task of selectively protecting the indazolinone core
more difficult.
2. Selective debenzylation during the last step of the route is not possible due to
the possible reduction of the allyl alkene functionality under the hydrogen, Pd/C
conditions used to remove the benzyl group.
3. Treatment with excess ethyl chloroformate (not benzyl chloroformate,
because it would be deprotected under hydrogenolysis conditions) and partial
deprotection would give the A7-protected indazolinone 263. 263 could then be
debenzylated to afford 264 and a Mitsunobu reaction using an excess of allyl alcohol
could be used to enable reaction of the amide of 264 to give 265 and 266 without
homodimerisation or potential polymerisation of 264. We therefore decided to pursue
the strategy shown in Scheme 153.
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Scheme 153: Synthesis of 265 and 266 from 232; a) i) EtOCOCl, Et3N, THF, ii) morpholine,
89%, b) Pd/C 10%, H2 (20 bars), 86%, c) allyl alcohol, PPh3, DEAD, toluene, 30% of 265 and
60% of 266.
N1 -protection on 232 did not present any problems. This strategy had previously
been used with benzyl chloroformate (section 2.2.2.2) and was as effective when ethyl
chloroformate was used. The two-step procedure including reaction with excess ethyl
chloroformate and partial deprotection using morpholine gave 263 in 89% overall yield.
Removal of the benzyl protecting group in 263 was attempted at room
temperature. Using hydrogen in a balloon at atmospheric pressure, the reaction went to
completion after 4 days (on 100 mg scale); whereas, when the pressure was increased to
20 bars the reaction rate increased and the reaction was complete in 2 days. Depending
on the scale of the reaction, the autoclave was kept between 2 and 7 days under 20 bars
of pressure of hydrogen at room temperature. The work up of the reaction was straight
forward. Filtration through celite was necessary to remove the palladium on charcoal.
The solid residue was then washed with methanol and the solvent removed in vacuo to
give a white solid which was identified as 264. No further purification step was
necessary because of the excellent purity as judged by !H NMR analysis.
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At this stage, 264 is a base and acid sensitive molecule that contains two
functional groups which could react depending on the reaction conditions. Nevertheless,
one of the future steps in the sequence is the formation of a Si-0 bond. The amide
moiety could compete with the primary alcohol for reaction with a silylating reagent.
Alkylating the amide using the Mitsunobu reaction was therefore a priority to avoid
obtaining mixtures of isomers during loading onto the resin. However, by adopting this
strategy it was possible that both of the two alcohols present could participate in the
Mitsunobu [117] reaction (i.e. the allyl alcohol to make the 3-allyloxyindazole derivative
and the alcohol present in the terminal position of the alkyl chain in 264). It was
proposed that the use of excess allyl alcohol would favour the coupling with allyl
alcohol and so avoid an intermolecular coupling between two molecules of 264. The
first attempt at this reaction showed complete coupling between allyl alcohol and
indazolinone 264 and the intermolecular reaction was not observed.
The 'id NMR spectrum of the crude reaction mixture shows the presence of both
the O-allyl 265 and A-allyl 266 derivatives.
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Figure 34: 'H NMR spectrum (6.2-4.8 ppm) of the crude Mitsunobu reaction on 264 to obtain
265 and 266.
265 and 266 were therefore synthesised from commercially available methyl 5-
bromoanthranilate 228 and correspond to the starting point for our library blueprint.
2.3.3.Solution phase studies
The previous section described the preparation of 265, a substrate that can be
loaded onto the solid support. The general sequence developed for the library synthesis
has previously been described in section 2.2. The combination of these two studies is
described in the following section which culminates in the transfer of all the described
chemistry from the solution to the solid phase. The different targets and intermediates
were all prepared in solution to allow full analytical characterisation of the products.
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Because solid phase synthesis does not easily allow the synthesis of large quantities of
product, it was decided to synthesise the targets and intermediates on the solid support
and then compare them with the authentic materials synthesised in solution phase using
LC/MS techniques.
2.3.3.1. Synthesis of 270
As mentioned previously in the goals of the project, a silicon-based resin was
chosen to carry out the solid phase synthesis. The solution-phase analogue of the
silicon-based resin was the triisopropylsilyl (TIPS) moiety. The reagent used in order to
protect the primary alcohol in 265 was triisopropylsilyl trifluoromethane sulfonate
(TIPSOTf), which allowed, in the presence of triethylamine, the synthesis of 267 in
quantitative yield. Evidence to support the successful displacement of the triflate by the
primary alcohol in 265 came from the fact that the polarity of 267 decreased
dramatically compared with 265. Flash column chromatography of 267 was run in neat
hexane whereas 265 was purified using 20% ethyl acetate/hexane. In addition, the
multiplet at 0.99 ppm in the 'H NMR spectrum of 267 integrated for 21 protons
corresponded to the two types of protons (CH3 and CH) present in the TIPS group.
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Scheme 154: Synthesis of 270 in solution; a) TIPSOTf, Et3N, THF, 1 h, rt, quantitative, b) aq.
LiOH, THF, o/n, rt, 75%, c) BnBr, 'BuOK, THF, o/n, rt, 67%, d) TBAF, THF, 16 h, rt, 89%.
In order to insert diversity at the N1 position, the carbamate functionality in 267
must be removed. This was achieved in a vigorously stirred biphasic system of aqueous
lithium hydroxide and THF. 268 was the expected product of the deprotection. The
presence of a new band at 3205 cm"1 in the infrared spectrum of 268 was consistent with
the deprotection of the carbamate group as this band was assigned to the NH in 268.
The absence of the bands at 1755 and 1725 cm"1 reinforced our view that N1
deprotection has occured, as these two bands were assigned to the carbonyl group of the
carbamate protecting the N1 position in 267. The deprotection of 267 to 268 was
achieved in 75 % yield after purification of 268 by flash column chromatography.
In the next step, we decided to use an alkylating agent as an example of diversity
incorporation at the N1 position. 268 was therefore reacted with potassium t-butoxide
and benzyl bromide in THF. The reaction was quenched after 30 minutes as TLC
analysis showed that all the starting material 268 had reacted. High resolution mass
spectroscopic analysis of 269 is consistent with the assigned structure (chemical
ionisation mode m/z\ 479.3094, corresponding to the molecular formula Cig^NiChSi
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[M+H]+ (calculated for 269 479.3092)). Absence of the signal at 3205 cm"1 in the
infrared spectrum (corresponding to the NH functionality) and the presence of a singlet
at 5.23 ppm in the 'H NMR spectrum (integrating to 2 protons, benzylic CH2), that
coupled with C-8 (52,3 ppm) in the HSQC spectrum provided evidence that the benzyl
group was in the N1 position. 269 was isolated in 67% yield.
The final step en route to 270 in solution was the deprotection of the TIPS group
[171]. Generally, Si-O bonds are cleaved with a source of fluoride [172'1731 due to the fact
that the Si-F bond strength is 3 kcal/mol greater than the Si-0 bond strength |173'. As
purification is possible in solution phase to remove the by-products, the silicon-oxygen
bond was cleaved with an inorganic source of fluoride, tetrabutylammonium fluoride
(TBAF) in THF to yield 270 in 89%. The presence of the primary alcohol in 270 was
confirmed by the presence of a broad signal at 7.41 ppm in the 'H NMR spectrum. The
presence of the allyl group on the oxygen was confirmed by HSQC and HMBC
experiments. Indeed, the allylic CH2 (4.83 ppm) was coupled with C-3 (155.4 ppm) in
the HMBC spectrum. This indicates that the allyl moiety is on the oxygen of the
indazolinone core. Finally, high resolution mass spectroscopic analysis of 270 was
consistent with the assigned structure (m/z: 323.1752 indicates a general formula of
C20H22N2O2, (calculated for 270 323.1760)).
To enable facile characterisation of products cleaved from the solid phase resin,
it is necessary to compare them with authentic samples prepared in solution. For this
purpose, all TIPS-containing intermediates (e.g. 268) were deprotected to give the
corresponding alcohols (e.g. 271).
Scheme 155: Synthesis of 271 in solution; a) TBAF, THF, 16 hours, rt, 66%.
The conditions used in the deprotection of the TIPS group in 269 were also
applied to the substrate 268 (Scheme 155) to yield 271 in 66%. No signals
corresponding to a TIPS group were present in the "H NMR spectrum of 271. The broad
singlet at 8.90 ppm in the 'H NMR spectrum, also present at 8.74 ppm in the starting
material 268, was assigned as the NH in 271.
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2.3.3.2. Synthesis of 275
2.3.3.2.1. Synthesis of 275 from 266 (Route 1)
As described in section 2.2.7 (page 105), alkylation of 7/2-substituted
indazolinones of type 23 occurs at the N1 position. A route to 275 that takes advantage
of this observation was therefore pursued starting from 266 (page 146). The reaction
sequence involves protection of the primary alcohol using triisopropyl trifluoromethane
sulfonate (TIPSOTf), deprotection of the carbamate group at the N1 position and
benzylation of the N1 nitrogen to give 274. Finally, removal of the silyl protecting
group would give 275. This strategy is described in Scheme 156.
Scheme 156: Synthesis of 275 from 266 in solution; a) TIPSOTf, Et2N, THF, 2 h, rt, 99%, b) aq.
LiOH, THF, o/n, rt, 60%, c) BnBr, Et3N, THF, o/n, rt, 99%, e) TBAF, THF, o/n, rt, 74%.
The first step of the sequence involved the protection of the primary alcohol
present in 266 by a silicon-based reagent. Triisopropylsilyl trifluoromethane sulfonate
was used in THF in the presence of triethylamine to prepare 272, which was isolated in
99% yield. Transforming the alcohol in 266 to the silyl ether 272 decreased the polarity
considerably;
Rf266: 0.07 (50% EtOAc/PE) and Rf272: 0.43 (20% EtOAc/PE).
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The insertion of the TIPS group was also confirmed by the disappearance of the
band at 3426 cm"1 in the infrared spectrum, corresponding to the alcohol functionality in
266, and the coupling observed in the HSQC spectrum between the protons observed at
0.99 ppm (!H NMR), corresponding to the CH and CH3 of TIPS group, and the two
signals at 12.0 ppm and 18.0 ppm (13C NMR) corresponding to the two different carbon
environments in the isopropyl moiety.
272 was then reacted with a biphasic system of aqueous lithium hydroxide and
THF. The biphasic system was stirred vigorously for 16 hours. The crude reaction
mixture was purified using flash column chromatography to give 273 in 75% yield. The
preparation of 273 was confirmed by 'H NMR spectroscopy with the presence of a new
signal at 7.39 ppm corresponding to the NH group and the disappearance of the
quadruplet at 4.36 ppm (CH2 of the ethyl carbamate) and the triplet at 1.38 ppm (CH3 of
the ethyl carbamate) being consistent with the assigned structure of 273. 273 is a low
melting solid (m.p. = 63-65°C), suggesting that hydrogen-bond interactions between the
carbonyl and the NH are presumably present.
273 was then reacted with benzyl bromide in the presence of potassium t-
butoxide in THF at room temperature for 16 hours to give 274 in 99% yield. A band at
1674 cm"1 in the infrared spectrum supported the presence of the carbonyl of the
1 "3
indazolinone in 274. Moreover, a signal at 53.7 ppm in the C NMR spectrum was
assigned as the benzylic carbon. The chemical shift indicates that the benzyl group is
bonded to the N1 position, as the equivalent carbon in 269 appears in the same region
(S: 52.3 ppm). The interpretation of the HMBC spectrum for 274 also confirmed that
benzylation of the N1 position had occurred as no coupling between the benzylic
protons and the C-3 of the indazolinone was observed. This coupling would have been
observed ifO-benzylation had occurred.
274 was then deprotected to the corresponding alcohol using
tetrabutylammonium fluoride to give 275 in 74% yield after flash column
chromatography. The successful deprotection of the alcohol was confirmed by the
presence of a band at 3362 cm"1 in the infrared spectrum, characteristic of an OH
functional group, and the absence of two signals at 12.0 and 18.3 ppm in the 13C NMR
spectrum of 275 (these two types of carbon environment were present in 275 and have
been assigned to the carbons in the isopropyl group).
Deprotection of 273 was also carried out under standard conditions to give an
authentic sample of 276 in a modest 60% yield.
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Scheme 157: Synthesis of 276 in solution; a) TBAF, THF, o/n, rt, 60%.
The preparation of 276 was considered successful as the signals characteristic of
the TIPS group at 11.9 and 18.0 ppm in the 13C NMR spectrum of 273 were not present
in the spectrum of 276. High resolution mass spectroscopic analysis of 276 confirmed
that the molecular formula of 276 was as expected (m/z: 233.1288 corresponded to
[M+H]+, Q3H17N2O2 (calculated m/z: 233.1290)).
2.3.3.2.2. Synthesis of 275 by Claisen rearrangement (Route 2)
The strategy described in section 2.3.3.2.1 relies on the fact that benzylation
(alkylation) occurs specifically at the N1 position of ^-substituted indazolinones. Two
strategies leading to 275 are possible starting from 265, one of which also relies on this
information. Starting from the 3-allyloxyindazole derivative 265, the rearrangement of
the allyl moiety from the O position to the N2 position can be induced at two different
stages (dotted arrows in Scheme 158):
A) when the N1 position is protected by the carbamate group, from 267 to 272.
B) when the N1 position is substituted by the benzyl group, from 269 to 274.
153
Scheme 158: Two paths to 275 from 265.
2.3.3.2.2.1. Synthesis of 272 from 265 via 272
The preparation of 275 from 272 was successful (Scheme 156, page 151).
Therefore, in order to show that 275 can be prepared from 265 via route A, it was
necessary to show that the rearrangement of 267 to 272 (Scheme 159) was possible.
Scheme 159: Synthesis of 267 from 272; a) Pd(PPh3)4, THF, 90%.
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267 was dissolved in dry THF and a catalytic amount of
tetrakis(triphenylphosphine)palladium(0) was added. The reaction was protected from
the light by foil and stirred at room temperature under an inert atmosphere for 16 hours.
The product isolated from the reaction was compared to the starting material 267 and to
the expected product 272. The 'H NMR spectra comparison shows clearly that the
starting material (Figure 35a) was converted to the desired product of the rearrangement
reaction (Figure 35b). The material obtained after the rearrangement reaction was then
compared to the expected product (Figure 35c). The similarity of the signals in the allyl
region (6.3-4.5 ppm) indicates that the material obtained after rearrangement of 267 is
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Figure 35: *H NMR spectra comparison of a) starting material 267, b) 267 after reaction with
tetrakis(triphenylphosphine)palladium(0), and c) expected product 272.
2.3.3.2.2.2. Synthesis of 275 from 265 via 269
We have previously described the successful preparation of 269 from 265
(Scheme 154, page 149). Subsequent rearrangement of 269 to give 274 was therefore
attempted.
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Scheme 160: Synthesis of 274 from 269; a) Pd(PPh3)4, THF, 90%.
269 was treated with tetrakis(triphenylphosphine)palladium(0) in THF at room
temperature under an inert atmosphere. The reaction was stirred for 16 hours and the
crude reaction mixture was purified by flash column chromatography to give 274 in
90% yield. The 'H and 13C NMR spectra of 274 prepared by this route were compared
















Figure 36: 'H NMR spectra comparison of a) starting material 269, b) 269 after reaction with
Pd(PPh3)4 and c) authentic 274.
2.3.4.Solid phase studies
In order to evaluate the synthesis developed on insoluble polymer, every step
was analysed by LC/MS to compare the product synthesised on the resin and cleaved
from the solid support with the fully characterised authentic material made in solution.
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The LC/MS conditions were set up and optimised using the authentic materials using a
C18 reverse phase column.
2.3.4.1. The loading
2.3.4.1.1. The solid support and the loading reaction
The TIPS group previously used in the solution phase was viewed as a model of
the silicon-tethered resin planned for the solid phase synthesis. The details of this
commercially available resin (Novabiochem, 50-100 pm, 1.50 mmol per gram of resin)
appear in Scheme 161. This resin is a copolymer based on polystyrene, made from 4-
bromostyrene (in blue), styrene (in clear blue) and a cross linker unit, divinylbcnzene
(in red) (277). The bromine was then replaced using a Suzuki coupling reaction with the
boronate derived from the allyl moiety in 278 to insert the three carbon chain (purple).
The metho\\ phen\ i moiety (in green) is the group that allows the activation of the
resin 278R and the loading of the small molecule of interest through an alcohol
functional group.
Scheme 161: Structure of the bromopolystyrene resin 277. 278 and 278R, silicon-based resin
before activation.
The activation of the resin 278R is generally carried out in the presence of triflic
acid (trifluoromcthanesulfonic acid), one of the strongest organic acids ^l59^. It is
employed as a protonating reagent. The protonation of the paramethoxyphenyl group
allows its removal, giving a very electrophilic silicon atom which is then attacked by the





Scheme 162: Loading of alcohol on the silicon-based resin, a) TFA, DCM, rt, 30 min. b) i) 2,6-
lutidine, DCM, rt, 15 min. ii) ROH, DCM, rt, 10 h.
Any trace of water or competing nucleophiles must be avoided as they could
interfere during the loading procedure. This would result in residual reactive sites on the
resin (Scheme 163) and would contaminate the compound of interest after final
cleavage.
278R, ii) presence ofwater, iii) presence of undesired alcohol during activation/loading step.
The advantages of this resin are that the reaction conditions for the cleavage are
specific as the Si-0 bond is cleaved by fluoride anion. HF/pyridine is typically used for
cleavage when this resin is used.[I59] The reaction is quantitative and occurs at room
temperature under mild conditions.1'The main advantage of this strategy is the fact
when the cleavage reaction is quenched with methoxy trimcthylsilane, all the by¬











Scheme 164: Cleavage of resin 280 by HF/pyridine and quenching with methoxy
trimethylsilane; a) HF/pyridine, THF, 3h, rt, b) MejSiOMe, 30 min, rt.
The loading level was determined by mass differences. Two equivalents of
alcohol were used for the loading step. Any unloaded alcohol was recovered by
filtration and carefully purified. The difference between the initial mass of alcohol and
the mass obtained after loading/purification gave the mass of alcohol loaded onto the
resin.
After loading, a small amount of the resulting resin was cleaved and the product
analysed by I.C/MS. The nanomolar quantities of product cleaved from the resin were
collected and injected on a CI8 reverse column and compared with the corresponding
authentic material.
2.3.4.1.2. Loading and proof of loading of the N-allyl isomer 266
266 was prepared and dried initially by azeotropic distillation with toluene and
then under high vacuum 'l36' in order to remove any traces of moisture. 266 was then
loaded onto the solid support according to the standard procedure.'136' The quantity of
material recovered from the loading after careful purification led to a calculated loading
level of 33%. Whilst disappointingly low it was still possible to carry out the desired
reactions using this material.
In order to prove the loading reaction was successful, 266R (Scheme 165) was
cleaved using HF/pyridine according to the standard procedure.1136' The solution was
then separated from the insoluble polymer by filtration and solvent and by-products
were evaporated in vacuo. The residue was dissolved in a mixture of water/methanol 1:1
and injected onto the CI8 reverse phase column.
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Scheme 165: Cleavage of 266R; a) i) HF-Pyridine, THF, 3 h, rt, ii) Me3SiOMe, 30 min, rt.
LC/MS traces of the authentic material 266 made in solution phase (page 146)










Figure 37: Comparison by LC/MS of a) 266 authentic material obtained by direct synthesis and
b) material cleaved off the resin 266R.
The retention times of 266 and material cleaved of 266R are near identical
(Figure 37). Moreover, additional data confirmed that the products are the same (m/z:
327 corresponding to [M+E1]+ in both products). Finally, UV traces recorded on the
diode array concluded that the product 266 loaded onto the resin to make 266R, and
cleaved off the resin afforded 266 as the only product loaded onto the resin.
2.3.4.1.3. Loading and proof of loading of the O-allyl isomer 265
265 was prepared and dried in order to remove any trace of moisture. 265 was
then loaded onto the solid support.[136] The quantity of material recovered from the
loading after careful purification led us to a loading level of 33%.
265R (Scheme 166) was then cleaved using HF/pyridine according to the
standard procedure1136] to judge the success of the loading reaction. The solution was
then separated from the insoluble polymer by filtration and solvent and by-products
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were evaporated in vacuo. The residue was dissolved in a mixture ofwater/methanol 1:1
and injected onto the CI 8 reverse phase column.
Scheme 166: Cleavage of 265R; a) i) HF-Pyridine, THF, 3 h, rt, ii) Me3SiOMe, 30 min, rt.
LC/MS traces of the authentic material 265 made in solution phase and the
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Figure 38: Comparison by LC/MS of a) 265 authentic material obtained by direct synthesis and
b) the material cleaved off the resin 265R.
The retention times of 265 and material cleaved of 265R are very similar (Figure
38). Moreover, data collected confirmed that the products are the same, with m/z: 327
corresponding to [M+H]+ in both products. Finally, UV traces recorded on the diode
array concluded that the product 265 loaded onto the resin to make 265R, and cleaved
off the resin afforded 265 as the only product loaded onto the resin.
2.3.4.2. Deprotection of the carbamate using LiOH
The loadings of 265 and 266 were both successful. The next step in order to
transfer the solution phase reaction sequence to the solid support was to remove Nl-
ethyl carbamate protecting groups on resin 265R and 266R to allow for subsequent
functionalisation.
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2.3.4.2.1. N1 deprotection of 266R
The resin 266R was treated with a suspension of LiOH in THF/H2O. Multiple
conditions were tried, but 300 pL of 2M LiOH in 3 mL of THF, despite the fact that it
resulted in a biphasic mixture, was shaken vigorously and allowed the complete
deprotection over 2 days, at room temperature. The product resulting from the lithium
hydroxide treatment was subsequently cleaved off the resin by a solution of hydrogen
fluoride/pyridine in THF (Scheme 167). The solvent was removed in vacuo and the
product was injected onto the CI8 reverse phase column.
R=resin (276R)
^R=H (276) H
Scheme 167: Synthesis of 276 on solid phase; a) LiOH, THF, 48 h, rt, b) i) HF-Pyridine, THF, 3
h, rt, ii) MesSiOMe, 30 min, rt.
LC/MS traces of the authentic material 276 (page 153) made in solution phase
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Figure 39: Comparison by LC/MS of a) 276 authentic material obtained by direct synthesis and
b) the material cleaved off the resin after treatment with lithium hydroxide, and expansion of the
area of interest.
Figure 39 shows that 276 obtained by direct synthesis and 276 made from 266R
via 276R and cleaved by HF/pyridine are identical confirming that the deprotection step
on the solid phase had worked. The retention times are slightly different (10 seconds)
due to a different internal pressure in the system. However, the UV traces show two
maxima at 219 and 313 nm for both the authentic material 276 and for the material
cleaved from resin 276R. Moreover, identical masses (m/z: 233 [M+H]+) allowed us to
conclude that the deprotection of the N1 carbamate of 266R on solid phase was
successful.
The idea of a biphasic system (THF/LiOH) was initially viewed as a possible
disadvantage but the experiment proved that this concern was unjustified.
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2.3.4.2.2. NT deprotection of 265R
The conditions previously used for the deprotection of 266R on solid support
were used for the dcprotcction of 265R. However, after two days, no deprotection of the
carbamate on 265R was observed. The carbonyl carbon in the carbamate of 265R is less
electrophile than in 266R as the resulting N2 substituted indazolinone 283 is a better
leaving group that the O isomer 284, due to the increased stabilisation of the negative
charge by the oxygen atom (O atom more electronegative than N atom) (Scheme 168).
Scheme 168: 283 as a better leaving group by stabilisation of the negative charge by the
carbonyl.
Therefore, the deprotection conditions had to be changed to remove the
carbamate group on 265R. From 2 days at room temperature (to deprotect A^-allyl
indazolinone 266R), the conditions needed were set up at 2 days at 50°C to allow
complete deprotection in the N1 position.
(265R)
b) C R=resin (271R)^R=H (271)
Scheme 169: Synthesis of 271 on solid support; a) LiOH in THF, 50°C for 2 days, b) i) FIF-
Pyridine, TIIF, 3 h, it, ii) Me3SiOMe, 30 min, rt.
LC/MS traces of the authentic material 271 (page 150) made in solution phase










Figure 40: Comparison by LC/MS of a) 271 authentic material obtained by direct synthesis and
b) the material cleaved off the resin 271R.
The similar retention times, 4.70 min for the authentic material 271 and 4.50 min
for the material cleaved of the resin 271R provides some support for the fact that the
deprotection of 265R on the solid phase gave the product of interest. Mass
spectroscopic analysis gave the same major peak (m/z: 233 [M+H]+) and UV data
showed the maxima at 216 and 303/304 nm in both products. Despite the slightly
different retention times due to the fact that the two samples were run at different days,
the deprotection of 265R by lithium hydroxide treatment at 50°C for 2 days was
successful and gave 271 as the unique product of the reaction.
2.3.4.3. Nl-functionalisation
2.3.4.3.1. Functionalisation of 276R
The benzylation of 276R (page 162) was achieved by vigorously shaking the
resin in the presence of potassium /-butoxide and benzyl bromide in THF for 2 days at
room temperature. The resulting product was cleaved off the resin according to the
procedure reported in the literature [136] (Scheme 170).
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(276R)
Scheme 170: Synthesis of 275 on solid phase; a) BnBr, 'BuOK, THF, 48 h, rt, b) i) HF-Pyridine,
THF, 3 h, rt, ii) Me3SiOMe, 30 min, rt
LC/MS traces of the authentic material 275 (page 151) made in solution phase
and the material cleaved from the solid support 275R are shown in Figure 41.
b) the material cleaved of the resin 275R.
The chromatograms of the authentic material 275 and the material cleaved off
the resin 275R show similar retention time at 6.00 minutes. The UV spectra show also
the same maxima at 207, 223, 244 and 322(±1) nm for both products. The mass
spectroscopic analysis showed the same major peaks at m/z\ 345 (100%) corresponding
to the sodium adduct |44+Naj' and at m/z\ 323 (70%) corresponding to [M+H]+ of
C20H22N2O2. The synthesis of 275 on the solid support was therefore successful after 2
days of reaction. Another minor product that appeared in the chromatogram at a
retention time of 10.25 minutes has not been identified. However, it has been compared
with the materials previously obtained and does not correspond to the unreacted starting
material 276.
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2.3.4.3.2. Functionalisation of 271R
The benzylation of 271R was attempted using the same conditions previously
described for the benzylation of the /V2-allyl isomer 276R. However, a reaction time of
two days was not enough to push the reaction to completion as unreacted starting
material was detected by LC/MS. The reaction was pushed to completion by leaving the
beads in contact with benzyl bromide and the base ('BuOK) for 5 days at room
temperature (Scheme 171). The resin 270R was then submitted to the cleavage
conditions (HF/pyridine then MeOSi(Me)3)J136^
b)C^eR=resin (270R)(270)
Scheme 171: Synthesis of 270 on solid phase; a) BnBr, 'BuOK, THF, 5 days, rt, b) i) HF-
Pyridine, THF, 3 h, rt, ii) Me3SiOMe, 30 min, rt
LC/MS traces of the authentic material 270 made in solution phase and the











Figure 42: Comparison by LC/MS of a) 270 authentic material obtained by direct synthesis and
b) the material cleaved off the resin 270R.
The material cleaved off the resin 270R has a retention time different by 2
minutes compared to authentic 270. This difference is explained by the differences in
back pressure in the HPLC system at the moment of the analysis (the two spectra were
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recorded on different days). However, the UV properties of the two materials appeared
to be almost identical as 270 shows two maxima at 217 and 315 nm and the product
cleaved from 270R gave two maxima in the same regions, 225 and 313 nm. Moreover,
the authentic material of formula C20H22N2O2 shows on the chromatogram a peak at
m/z: 345, corresponding to the sodium adduct [M+Na]+ and a peak at m/z: 323,
corresponding to the protonated species [M+H]+ and two fragments at m/z\ 304 and 282.
The material cleaved off the resin contains peaks at m/z: 345 and 304, corresponding to
the sodium adduct of the material of interest and the common fragment [M-19]+
respectively.
This data has been interpreted as supporting the successful synthesis of 270 on
the solid support.
2.3.4.4. The rearrangement
One of the main driving forces of the project is the aza-Claisen rearrangement of
the allyl moiety from the oxygen to the nitrogen position. Described in Scheme 18 (page
39), our aim was to access different cores from a single starting material. We have
shown so far that we could make the two targets on solid support. However, the
synthesis of these targets does not involve the aza-Claisen rearrangement. In this
section, the rearrangement of the allyl moiety was studied to prove that the aza-Claisen
rearrangement can be used as a skeleton diversity reaction in the case of indazolinones
on the solid phase resin. The rearrangement of the two species 265R and 270R by the
use of the two methods described previously in solution (section 2.2.4, page 73)
(palladium-catalysis and microwave-induced) was the ultimate goal of our project.
2.3.4.4.1. Pd(PPh3)4 Rearrangement
2.3.4.4.1.1. Rearrangement of 265R using palladium (0) catalysis
The resin 265R was treated with tetrakis(triphenylphosphine)palladium(0) in
solution in THF. The reaction was left for 24 hours at room temperature under an inert
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Scheme 172: Synthesis of 266 on solid phase; a) Pd(PPh3)4, THF, 24 h, rt b) i) HF-Pyridine,
THF, 3 h, rt, ii) Me3SiOMe, 30 min, rt.
LC/MS traces of the authentic material 266 (page 146) made in solution phase
and the material made on the solid support from 265R via 266R are shown in Figure 43.
Figure 43: Comparison by LC/MS of a) 266 authentic material obtained by direct synthesis and
b) the product obtained by rearrangement with Pd(PPh3)4 on the resin 265R.
According to the chromatogram (Figure 43), the reaction catalysed by
tetrakis(triphenylphosphine)palladium(0) gave two products. The peak at 6.37 minutes
corresponds to the expected product 266. The authentic material of formula Ci6H2oN204
shows on the chromatogram a peak at m/z: 327, corresponding to the sodium adduct
[M+Na]+ and a peak at m/z\ 305, corresponding to the protonated species [M+H]+. The
material cleaved off the resin contains peaks at m/z: 327 corresponding to the sodium
adduct of the material of interest. The UV spectra show the same maxima at 310 and
225 nm.
The signal appearing at 3.90 minutes shows a UV spectrum characteristic of
indazolinones (data not shown). According to the molecular mass (m/z: 287), the
product was assigned as the de-allylated compound 264. The peak at m/z: 287 could
correspond to the sodium adduct of 264 (264+23(Na)=287 [M+Na]+) and the peak at
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Scheme 173: Structure and UV spectrum of 264.
The use of excess tetrakis(triphenylphosphine)palladium(0) in this reaction is a
possible reason of obtaining 264. It is known that palladium (0) can be used to deprotect
iV-allyl[174] and 0-allyl[175] compounds in the presence of a nucleophile. The presence of
adventitious water acting as nucleophile might have aided the removal of the allyl
group, either in the starting material or in the expected product, giving 264 in both
cases.
It has been shown that the rearrangement of the allyl moiety from the O to the
N2 position on the solid phase is possible. It is believed that the amount of the observed
the side reaction could be decreased by reducing the amount of catalyst. This
transformation has not been optimised further due to time constraints.
2.3.4.4.1.2. Rearrangement of 270R by palladium catalysis
(270R)
Scheme 174: Synthesis of 275 on solid phase; a) Pd(PPh3)4, THF, 24 h, rt, b) i) HF-Pyridine,
THF, 3 h, rt, ii) Me3SiOMe, 30 min, rt.
LC/MS traces of the authentic material 275 made in solution phase and the
material obtained after reaction of 270R with tetrakis(triphenylphosphine)palladium(0)
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Figure 44: Comparison by LC/MS of a) 275 authentic material made by direct synthesis in
solution, b) the products obtained by rearrangement with Palladium on the resin after 24 hours,
c) the product obtained by rearrangement with Palladium on the resin after 72 hours.
The rearrangement of 270R under these conditions shows that there is unreacted
starting material present after 24 hours (peak at r.t= 32.3 min). However, the peak with
a retention time of 7 minutes corresponds to the desired product 275 as seen by the
comparison with authentic material. Unfortunately, an analogous problem to that
observed for 265R was also seen. The peak at 4.5 minutes corresponds to 285 resulting
from deprotection of the allyl group (Scheme 175). The mass corresponding to this peak
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Scheme 175: Structure, UV spectrum and main ion currents observed by mass spectroscopy of
285.
When the reaction was repeated with an extended reaction time (72 hours), the
material cleaved off the resin corresponded predominantly to 285. However, even after
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72 hours, a broad flat peak appearing at 33 minutes reveals the presence of unreacted
starting material 270 (Figure 44).
As discussed above, the formation of 285 probably occurs via Pd(0) catalysed
deallylation in the presence of adventitious water (nucleophile).
2.3.4.4.2. Rearrangement using Microwave
2.3.4.4.2.1. Rearrangement of 265R
Our solution phase studies (Section 2.2.4) suggested that the use of microwave
irradiation to induce rearrangement of the N1-protected indazolinone 265R were
unlikely to be successful as the required reaction conditions cleaved the N-C bond in the
carbamate protecting group, resulting in N1 deprotection. However, we decided to try
this reaction.
Scheme 176: Synthesis of 266 on solid phase; a) Microwave irradiation in DMF, b) i) HF-






Figure 45: Comparison by LC/MS of a) 266 obtained by direct synthesis in solution and b) the
products obtained by rearrangement with microwave on the resin 265R.
Studying the LC/MS traces obtained for the rearrangement reaction of 265R
induced by microwave irradiation revealed that all the starting material has reacted.
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However, the reaction did not produce a single product. Four peaks corresponding to
four products were detected. Each product was compared with the intermediates already
characterised and assigned as follows:
- Rt= 2.5 minutes: 276 (page 162), product of the rearrangement that has been
subsequently deprotected
- Rt= 3.0 minutes: unidentified product
- Rt= 5.0 minutes: 271 (page 150), deprotected starting material
- Rt= 6.2 minutes: 266 (37%) (page 146) desired product from the
rearrangement.
According to the result of this experiment, it has been shown that the allyl group
can be rearranged from the O to the N2 position under microwave conditions. However,
when the N1 position is substituted by a carbamate group this group does not survive
the reaction.
2.3.4.4.2.2. Rearrangement of 270R
(270R)
Scheme 177: Synthesis of 275 on solid phase; a) microwave irradiation in DMF, b) i) HF-
Pyridine, THF, 3 h, rt, ii) Me3SiOMe, 30 min, rt.
The comparison of the authentic material 275 made in solution and the material
made on the solid support by LC/MS leads to the conclusion that a successful
rearrangement under microwave irradiation has occurred. As shown in Figure 46, the
retention times are very similar. Moreover, the UV properties are similar and maxima
are observed at 323 and 225 nm. The masses recorded for the two samples are identical,
i.e. m/z\ 345 corresponding to the sodium adduct of the desired product 275 and m/z\
323 ([M+H]+). This result proves that microwave induced rearrangement of 270 on solid











Figure 46: Comparison by LC/MS of a) 275 authentic product made in solution and b) the
product obtained by rearrangement with microwave on the resin.
2.3.5.Conclusions
The final part of the project was to develop the methodology reported in section
2.2 so that it was applicable to the synthesis of a library based on indazolinones as the
central core.
The objectives were to create and synthesise an indazolinone derivative
containing a linker that enabled it to be loaded onto a solid phase resin. The covalent
bond formed between the solid support and the small molecule was chosen to be a
silicon-oxygen bond. Therefore, the indazolinone derivative had to contain an alcohol
functionality. The synthesis of 231 by Suzuki coupling of commercially available
anthranilic derivative 228 followed by iodination and cyclisation proved a successful
route to reach the targeted indazolinone derivative 232. Orthogonal protecting groups
were chosen to synthesise 264, which was submitted to Mitsunobu conditions with allyl
alcohol to access 265 and 266 as the two key structures designed for solid phase studies.
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Scheme 178: Summary structures.
Indeed, 265 and 266 were protected first by a TIPS group to simulate attachment
to a solid support. A series of reactions were then carried out to provide authentic
material. The same sequence was repeated with solid supported material after loading
265 and 266 onto the silicon-based resin. Cleavage of the small molecules from the
solid support by HF-pyridine treatment and analysis by LC/MS on a reverse phase
column were used to analyse reaction success. Both 265 and 266 were successfully
loaded onto the polystyrene-based resin. Deprotection of the carbamate on the N1
position with lithium hydroxide allowed the synthesis of 271 and 276 respectively.
Finally, alkylation of 271 and 276 on the solid support was successful in the presence of











Scheme 179: Summary structures.
The aza-Claisen rearrangement studied in section 2.2.4 involving palladium
catalysts and thermal methods (microwave) was applied to 265R and 270R in an
attempt to transform them into 266 and 275 respectively after Si-0 cleavage.
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Tetrakis(triphenylphosphine)palladium(0) catalysed sigmatropic rearrangement led to
the formation of the desired products when the N1 position was protected by a
carbamate group 265 or functionalised by a benzyl group 270. Unfortunately, additional
deallylated products were also present. This result could be explained either by the use
of excess Pd(0) or by the presence of an adventitious nucleophile trapping the 7t—allyl
palladium reactive species.
The microwave-induced rearrangement showed analogous results when the N1
position was protected by the ethyl carbamate group. The high temperatures do not
allow the C-N bond of the carbamate to survive causing its cleavage presumably by
adventitious water. However, the allyl group was rearranged successfully from the O
position to the N position in 270R, giving the desired product 275 as the unique product




This project is based on indazolinone core and involves three mains sections:
- The use of an aza-Claisen rearrangement of 3-allyloxyindazoles to the
corresponding N isomers. This sigmatropic rearrangement was induced by thermal and
catalytic methods. The classical thermal method using an oil bath and high boiling point
solvent did not show any interesting results. However, an alternative method using
microwave heating did show interesting results when the group at the N1 position of the
indazolinone was sufficiently stable. Mechanistic studies using substituted allyl groups
proved that the mechanism of the rearrangement is dependent of the substrate. Under
microwave conditions, the crotyl group was rearranged via a [1 ;3] mechanism
exclusively, whereas the cinnamyl group followed a [3 ;3] mechanism exclusively. This
is rationalised on steric grounds with a bulky group such a phenyl not allowing the
[1 ;3] rearrangement. The mechanism of the transition metal catalysed aza-Claisen
rearrangements with other tetrakis(triphenylphosphine)palladium(0) or
dichlorobis(acetonitrile) palladium (II) were consistent with literature results on
unrelated structures. The palladium (0) induces a unselective rearrangement of the
crotyl group to give a mixture of products corresponding to [1 ;3] and [3 ;3]
mechanisms but induces exclusive [1 ;3] rearrangement of the cinnamyl group.
Palladium (II) based catalyst rearranged the crotyl group via a [3 ;3] rearrangement
exclusively but did not have any influence of the cinnamyl group.
- Inspired by Schreiber's core-switching concept (section 1.3.1), the
rearrangement was the main driving force of the project. Example of potential library
building block were added onto the indazolinone structure and then submitted to the
rearrangement reaction. It has been noticed that building blocks such as isocyanate and
acid chloride could not be included in this library strategy. These substrates, under the
palladium (0) conditions resulted in formation of a single product which was
unfortunately not the desired product. However, electrophiles such as alkyl bromides,
sulfonyl chlorides, epoxides could be involved in building block selection because the
rearrangement was successful on these examples.
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The successful synthesis of an indazolinone derivative capable of being loaded
onto a resin was the starting point of the solid supported synthesis. The next step in this
approach was to simulate the solid support by use of a TIPS group and to develop the
synthesis in solution to create authentic compounds. These were fully characterised by
standard analytical method. The transfer of the reaction sequence to the solid support
involved the development of suitable analysis system, LC/MS system using a reverse
phase column. Comparison of the authentic compounds made in solution and the
products from the solid phase synthesis was the method of choice to validate the solid
phase strategy.
Deprotection of the carbamate and functionalisation on the N1 position were
optimised on the solid phase successfully. Aza-Claisen rearrangement at different points
of the route (N1 -protected and AC-benzylated) using different methods (catalysts and
microwave) concluded that the microwave irradiation on indazolinones with a non-
labile group attached on the N1 position (e.g. benzyl group) was the best method to
arrive at the desired products.
3.2. Possible future directions
Through the combination of the solid phase synthesis studies, the diversity
incorporation in the N1 position tolerated by the aza-Claisen rearrangement conditions
and the mechanistic studies on substituted allyl moieties, a compound library could be
generated.
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Scheme 180: Possible diversity generation by core-switching reaction using aza-Claisen
rearrangement methodology (catalysis or microwave irradiation).
The dichlorobis(acetonitrile) palladium (II) converts the crotyl group by
inducing a [3';3] mechanism and creates a new stereogenic center. At present, because a
an achiral catalyst has been used in the rearrangement reaction, the product is racemic.
However, a possible future direction for this project, after preliminary biological assays,
would be to investigate the importance of the absolute stereochemistry of the new
stereogenic centre using different chiral ligands on the transition metal to aid synthesis
of the enantiomerically enriched compounds. An analogous approach has been
described by Overman and it is the method of choice for synthesising chiral amines
from imidates (sec section 2.2.4.1).
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Scheme 181: Possible diversity generation involving aza-Claisen rearrangement using optically
pure ligands on the transition metal to induce enantiomerically enriched compounds.
When the terminal alkene is not substituted (R]=H or R1 = Me after Pd(II) or
microwave rearrangement), another level of diversity could be incorporated by using an
olefin metathesis reaction to couple the double bond of the allyl group, classified as type
1, to another double bond of for example type 3 according to Grubbs' classification [176'
177]




Unless otherwise stated, all reactions were performed under an atmosphere of
argon/oxygen free nitrogen. All glassware was dried at 140°C prior to use. Chemicals
and solvents were purchased from Acros, Aldrich, Avocado or Fluka and were used as
received unless otherwise stated. Tetrahydrofuran (THF) was dried by refluxing with
sodium-benzophenone under an N2 atmosphere and collected by distillation.
Dichloromethane (DCM) was dried by heating under reflux over calcium hydride and
distilled under N2 atmosphere. Toluene was dried by refluxing with sodium under an N2
atmosphere and collected by distillation. "Petrol" (petroleum ether) refers to that
fraction in the boiling range 40-60°C. Thin-layer chromatography (TLC) was performed
on glass plates coated with Merck Kieselgel 60 F254. Developed plates were air-dried
and scrutinised under a UV lamp (254&366 nm), and where necessary, stained with
iodine, ninhydrin or potassium permanganate to aid identification. Melting points were
determined using an Electrothermal 9100 melting point apparatus and are uncorrected.
Flash column chromatography was performed using Kieselgel 60 (0.040-0.063 mm
mesh, Merck 9385).
'id nuclear magnetic resonance (XH NMR) spectra were recorded on a Bruker
Avance 300 (300.1 MHz) or a Varian Gemini 2000 (300.0 MHz) spectrometer using the
deuterated solvent as the lock and the residual solvent as the internal reference in all
11
cases. C NMR spectra using the PENDANT sequence were recorded in a Bruker
Avance 300 (75.5 MHz) spectrometer. All other 13C spectra were recorded on a Varian
Gemini 2000 (75.5 MHz) spectrometer using composite pulse *H decoupling. Unless
otherwise stated, NMR spectra were run in CDCI3. Assigned carbon resonances have
been assigned using HSQC and HMBC. All coupling constants are quoted to the nearest
0.1 Hz. In NMR, s = singlet, d = doublet, t = triplet, q = quadruplet, m = multiplet, br =
broad.
Low resolution (LRMS) and high-resolution (HRMS) spectra recorded using
electron impact (EI) or chemical ionisation (CI) were acquired using the VG Autospec.
instrument and low resolution spectra recorded using Electrospray Ionisation (ESI) were
acquired using the VG Platform I instrument at the MS service as the University of St
Andrews.
I.R. spectra were recorded using Perkin-Elmer Paragon series 1000 Fourier
Transform spectrometer. Absorption maxima are reported in wavenumbers (cm"1).
Intensities of the maxima are quoted as strong (stg), medium (m), weak (w), broad (br).
Microanalyses were carried out in the Centre for Solid characterisation at the
University of St Andrews.
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Synthesis ofAf/-benzyloxycarboxy-2i7-indazolinone 17
To a solution of 17 (3.00 g, 22.4 mmol) in dry THF (250 mL) was added triethylamine
quenched by addition of a saturated solution of ammonium chloride (10 mL) and
extracted with ethyl acetate (5x50 mL). The combined organic extracts were dried
(MgSCL) and concentrated in vacuo. The crude product was redissolved in dry THF
(100 mL). To this solution was added morpholine (1.96 mL, 22.4 mmol, 1.00 equiv.).
After stirring overnight at room temperature under an inert atmosphere, the reaction was
quenched by addition of a saturated solution of ammonium chloride (10 mL) and
extracted with ethyl acetate (5x50 mL). The combine organic extracts were dried
(MgSCL) and concentrated in vacuo. The crude product was recrystallised from ethyl
acetate to give 111 as a white solid (3.05 g, 11.8 mmol, 53%); mp 191-192°C; !H NMR
S 8.02 (br s, 1H; NH), 7.72 (d, J= 7.9 Hz, 1H; H-4), 7.54-7.23 (m, 8H; H-aromatic),
5.45 (s, 2H; H-10); 13C NMR S 160.4 (C-3), 149.9 (C-8), 140.3 (C-7a), 134.8 (C-12),
131.2 (C-aromatic), 128.9 (C-aromatic), 128.8 (C-aromatic), 128.7 (C-aromatic),
124.5 (C-quat.), 123.8 (C-aromatic), 121.5 (C-4), 69.2 (C-10), one C-quat. too weak
to observe; LR MS (ES") m/z: 267 [M-H]\ HR MS (ES") calcd for Ci5HnN203 [M-H]"
267.0770, found 267.0775; IR (thin film, cm"1) 3426 m (br) (N-H), 3054 m, 2999 m,
2362 m, 1721 stg (C=0), 1603 stg (C=0), 749 stg;
O (9.36 mL, 67.2 mmol, 3.00 equiv.); the mixture was
stirred for two hours at room temperature under an
inert atmosphere. To this solution was added benzyl
chloroformate (9.55 mL, 67.2 mmol, 3.00 eq.) and
stirring was maintained for 16 hours. The reaction was
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Synthesis of ./W-benzyloxvcarboxy 3-allyloxyindazole 112 and Nl-
benzyloxycarboxy N2-a\\y\ indazolinone 113
To a solution of 111 (6.00 g, 22.4 mmol, 1.0 equiv.), triphenylphosphine (6.46 g, 24.6
mmol, 1.1 equiv.) and allyl alcohol (1.67 mL, 24.6 mmol, 1.1 equiv.) in dry toluene
(400 mL) was slowly added diethylazodicarboxylate (3.87 mL, 24.6 mmol, 1.1 equiv.).
The reaction mixture was stirred at room temperature overnight under an inert
atmosphere. The solvent was removed under reduced pressure and a saturated solution
of ammonium chloride was added. The aqueous layer was extracted with ethyl acetate
(3x50 mL). The combined organic extracts were dried (MgSCL) and concentrated in
vacuo. The crude product was purified by flash chromatography eluting with 5% to
20% ethyl acetate/petrol to give 112 (2.65 g, 38%) as a white solid and 113 (4.23 g,
61%) as a colourless oil;
(112): Rf(10% ethyl acetate/hexane) 0.37; mp 68-69°C;
'H NMR S 8.07 (br d, 1H; H-7), 7.70 (dt, J = 7.9, 1.0
Hz, 1H; H-4), 7.45-7.18 (m, 7H; H-aromatic), 6.07
(ddt, J=17.2, 10.5, 5.7 Hz, 1H; H-19), 5.42 (s, 2H, H-
10), 5.41 (dq, J= 17.2, 1.5 Hz, 1H; H-20a), 5.25 (ddt, J
= 10.5, 2.6, 1.2 Hz, 1H; H-20b), 4.92 (dt, J= 5.7, 1.3 Hz, 2H; H-18); !3C NMR S 159.6
(C-3), 150.8 (C-8), 140.3 (C-7a), 135.3 (C-ll), 132.3 (C-19), 130.0 (C-aromatic),
128.7 (C-aromatic), 128.6 (C-aromatic), 128.5 (C-aromatic), 123.5 (C-aromatic),
120.0 (C-4), 118.7 (C-20), 117.3 (C-3a), 114.8 (C-7), 70.0 (C-18), 68.8 (C-10); LR MS
(CI+) m/z: 309 [M+H]+; HR MS (CI+) calcd for Ci8Hi7N203 [M+H]+ 309.1239, found
309.1236; IR (thin film, cm"1) 3060 m, 3035 m, 2970 m, 2360 m, 1723 stg (C=0);
19 (113): Rf (10% ethyl acetate/hexane) 0.1; 'H NMR <5
7.87 (m, 2H; H-4 and H-aromatic), 7.59 (ddd, J= 8.6,
7.3, 1.3 Hz, 1H; H-aromatic); 7.43 (m, 5H; H-
aromatic), 7.31 (m, 1H; H-aromatic), 5.67 (ddt, J =
14
17.2, 9.9, 6.3 Hz, 1H; H-18), 5.40 (s, 2H; H-10), 5.11
(m, 2H; H-19), 4.81 (dt, J= 6.3, 1.2 Hz, 2H; H-17); 13C NMR 5 164.7 (C-3), 150.7 (C-
8), 143.0 (C-aromatic), 134.3 (C-aromatic), 133.5 (C-18), 131.4 (C-aromatic), 129.0
(C-aromatic), 128.8 (C-aromatic), 128.6 (C-aromatic), 124.6 (C-aromatic), 123.8
(C-aromatic), 119.2 (C-19), 118.6 (C-3a), 115.3 (C-aromatic), 69.4 (C-10), 49.1 (C-
17); LR (CI+) m/z: 309 [A/+H]+; HR (CI+) calcd for C18H17N2O3 [M+H]+ 309.1239,
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found 309.1246; IR (thin film, cm0) 1738 stg (C=0), 1700 stg (C=0), 1462 m, 1279 m,
751 m;
Synthesis of 3-aIlyloxyindazole 104
To a solution of 112 (2.50 g, 8.1 mmol, 1.0 equiv.) in THF (50 mL) was added a
solution of sodium hydroxyde 2 M (50 mL). The solution was stirred overnight at room
temperature. The organic solvent was removed in vacuo and the basic solution was
neutralised with diluted hydrochloric acid (10%) before extracting with ethyl acetate
(3><50 mL). The combined organic extracts were dried (MgSCL) and concentrated in
vacuo. The crude orange oil was purified by flash chromatography eluting with 20%
ethyl acetate/petrol to give 104 as a white solid (1.43 g, 99%); Rf (20% ethyl
acetate/petrol) 0.14; mp 81-82°C; 'H NMR 8 9.12 (br s, 1H; H-l), 7.71 (dt, J = 8.1, TO
Hz, 1H; H-aromatic), 7.39-7.25 (m, 2H; H-aromatic), 7.10 (ddd, J = 7.9, 6.7, 1.0 Hz,
1H; H-aromatic), 6.17 (ddt, J= 17.2, 10.6, 5.5 Hz, 1H; H-10), 5.48 (dq, J= 17.2, 1.6
Hz, 1H; H-l la), 5.32 (dq, J = 10.5, 1.4 Hz, 1H; H-l lb), 4.93 (dt, 7=5.5,1.5 Hz, 2H;
H-9); 13C NMR 8 157.1 (C-3), 142.5 (C-7a), 133.1 (C-10), 127.8 (C-6), 119.9 (C-4),
119.8 (C-5), 117.8 (C-ll), 112.6 (C-3a), 109.6 (C-7), 69.5 (C-9); LR MS (ES+) m/z\
175 [M+H] ; HR MS (ES ) calcd C10H,,N2O [M+H]' 175.0871, found 175.0871; IR
(thin film, cm"1) 3175 m (br) (N-H). 2925 m, 2858 w, 1625 m, 1525 stg (C=0), 1503 m,
1436 m, 1420 m, 1336 stg, 1250 m, 1 154 m, 989 m, 932 m, 766 stg, 746 m;
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Synthesis of (V2-allyl indazolinone 23
To a solution of 113 (64.0 mg, 0.021 mmol) in THF (TO mL) was added a solution of
sodium hydroxide 2 M (2 mL). The solution was stirred at room temperature overnight.
The solution was neutralised with a solution of hydrochloric acid (5%) and extracted
with dichloromcthane (3x50 mL). The combined organic extracts were dried (MgSCL)
and concentrated in vacuo. The crude product was purified by flash column
chromatography (50% and 100% ethyl acetate/hexane) to give 23 (35.0 mg, 97%) as a
white solid; Rf (50% ethyl acetate/petrol) 0.04; mp 113-114°C; 'H NMR S 8.58 (br s,
1H; H-l), 7.69 (dt, J= 7.9, 0.9 Hz, 1H; H-4), 7.40 (ddd, J= 8.3, 7.2, 1.2 Hz, 1H; H-6),
7.14 (dt, J= 8.3, 0.8 Hz, 1H; H-7), 7.07 (ddd, J = 7.9, 7.2, 0.8 Hz, 1H; H-5), 5.80 (ddt,
J= 17.1, 10.1, 5.9 Hz, 1H; H-9), 5.34 (dq, J= 13.8, 1.4 Hz, 1H; H-lOa), 5.14 (dq, J =
6.8, 1.2 Hz, 1H; H-lOb), 4.43 (dt, 7= 5.9, 1.4 Hz, 2H; H-8); l3C NMR S 162.0 (C-3),
146.5 (C-7a), 131.8 (C-6), 131.6 (C-9), 123.5 (C-5), 122.1 (C-4), 119.1 (C-10), 118.4
(C-3a), 112.3 (C-7), 46.6 (C-8); LR MS (ES^) m/z: 175 [M+H]+; HR MS (ES^) calcd
for CioHnN20 [M+H]+ 175.0871, found 175.0867; IR (thin film, cm"1) 3069 m (N-H),
2924 m, 2848 m, 2737 stg, 1628 stg (C=0), 1326 m, 926 stg, 747 m; Calculated for
C,oHioN20: C 68.95, H 5.79, N 16.08; found C 68.54, H 5.88, N 16.37%.
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Synthesis of 7V7-allyl 3-allyloxyindazole 106
Ha
12 Ha
To a solution of 104 (79.0 mg, 0.45 mmol) in dry THF (3.00
mL) was added potassium /-butoxide (61.0 mg, 0.54 mmol,
1.2 equiv.) and allyl bromide (45.0 pL, 0.50 mmol, 1.1
equiv.). The solution was stirred for 16 hours at room
temperature. The reaction was quenched by addition of
saturated ammonium chloride solution (20 mL) and
extracted with ethyl acetate (3x10 mL). The combined
organic extracts were dried (MgSCL) and concentrated in vacuo. The crude material was
purified by flash chromatography eluting with 10% ethyl acetate/hexane to give the
desired product 106 as a bright yellow oil (87.0 mg, 89%); Rf (40% ethyl acetate/petrol)
0.79; "H NMR <5 7.60 (dt, J= 8.1, 0.9 Hz, 1H; H-4), 7.24 (ddd, J = 8.5, 6.8, 1.1 Hz, 1H;
H-6), 7.12 (dt, J= 8.6, 0.9 Hz, 1H; H-7), 6.95 (ddd, 7.8, 6.9, 0.8 Hz, 1H; H-5), 6.08
(ddt, J = 17.1, 10.4, 5.5 Hz, 1H; H-13), 5.88 (ddt, J= 17.1, 10.4, 5.4 Hz, 1H; H-9), 5.38
(dq, J — 17.2, 1.6 Hz, 1H; H-14a), 5.21 (ddd, J = 10.5, 2.8, 1.3 Hz, 1H; H-14b), 5.08
(ddd, J = 10.3, 2.8, 1.4 Hz, 1H; H-lOb), 5.00 (ddd, J= 17.1, 3.0, 1.6 Hz, 1H; H-lOa),
4.82 (dt, J= 5.6, 1.4 Hz, 2H; H-12), 4.71 (dt, J= 5.4, 1.6 Hz, 2H; H-8) ; 13C NMR S
155.5 (C-3), 141.5 (C-7a), 133.23 and 133.18 (C-9 and C-13), 127.2 (C-6), 120.0 (C-
4), 119.0 (C-5), 117.7 and 117.0 (C-14 and C-10), 112.9 (C-3a), 108.8 (C-7), 69.6 (C-
12), 51.1 (C-8); LR MS (CI+) m/z: 215 [M+H]+; HR MS (CI+) calcd for Ci3H15N20
[M+H]+: 215.1184; found: 215.1193; IR (thin fdm, cm"1) 3081 w, 2924 w, 2363 w,
1619 m, 1527 stg (ON), 1494 m (ON), 1442 m, 1417 m, 1342 m, 1259 w, 1195 m,
1144 w, 1035 w, 985 m, 923 w, 740 stg (OC).
187
Synthesis ofA^,iV2-diallylindazolinone 107
To a solution of 23 (100 mg, 0.57 mmol) in dry THF (10.0
mL) was added potassium carbonate (87 mg, 0.63 mmol,
1.1 equiv.). After 30 minutes, allyl bromide (55.0 pL, 0.63
mmol, 1.1 equiv.) was added and the reaction was stirred at
room temperature under an inert atmosphere for 16 hours.
The reaction was quenched by addition of saturated
ammonium chloride solution (20 mL) and extracted with
ethyl acetate (3x30 mL). The combined organic extracts were dried (MgSCL) and
concentrated in vacuo. The crude material was purified by flash chromatography eluting
with 50% ethyl acetate/hexane to give the desired product 107 as a yellow oil (114 mg,
96%); Rf (50% ethyl acetate/petrol) 0.28; !H NMR 8 7.78 (m, 1H; H-4), 7.45 (ddd, J =
8.4, 7.2, 1.3 Hz, 1H; H-5), 7.10 (m, 2H; H-6 and H-7), 5.76 (ddt, J= 17.1, 10.2, 5.9 Hz,
1H; H-12), 5.42 (ddt, J= 17.0, 10.2, 6.1 Hz, 1H; H-9), 5.19 (ddd,T= 11.6,2.7, 1.4 Hz,
1H; H-13), 5.14 (m, 2H; H-10 and H-13), 5.06 (dq, J = 10.2, 1.2 Hz, 1H; H-10), 4.46
(dt, J= 5.9, 1.5 Hz, 2H; H-ll), 4.23 (dt, J= 6.2, 1.2 Hz, 2H; H-8); 13C NMR 8 163.2
(C-3), 148.9 (C-7a), 132.6 (C-12), 132.0 (C-6), 130.2 (C-9), 124.0 (C-4), 122.1 (C-5),
120.0 (C-10), 118.8 (C-3a), 117.9 (C-13), 111.7 (C-7), 51.8 (C-8), 44.7 (C-ll); LR MS
(CI+) m/z: 215 [M+H]+; HR MS (CI+) calcd for Ci3Hi5N20 [M+H]+: 215.1184, found:
215.1185; IR (thin film, cm"1) 3086 w, 2979 w, 2928 w, 1666 stg (C=0), 1615 m, 1479
m, 1461 m, 1258 m, 926 m, 756 stg (C=C);
188
Synthesis ofAO(2-hydroxypropyl) 3-allyloxyindazole 122
To a solution of 104 (200 mg, 1.15 mmol, 1.0 equiv.) in dry
THF (10.0 mL) was added potassium /-butoxide (257 mg,
2.30 mmol, 2.0 equiv.). The solution was stirred 1 hour at
room temperature. To the resulting solution was added
propylene oxide (400 pL, 5.70 mmol, 5.0 equiv.) and the
reaction was stirred at room temperature for 16 hours. The
reaction was quenched by addition of saturated ammonium chloride solution (15 mL)
and extracted with ethyl acetate (3x10 mL). The combined organic extracts were dried
(MgSCL) and concentrated in vacuo. The crude material was purified by flash
chromatography eluting with 20% ethyl acetate/hexane to give the desired product 122
as an orange oil (174 mg, 65%); Rf(10% ethyl acetate/hexane) 0.08; *H NMR <5 7.60
(dt, J = 8.1, 1.0 Hz, 1H; H-4), 7.28 (ddd, J= 8.4, 6.8, 1.0 Hz, 1H; H-6), 7.14 (dt, J =
8.7, 1.0 Hz, 1H; H-7), 7.96 (ddd, J = 7.9, 6.8, 0.8 Hz, 1H; H-5), 6.06 (ddt, J = 17.2,
10.5, 5.6 Hz, 1H; H-13), 5.38 (dq, J= 17.2, 1.6 Hz, 1H; H-14a), 5.22 (dq,7= 10.5, 2.7
Hz, 1H; H-14b), 4.80 (dt, J = 5.6, 1.4 Hz, 2H; H-12), 4.05 (m, 3H; H-8 and H-9), 3.24
(br s, 1H; OH), 1.15 (d, J= 6.3 Hz, 3H; H-10); 13C NMR 8 155.7 (C-3), 142.0 (C-7a),
133.0 (C-13), 127.7 (C-6), 120.1 (C-4), 119.3 (C-5), 118.0 (C-14), 112.1 (C-3a), 108.5
(C-7), 69.7 (C-12), 67.5 (C-9), 54.4 (C-8), 20.1 (C-10); LR MS (CI+) m/z: 233 [M+H]+;
HR MS (CI+) calcd for C13H17N2O2 [M+H]+: 233.1290; found 233.1282; IR (thin film,
cm"1) 3379 m (br)(0-H), 2971 stg, 2928 stg, 1617 stg, 1529 m (ON), 1494 m (ON),
1444 m, 1417 m;
189
Synthesis ofA/"7-(2-triisopropylsilyloxv)propyl 3-allyloxyindazole 139
To a solution of 122 (80.0 mg, 0.34 mmol, 1.0 equiv.) in dry THF (5 mL) was added
extracted with ethyl acetate (3x10 mL). The combined organic extracts were dried
(MgSCb) and concentrated in vacuo. The crude material was purified by flash
chromatography eluting with 5% ethyl acetate/hexane to give the desired product 139 as
a colourless oil (114 mg, 85%); Rf (10% ethyl acetate/hexane) 0.56; 'H NMR S 7.56 (dt,
J= 8.1, 0.9 Hz, 1H; H-4), 7.22 (m, 2H; H-6 and H-7), 6.93 (ddd, J= 7.84, 6.52, 1.15
Hz, 1H; H-5), 6.09 (ddt, J= 17.2, 10.5, 5.6 Hz, 1H; H-16), 5.39 (dq, J = 17.2, 1.59 Hz,
1H; H-17a), 5.22 (ddt, J = 10.4, 2.80, 1.29 Hz, 1H; H-17b), 4.81 (dt, J= 5.6, 1.39 Hz,
2H; H-15), 4.36 (sext., J= 6.1 Hz, 1H; H-9), 4.04 (ABX ,J = 14.1, 6.2 Hz, 2H; H-8a
and H-8b), 1.09 (d, J= 6.09 Hz, 3H; H-10), 0.89 (s, 21H; H-13 and H-14); I3C NMR S
155.3 (C-3), 142.0 (C-7a), 133.4 (C-16), 127.0 (C-6), 119.8 (C-4), 118.8 (C-5), 117.8
(C-17), 112.2 (C-3a), 109.0 (C-7), 69.6 (C-15), 68.0 (C-9), 56.0 (C-8), 22.0 (C-10),
17.9 (C-14), 12.4 (C-13); LR MS (CI+) m/z: 389 [M+H]+; HR MS (CI+) calcd for
C22H37N202Si [M+H]+: 389.2624, found: 389.2627; IR (thin film, cm"1) 2943 m, 2870
m, 2348 m, 1526 m (C=N), 988 m.
15 Ha
3
triethylamine (150 pL, 1.0 mmol, 3.0 equiv.). The
solution was stirred 10 minutes at room temperature. To
the resulting solution was added triisopropylsilyl
trifluoromethanesulfonate (180 pL, 0.52 mmol, 1.5
equiv.) and the reaction was stirred at room temperature
for 1 hour. The reaction was then quenched by addition
of saturated ammonium chloride solution (10 mL) and
190
Synthesis ofA7-benzy1-3-allyloxyindazole 118
To a solution of 104 (100 mg, 0.58 mmol, 1.0 equiv.) in dry
THF (10 mL) was added potassium carbonate (87.0 mg,
0.63 mmol, 1.1 equiv.), the solution was stirred at room
temperature under an inert atmosphere for 30 minutes.
Benzyl bromide (75 pL, 0.63 mmol, 1.1 equiv.) was added
to the solution and the reaction was stirred overnight at
room temperature under an inert atmosphere. The reaction
was quenched by addition of ammonium chloride (12 mL) and extracted with ethyl
acetate (3x10 mL). The combined organic extracts were dried (MgSCL) and
concentrated in vacuo. The crude material was purified by flash chromatography eluting
with 5% ethyl acetate/petrol to afford 118 (90.0 mg) as a yellow oil in 99% yield based
on recovered starting material (41.0 mg) (60% conversion, 40% of starting material
recovered); Rf (20% ethyl acetate/petrol) 0.47; 'H NMR S 7.60 (dd, J= 8.1, 0.6 Hz, 1H;
H-4), 7.15 (m, 8H; H-aromatic), 6.94 (m, 1H; H-5), 6.08 (m, 1H; H-17), 5.38 (dt, J =
17.2, 1.3 Hz, 1H; H-18a), 5.30 (s, 1H; H-8), 5.21 (d, J= 10.4 Hz, 1H; H-18b), 4.83 (dd,
J= 5.6, 1.2 Hz, 2H; H-16); 13C NMR S 155.6 (C-3), 141.6 (C-7a), 137.4 (C-9), 133.2
(C-17), 128.5 (C-aromatic), 127.4 (C-aromatic), 127.3 (C-aromatic), 126.9 (C-
aromatic), 120.1 (C-4), 119.1 (C-5), 117.8 (C-18), 113.0 (C-3a), 108.8 (C-7), 69.6 (C-
16), 52.3 (C-8); LR MS (CI+) m/z: 265 [M+H]+; HR MS (CI+) calcd for CnHnNzO
[M+H]+: 265.1341; found 265.1340; IR (thin film, cm"1) 3060 m (C-H), 3030 m, 2924
m, 2852 m, 1615 m, 1527 stg (C=N), 1494 m (C=N), 1444 m, 1342 m, 1187 m, 1144 m;
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Synthesis ofM-benzoy1-3-allyloxyindazole 119
To a solution of 104 (100 mg, 0.57 mmol) in dry THF (5
mL) was added triethylamine (88.0 pL, 0.63 mmol, 1.1
equiv.), the solution was stirred at room temperature under
an inert atmosphere for 30 minutes. Benzoyl chloride (73.0
pL, 0.63 mmol, 1.1 equiv.) was added to the solution and
the reaction was stirred 16 hours at room temperature under
an inert atmosphere. The reaction was quenched by addition
of ammonium chloride and extracted with ethyl acetate (3x30 mL). The combined
organic extracts were dried (MgSCL) and concentrated in vacuo. The crude material was
purified by flash chromatography eluting with 10% ethyl acetate/hexane to afford 119
(71.0 mg) as a white solid (99% based on starting material recovery, 45% conversion);
Rf (20% ethyl acetate/petrol) 0.48; mp 66-68°C; 'H NMR <5 8.46 (dt, J = 8.4, 0.8 Hz,
1H; H-4), 8.04 (m, 2H; H-aromatic), 7.67 (app. dt, J = 7.9, 1.0 Hz, 1H; H-aromatic),
7.57-7.39 (m, 4H; H-aromatic), 7.31 (ddd, /= 8.0, 7.2, 0.9 Hz, 1H; H-5), 6.06 (ddt, J=
17.2, 10.4, 5.8 Hz, 1H; H-17), 5.40 (dq, /= 17.2, 1.5 Hz, 1H; H-18a), 5.28 (ddd, J =
10.4, 2.6, 1.2 Hz, 1H; H-18b), 4.83 (dt, J= 5.8, 1.3 Hz, 2H; H-16); 13C NMR S 168.4
(C-8), 160.0 (C-3), 142.4 (C-aromatic), 134.7 (C-aromatic), 133.0 (C-aromatic),
132.5 (C-17), 131.9 (C-aromatic), 131.1 (C-aromatic), 130.5 (C-aromatic), 127.9 (C-
aromatic), 124.6 (C-aromatic), 119.9 (C-aromatic), 119.1 (C-18), 116.5 (C-
aromatic), 70.2 (C-16); LR MS (CI+) m/z: 279 [M+//]+; HR MS (CI+) calcd for
Ci7H15N202 [M+H]+: 279.1134, found: 279.1131; IR (thin film, cm"1) 3060 w, 2933 m,
2856 w, 1876 stg (C=0), 1548 stg (C=N), 1445 stg (C=N), 1406 stg, 1375 stg, 1336 stg
(C=C), 1236 w, 1186 m, 878 stg, 750 stg (C=C), 694 m;
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Synthesis ofAO(A^-phenylcarboxamide)-3-allyloxyindazole 120
To a solution of 104 (100 mg, 0.58 mmol, 1.0 equiv.) in dry
THF (10 mL) was added potassium t-butoxide (71 mg, 0.63
mmol, 1.1 equiv.), the solution was stirred at room
temperature under an inert atmosphere for 30 minutes.
Phenyl isocyanate (70 pL, 0.63 mmol, 1.1 equiv.) was
added to the solution and the reaction was stirred 16 hours
at room temperature under an inert atmosphere. The
reaction was quenched by addition of ammonium chloride
and extracted with ethyl acetate (3x10 mL). The combined organic extracts were dried
(MgSCL) and concentrated in vacuo. The crude material was purified by flash
chromatography eluting with 20% ethyl acetate/hexane to afford 120 as a white solid
(150 mg, 89%); Rf (20% ethyl acetate/petrol) 0.44; mp 89-91°C; *H NMR S 8.58 (br s,
1H; NH), 8.26 (d, J= 8.5 Hz, 1H; H-7), 7.62-7.17 (m, 7H; H-aromatic), 7.04 (t, J= 7.4
Hz, 1H; H-13), 6.09 (m, 1H; H-18), 5.44 (dq, J= 17.2, 1.4 Hz, 1H; H-19a), 5.29 (dq, J
= 10.5, 1.4 Hz, 1H; H-19b), 4.89 (dt, J= 5.7, 1.4 Hz, 2H; H-17); l3CNMR<5 157.8 (C-
3), 149.0 (C-8), 140.6 (C-7a), 137.3 (C-10), 132.2 (C-18), 130.2 (C-6), 129.1 (C-12),
124.0 (C-13), 122.9 (C-5), 119.9 (C-4), 119.6 (C-ll), 118.8 (C-19), 116.6 (C-3a),
114.8 (C-7), 70.0 (C-17); LR MS (CI+) m/z: 294 [M+H]+; HR MS (CI+) calcd for
Ci7H16N302 [M+H]+: 294.1243, found 294.1236; IR (thin film, cm'1) 3375 m (N-H),
2928 w (C-H), 2852 w (C-H), 1716 stg (OO), 1596 m (OO), 1524 stg (ON), 1446
m, 1406 m, 1361 m, 1344 m, 1219 m, 1097 m, 973 m, 928 m, 748 m;
193
Synthesis of 3-allyloxy-AObenzvlsulfonylindazole 121
To a solution of 104 (100 mg, 0.58 mmol, 1.0 equiv.) in dry
THF (10 mL) was added triethylamine (90 pL, 0.64 mmol,
1.1 equiv.), the solution was stirred at room temperature
under an inert atmosphere for 30 minutes. Benzyl sulfonyl
chloride (121 mg, 0.64 mmol, 1.1 equiv.) was added to the
solution and the reaction was stirred 16 hours at room
temperature under an inert atmosphere. The reaction was
quenched by addition of ammonium chloride and extracted
with ethyl acetate (3x30 mL). The combined organic extracts were dried (MgSCL) and
concentrated in vacuo. The crude material was purified by flash chromatography eluting
with 20% ethyl acetate/hexane to afford 121 as a white solid (68.0 mg, 37% conversion,
100% yield based on the recovered starting material); Rf (20% ethyl acetate/petrol)
0.28; mp 100-101°C; !H NMR d 8.06 (dt, J = 8.4, 0.8Hz, 1H; H-4), 7.78 (m, 2H; H-
aromatic) 7.36 (m, 6H; H-aromatic), 5.99 (tdd, J= 17.1, 10.5, 5.7 Hz, 1H; H-17), 5.35
(dq, J = 17.2, 1.5 Hz, 1H; H-18a), 5.22 (dq, J = 10.4, 1.2 Hz, 1H; H-18b), 4.85 (dt, J =
5.7, 1.4 Hz, 2H; H-16); 13C NMR S 161.7 (C-3), 143.5 (C-7a), 137.1 (C-9), 134.2 (C-
12), 132.4 (C-17), 130.6 (C-6), 129.3 (C-ll), 128.0 (C-10), 124.7 (C-5), 120.7 (C-4),
119.2 (C-18), 118.5 (C-3a), 114.7 (C-7), 70.6 (C-16); LR MS (CI+) m/z: 315 [M+H]+;
HR MS (CI+) calcd for Ci6Hi5N203S [M+//]+: 315.0803, found: 315.0806; IR (thin
film, cm"1) 2920 m, 2847 m, 1543 m (C=N), 1372 stg (S02-N), 1342 m, 1181 stg (S02-
N), 569 m.
194
General procedure for the rearrangement with
tetrakis(triphenylphosphine)palladium(0)
To a solution of the substrate (allyloxyindazole specie of type 20) in dry THF was
added tetrakis(triphenylphosphine)palladium(0) 5 mol. %. The reaction was stirred at
room temperature under an inert atmosphere for 16 hours and protected from the light
with aluminium foil. The reaction was quenched by addition of ammonium chloride (10
mL) and extracted with ethyl acetate (3x30 mL). The combined organic extracts were
dried (MgSC>4) and concentrated in vacuo. The crude material was purified by flash
chromatography.
195
Synthesis ofM42-(triisopropylsilyloxy)propyl"l-A/2-allyl indazolinone 140
Hz, 1H; H-7), 7.03 (ddd, J = 8.0, 7.1, 0.7 Hz, 1H; H-5), 5.72 (ddt, J = 16.3, 10.6, 5.7
Hz, 1H; H-16), 5.10 (m, 2H; H-17), 4.53 (tt, 5.6, 1.5 Hz, 2H; H-15), 4.08 (dd, J =
12.4, 6.2 Hz, 1H; H-9), 3.68 (ABX system, J = 53.2, 15.4, 6.3 Hz, 2H; H-8), 0.97 (d, J
= 6.1 Hz, 3H; H-18), 0.92 (m, 21H; H-12, H-13 and H-14); 13C NMR 8 162.9 (C-3),
148.3 (C-7a), 132.5 (C-16), 132.0 (C-6), 124.1 (C-4), 121.0 (C-5), 117.8 (C-17), 116.8
(C-3a), 110.9 (C-7), 66.6 (C-9), 55.8 (C-8), 45.0 (C-15), 22.4 (C-18), 18.0, 17.9, 12.5
(C-12, C-13, C-14,); LR MS (CI+) m/z\ 389 [M+/7]+; HR MS (CI+) calcd for
C22H37N203Si [M+/f]+: 389.2624, found: 389.2629; IR (thin film, cm"1) 2945 stg, 2866
stg, 1681 stg (C=0), 1621 m, 1484 m, 1464 m, 1263 w, 1144 m, 1112 w, 999 m, 920 w,
883 m, 750 m, 681 m.
139 (56.0 mg, 0.14 mmol) was submitted to the general
conditions of the rearrangement. After work up, the
crude material was purified by flash chromatography
eluting with 30% ethyl acetate/hexane to afford 140 as a
colourless oil (34.0 mg, 60%); Rf (20% ethyl
acetate/hexane) 0.08, 'H NMR 8 7.77 (m, 1H; H-4), 7.42
(ddd, J= 8.4, 7.1, 1.2 Hz, 1H; H-6), 7.11 (dt, J= 8.4, 0.7
196
Synthesis ofA(/-(2-hydroxypropyl)--/V2-allyl indazolinone 141
To a solution of 140 (30.0 mg, 0.077 mmol) in dry THF (2
mL) was added tetrabutyl ammonium fluoride (20 mg, 0.077
mmol, 1.0 equiv.) and the reaction was stirred at room
temperature for 16 hours. The reaction was quenched by
addition of ammonium chloride (10 mL) and extracted with
ethyl acetate (3><15 mL). The combined organic extracts
were dried (MgSCL) and concentrated in vacuo. The crude material was purified by
flash chromatography eluting with 50% ethyl acetate/hexane to afford 141 as a brown
oil (11.0 mg, 60%); Rf (100% ethyl acetate) 0.19; 'H NMR S 7.77 (dt, J = 0.9, 7.7 Hz,
1H; H-4), 7.46 (ddd, J= 8.4, 7.1, 1.2 Hz, 1H; H-6), 7.14 (d, J = 8.4 Hz, 1H; H-7), 7.07
(ddd, J = 7.9, 7.2, 0.7 Hz, 1H; H-5), 5.73 (ddt, J= 16.1, 10.6, 5.6 Hz, 1H; H-12),
5.1 l(m, 2H; H-13), 4.52 (dt, J= 5.6, 1.5 Hz, 2H; H-ll), 3.98 (m, 1H; H-9), 3.66 (d, J =
3.7Hz, 1H; H-8), 3.6 (d, .7=1.1 Hz, 1H; H-8), 1.9 (brs, 1H; O-H), 1.12 (d, J= 6.3 Hz,
3H; H-10); 13C NMR S 163.0 (C-3), 148.9 (C-7a), 132.5 (C-12), 132.3 (C-6), 124.2 (C-
4), 121.7 (C-5), 117.9 (C-13), 111.3 (C-7), 65.7 (C-9), 56.7 (C-8), 45.2 (C-ll), 20.9
(C-10), C-3a not visible even by 2D experiment; LR MS (CI+) m/z: 233 [M+/f]+; HR
MS (CI+) calcd for C^HnNzOs [M+/T|+: 233.1290, found: 233.1299; IR (thin film, cm"
') 3332 m (br) (O-H), 2971 w, 2924 w, 2860 stg, 1640 s (C=0), 1487 m, 1461 m, 1329
m, 1272 m, 1132 m, 940 m, 751 stg (C=C), 681 m, 543 m.
197
Synthesis ofM-benzyl-7V2-allyl indazolinone 135
Hb (30.0 mg, 0.11 mmol) was submitted to the general
f —conditions of the rearrangement. After completion of the
15 reaction, the reaction was quenched by addition of
. x ammonium chloride (10 mL) and extracted with ethyl
//'2
acetate (3x10 mL). The combined organic extracts were
dried (MgSCL) and concentrated in vacuo. The crude material was purified by flash
chromatography eluting with 50% ethyl acetate/hexane to afford 135 as an orange oil
(27.0 mg, 90%); Rf (50% ethyl acetate/petrol) 0.24; 'H NMR 8 7.86 (dd, J = 7.8, 1.1
Hz, 1H; H-aromatic), 7.50 (m, 1H; H-aromatic), 7.18 (m, 7H; H-aromatic), 5.82 (ddt,
J =17.1, 10.1, 5.8 Hz, 1H; H-16), 5.21 (m, 2H, H-18), 4.84 (s, 2H; H-8), 4.52 (dt, J =
5.7, 1.3 Hz, 2H; H-15); 13C NMR S 163.2 (C-3), 149.2 (C-7a), 134.6 (C-9), 132.4 (C-
16), 132.1 (C-aromatic), 128.6 (C-aromatic), 128.1 (C-aromatic), 127.6 (C-
aromatic), 124.1 (C-4), 121.9 (C-aromatic), 118.3 (C-3a), 117.9 (C-17), 111.6 (C-
aromatic), 53.2 (C-8), 45.0 (C-15); LR MS (ES+) m/z: 287 [M+Na]+, HR MS (ES+)
calcd for Ci7Hi6N2ONa [M+Na]+: 287.1160, found: 287.1171; IR (thin film, cm"1) 3060
m (C-H), 3026 m (C-H), 2924 m (C-H), 2856 w (C-H), 1661 stg (C=0), 1615 m (C=C),
1496 m, 1482 m, 1464 m, 1454 m, 1324 m, 1261 m, 1152 m, 990 m, 928 m, 753 m,
700 m.
198
Synthesis ofN1 -benzyl sulfonyl A^-allyl indazolinone 136
O Hb 121 (35.0 mg, 0.12 mmol) was submitted to the general
j-j^| conditions of the rearrangement. After completion of the
1 15 reaction, the reaction was quenched by addition of
ammonium chloride and extracted with ethyl acetate (3><10
8 \ /7^2
mL). The combined organic extracts were dried (MgSC^)
and concentrated in vacuo. The crude material was purified by flash chromatography
eluting with 20% ethyl acetate/hexane to afford 136 as an orange oil (32.0 mg, 91%); Rf
(50% ethyl acetate/petrol) 0.44; 'H NMR 81.96 (dt, J = 8.3, 0.8 Hz, 1H; H-aromatic),
7.60 (ddd, J - 8.4, 7.3, 1.3 Hz, 1H; H-aromatic), 7.54 (ddd,J=7.8, 1.3, 0.8 Hz, 1H; H-
aromatic), 7.41 (m, 3H; H-aromatic), 7.24 (m, 3H; H-aromatic), 5.77 (ddt, J = 16.5,
10.1, 6.3 Hz, 1H; H-16), 5.26 (dq, J = 17.1, 1.3 Hz, 1H; H-17a), 5.17 (ddd, 10.1,
2.2, 1.0 Hz, 1H; H-17b), 4.75 (dt, J = 6.3, 1.2 Hz, 2H; H-15); 13C NMR 8 166.5 (C-3),
145.6 (C-7a), 134.5 (C-aromatic), 133.5 (C-aromatic), 130.9 (C-16), 130.6 (C-
aromatic), 128.8 (C-aromatic), 128.6 (C-aromatic), 126.8 (C-aromatic), 124.1 (C-
aromatic), 121.8 (C-aromatic), 120.0 (C-17), 118.1 (C-aromatic), 49.9 (C-15); LR
MS (EI+) m/z\ 314 [M]+; HR MS (EI+) calcd for C^H^OsS [M]+: 314.0725, found:
314.0725; IR (thin film, cm"1) 2928 m, 2853 m, 1704 stg (C=0), 1609 m, 1478 w, 1460
w, 1446 w, 1375 stg (S02N), 1182 stg (S02N), 1147 w, 1086 w, 761 stg (OC), 729 m,
683 stg, 571 stg;
199
Synthesis of7V7-benzoyl N2-al\y\ indazolinone 137
^ 119 (100 mg, 0.36 mmol) was submitted to the general
conditions of the rearrangement. After completion of the
Ha reaction, the reaction was quenched by addition of
ammonium chloride and extracted with ethyl acetate (3x15
12 mL). The combined organic extracts were dried (MgS04)
and concentrated in vacuo. The crude material was purified
by flash chromatography eluting with 10% ethyl acetate/ hexane to afford 137 as an
orange oil (5 mg, 5%); Rf (100% ethyl acetate) 0.70; *H NMR 8 7.86 (m, 1H; H-
aromatic), 7.75 (m, 2H; H-aromatic), 7.64 (m, 1H; H-aromatic), 7.50 (m, 3H; H-
aromatic), 7.40 (ddd, J = 8.1, 6.7, 1.1 Hz, 1H; H-aromatic), 7.24 (m, 1H; H-
aromatic), 5.73 (ddt, J= 16.6, 10.1, 6.5 Hz, 1H; H-16), 5.16 (dq, J= 8.8, 1.2 Hz, 1H;
H-17a), 5.11 (m, 1H; H-17b), 4.76 (dt, J = 6.5, 1.2 Hz, 2H; H-15); 13C NMR £166.3
(C-8), 133.5 (C-aromatic), 133.0 (C-aromatic), 131.6 (C-aromatic), 130.2 (C-
aromatic), 129.6 (C-aromatic), 129.3 (C-aromatic), 128.5 (C-aromatic), 124.6 (C-
aromatic), 124.4 (C-aromatic), 119.8 (C-17), 113.1 (C-aromatic), 47.8 (C-15); LR
MS (CI+) m/z: 279 [M+H]+, HR MS (CI+) calcd for C17H15N2O2 [M+H]+: 279.1134,
found: 279.1136; IR (thin film, cm"1) 2924 stg, 2852 stg, 1703 stg, 1461 m, 1280 m,
1264 m, 910 m, 735 stg.
200
Synthesis of7V7-benzyloxycarbonyl 3-crotyloxyindazole 157 andNl-
benzyloxycarbonyl A^2-allylindazolinone 158
To a solution of 111 (1.03 g, 3.94 mmol, 1.0 equiv.), triphenylphosphine (1.04 g, 3.96
mmol, 1.01 equiv.) and crotyl alcohol (0.34 mL, 4.02 mmol, 1.02 equiv.) in dry toluene
(30 mL) was slowly added diethylazodicarboxylate (0.63 mL, 3.96 mmol, 1.01 equiv.).
The reaction mixture was stirred at room temperature for 16 hours under an inert
atmosphere. The solvent was then removed under reduced pressure and a saturated
solution of ammonium chloride was added. The aqueous layer was extracted with ethyl
acetate (3x50 mL). The combined organic extracts were dried (MgSCL) and
concentrated in vacuo. The crude product was purified by flash chromatography eluting
with 5% to 20% ethyl acetate/petrol to give 157 (0.53 g, 44%) as a white solid and 158
(0.65 g, 54%) as a off-white solid;
(157): Rf (20% ethyl acetate/petrol) 0.70; mp 60-61°C;
'H NMR 8 8.06 (br s, 1H; H-7), 7.68 (dt, J = 7.9, 1.0
N 2 Hz, 1H; H-4), 7.54-7.36 (m, 6H; H-aromatic), 7.27
(ddd, J = 7.9, 7.2, 0.8 Hz, 1H; H-6), 5.88 (m, 2H; H-19
O 14 and H-20), 5.52 (s, 2H; H-10), 4.94 (app d, J = 6.3 Hz,
2H; H-18), 1.79 (ddd, J= 6.3, 2.3, 1.1 Hz, 3H; H-21); 13C NMR S 159.7 (C-3), 150.8
(C-8), 141.5 (C-7a), 135.3 (C-ll), 132.0 (C-19), 129.9 (C-6), 128.6 (C-aromatic),
128.5 (C-aromatic), 128.4 (C-aromatic), 125.2 (C-20), 123.4 (C-5), 120.0 (C-4),
117.4 (C-3a), 114.7 (C-7), 70.1 (C-18), 68.7 (C-10), 17.9 (C-21); LR MS (CI+) m/z:
323.14 [M+H]+; HR MS (CI+) calcd for Ci9H19N203 [M+H]+: 323.1396, found:
323.1399; IR (thin film, cm'1) 3030 w, 2948 w, 1727 stg (C=0), 1543 stg (C=0), 1444
stg, 1419 stg, 1403 stg, 1356 stg, 1236 stg, 1173 stg, 1028 stg, 749 stg (C=C).
(158): Rf(20% ethyl acetate/petrol) 0.42 ; mp 68-69°C; 'fl
NMR 8 7.87 (m, 2H; H-4 and H-7), 7.60 (ddd, J= 8.4, 7.3,
1.3 Hz, 1H; H-5), 7.48-7.39 (m, 5H; H-aromatic), 7.31
Q^0 (ddd, J= 8.0, 7.4, 0.8 Hz, 1H; H-6), 5.58 (m, 1H, H-18),
5.40 (s, 2H; H-10), 5.30 (dtq, J= 15.0, 6.6, 1.5 Hz, 1H; H-
19), 4.73 (dt, J= 6.7, 1.0 Hz, 2H; H-17), 1.56 (ddd, J = 6.6,
2.6, 1.1 Hz, 3H; H-20); 13C NMR 8 164.8 (C-3), 150.8 (C-8), 143.1 (C-7a), 134.5 (C-
201
11), 133.4 (C-6), 131.1 (C-18), 129.0 (C-aromatic), 128.8 (C-aromatic), 128.7 (C-
aromatic), 124.6 (C-5), 124.2 (C-19), 123.9 (C-4), 118.8 (C-3a), 115.4 (C-7), 69.4 (C-
10), 48.7 (C-17), 17.7 (C-20); LR MS (CI+) m/z: 323.14 [A/+H]+; HR MS (CI+) calcd
for Ci9H19N203 [M+H]+: 323.1396, found: 323.1398; IR (thin film, cm-1) 2933 m, 2852
m, 1742 stg (C=0), 1704 stg (CO), 1457 m, 1279 stg, 1150 w, 1032 w, 964 w, 751 m;
202
Synthesis of AObenzyloxycarbonyl 3-cinnamyloxyindazole 159 and Nl-
benzyloxycarbonyl A(2-cinnamyl indazolinone 160
To a solution of 111 (1.0 g, 3.5 mmol, 1.0 equiv.), triphenylphosphine (1.04 g, 3.97
mmol, 1.10 equiv.) and cinnamyl alcohol (0.52 mL, 3.85 mmol, 1.10 equiv.) in dry
toluene (30 mL) was slowly added diethylazodicarboxylate (0.63 mL, 3.85 mmol, 1.1
equiv.). The reaction mixture was stirred at room temperature overnight under an inert
atmosphere. The solvent was then removed under reduced pressure and a saturated
solution of ammonium chloride was added. The aqueous layer was extracted with ethyl
acetate (3x50 mL). The combined organic extracts were dried (MgSCL) and
concentrated in vacuo. The crude product was purified by flash chromatography eluting
with 5% to 20% ethyl acetate/petrol to give 159 (0.61 g, 45%) as a white solid and 160
(0.54 g, 40%) as an off-white solid;
128.6 (C-aromatic), 128.2 (C-aromatic), 126.8 (C-aromatic), 123.6 (C-aromatic),
123.3 (C-17), 120.1 (C-4), 117.4 (C-quat.), 114.9 (C-7), 70.1 (C-16), 68.9 (C-10); LR
MS (CI+) m/z: 385.16 [M+H]+; HR MS (CI+) calcd for C24H21N203 [M+H]+: 385.1552,
found: 385.1546; IR (thin film, cm"1) 3026 m, 2941 m, 1729 stg (C=0), 1547 stg (C=N),
1357 m, 1239 m, 1029 m, 750 stg (OC);
22
(159): Rf (20% ethyl acetate/petrol) 0.39; mp 86-87°C;
*H NMR S 7.98 (s, 1H; H-7), 7.60 (d, J =7.9 Hz, 1H; H-
4), 7.45-7.14 (m, 12H; H-aromatic), 6.71 (d, J = 15.9
Hz, 1H; H-18), 6.42 (dt, J = 15.9, 6.3 Hz, 1H; H-17),
5.42 (s, 2H; H-10), 5.07 (dd, J= 6.3, 1.0 Hz, 2H; H-16);
13C NMR S 159.7 (C-3), 150.9 (C-8), 141.3 (C-quat.),
136.3 (C-quat.), 135.4 (C-quat.), 134.6 (C-18), 130.1
(C-aromatic), 128.8 (C-aromatic), 128.7 (C-aromatic),
Hz, 2H; H-17); 13C NMR S 164.7 (C-3), 150.8 (C-8),
(160): Rf (20% ethyl acetate/petrol) 0.12; mp 66-67°C; 'H
NMR d 7.74 (m, 2H; H-4 and H-7), 7.43 (ddd, J = 8.5,
7.3, 1.3 Hz, 1H; H-6), 7.33-7.05 (m, 11H; H-aromatic),
6.35 (d, J= 15.8 Hz, 1H; H-19), 5.91 (dt, J = 15.8, 6.8
Hz, 1H; H-18), 5.27 (s, 2H; H-10), 4.85 (dd, J = 6.9, 0.9
203
143.1 (C-quat.), 136.0 (C-quat.), 134.6 (C-19), 134.2 (C-quat.), 133.6 (C-aromatic),
129.0 (C-aromatic), 128.8 (C-aromatic), 128.7 (C-aromatic), 128.4 (C-aromatic),
127.9 (C-aromatic), 126.5 (C-aromatic), 124.7 (C-aromatic), 123.8 (C-aromatic),
122.6 (C-18), 118.7 (C-quat.), 115.5 (C-aromatic), 69.4 (C-10), 48.9 (C-17); LR MS
(CI+) m/z\ 385.16 [M+H]+; HR MS (CI+) calcd for C24H21N203 [M+H]+: 385.1552,
found: 385.1556; IR (thin film, cm"1) 3026 m, 1738 stg (CO), 1700 stg (C=0), 1466 m,
1287 m, 1147 m, 752 stg (C=C),
Synthesis ofA^7-benzyloxycarbonyl-Ar2-(but-3-en-2-yl)indazolinone 161
To a solution of 157 (150 mg, 0.47 mmol) in dry THF (5
mL) was added 5 mol % of dichlorobis(acetonitrile)
palladium (II) (6.00 mg, 0.023 mmol) under an inert
atmosphere. The solution was stirred at room temperature
\ f°r 16 hours under an inert atmosphere. The solvent was
concentrated in vacuo and the reaction mixture was purified
by flash chromatography eluting with 5% ethyl acetate/hexane to give 161 as an orange
oil (146 mg, 97%); Rf (20% ethyl acetate/petrol) 0.22; !H NMR S 7.73 (ddd, J= 7.7,
1.7, 1.0 Hz, 2H; H-aromatic), 7.49 (ddd, J = 8.6, 7.3, 1.3 Hz, 1H; H-aromatic), 7.34
(m, 5H; H-aromatic), 7.21 (m, 1H; H-aromatic), 6.12 (ddd, J= 17.0, 10.3, 6.5 Hz, 1H;
H-18), 5.30 (s, 2H; H-10), 5.09 (dq, J= 15.0, 1.3 Hz, 1H; H-19a), 5.04 (dq, J= 8.0, 1.3
Hz, 1H; H-19b), 4.83 (m, 1H; H-17), 1.53 (d, J=7.0Hz, 3H; H-20); 13C NMR 8 166.3
(C-3), 151.9 (C-7a), 144.1 (C-ll), 136.8 (C-18), 134.2 (C-aromatic), 133.4 (C-
aromatic), 129.0 (C-aromatic), 128.78 (C-aromatic), 128.76 (C-aromatic), 124.8 (C-
aromatic), 123.6 (C-aromatic), 119.8 (C-3a), 116.5 (C-19), 115.6 (C-aromatic), 69.6
(C-10), 59.3 (C-17), 17.5 (C-20); LR MS (Cf) m/z: 323.14 [M+H]+; HR MS (CI+)
calcd for Ci9H,9N203 [M+H]+: 323.1396, found: 323.1398; IR (thin film, cm"1) 3069 m,
3030 m, 2979 m, 2937 m, 1742 stg (C=Q), 1700 stg (CO), 1614 stg (CO), 1462 m.
204
Synthesis of 3-crotyloxyindazole 162
To a solution of 157 (100 mg, 0.31 mmol) in THF (10 mL)
was added a solution of lithium hydroxide (3 mL, 2 M) and
the solution was stirred at room temperature for 16 hours. The
reaction was neutralised by addition of dilute hydrochloric
acid (10%) to pH 7 and extracted with ethyl acetate (3^10
mL). The combined organic extracts were dried (MgSCL) and concentrated in vacuo.
The crude material was purified by flash chromatography eluting with 15% ethyl
acetate/hexane to afford 162 (59.0 mg, 100%) as a white solid; Rf (20% ethyl
acetate/petrol) 0.40; mp 81°C, *H NMR S 9.07 (br s, 1H; NH), 7.63 (dd,J= 8.1, 0.9 Hz,
1H; H-4), 7.24 (m, 2H; H-6 and H-7), 7.00 (dd, J= 6.7, 1.0 Hz, 1H; H-5), 5.81 (m, 2H;
H-10 and 11), , 4.78 (m, 2H; H-9), 1.70 (dd, J=5.8, 0.9, 3H; H-12), 13C NMR S 157.3
(C-3), 142.5 (C-7a), 131.1 (C-10 or C-ll), 127.8 (C-6), 125.9 (C-ll or C-10), 119.9
(C-4), 119.8 (C-5), 112.7 (C-3a), 109.6 (C-7), 69.6 (C-9), 17.9 (C-12); LR MS (ES+)
m/z: 211 [M+Na]+; HR MS (ES+) calcd for CiiH12N2ONa [M+Na]+: 211.0847, found:
211.0841; IR (thin film, cm"1) 3154 m (br) (NH), 3040 m, 2922 m, 1623 stg, 1522 stg
(C=N), 1507 stg, 1438 stg, 1360 stg, 1339 stg, 1250 stg, 1160 stg, 972 stg, 739 m.
205





To a solution of 159 (108 mg, 0.28 mmol) in THF (10 mL) was added a solution of
lithium hydroxide (2 M, 3 mL) and the solution was stirred at room temperature for 16
hours. The reaction was neutralized to pH 7 by addition of dilute hydrochloric acid
(10%) and extracted with ethyl acetate (3x15 mL). The combined organic extracts were
dried (MgSCL) and concentrated in vacuo. The crude product was purified by flash
chromatography eluting with 15% ethyl acetate/hexane to afford 164 as a white solid
(69.0 mg, 96%); Rf(20% ethyl acetate/petrol) 0.32; mp 109°C; 'H NMR <5 9.22 (br s,
1H; NH), 7.64 (dt, J = 8.1, 1-0 Hz, 1H; H-aromatic), 7.26 (m, 7H; H-aromatic), 7.00
(ddd, J = 7.9, 6.8, 1.0 Hz, 1H; H-aroniatic), 6.70 (d, J = 16.0 Hz, 1H; H-ll), 6.45 (dt, J
= 15.9, 6.1 Hz, 1H; H-10), 5.00 (dd, 7=6.1, 1.3 Hz, 2H; H-9); l3C NMR d 157.1 (C-3),
142.5 (C-7a), 136.4 (C-12), 133.6 (C-ll), 128.5 (C-aromatic), 127.9 (C-aromatic),
127.8 (C-aromatic), 126.6 (C-aromatic), 124.2 (C-10), 119.9 (C-aromatic), 119.8 (C-
aromatic), 112.6 (C-3a), 109.7 (C-aromatic), 69.4 (C-9); LR MS (ES) m/z: 273
[A/+Na]+; HR MS (ES ) calcd for Ci6H|4N2ONa [Af+Na]b 273.1004, found 273.1003;
IR (thin film, cm"1) 2873 m, 1523 stg (C=N), 1438 m, 1343 m, 1149 m, 1106 m, 958 m,
738 stg (C=C).
206
Synthesis ofAf/-benzyl 3-crotyloxyindazole 163
14 To a solution of 162 (48.0 mg, 0.25 mmol, 1.0 equiv.) was
added solid potassium t-butoxide (34.0 mg, 0.31 mmol, 1.2
equiv.). The solution was stirred 30 minutes under an inert
atmosphere at room temperature. To that solution was added
benzyl bromide (30 pL, 0.31 mmol, 1.2 equiv.) and the
solution was stirred at room temperature under argon for 16
hours. The reaction was quenched by addition of ammonium chloride (10 mL) and
extracted with ethyl acetate (3x15 mL). The combined organic extracts were dried
(MgSCfi) and concentrated in vacuo. The crude material was purified by flash
chromatography eluting with hexane to afford 163 as a colourless oil (47.0 mg, 66%);
Rf(20% ethyl acetate/petrol) 0.51; 'H NMR 8 7.60 (dt, J= 8.1, 1.0 Hz, 1H; H-7), 7.20
(m, 7H; H-aromatic), 6.94 (ddd, J = 6.8, 0.8 Hz, 1H; H-aromatic), 5.81 (m, 2H; H-15
and H-16), 5.31 (s, 2H; H-8), 4.76 (dd, J = 5.2, 1.0 Hz, 2H; H-14), 1.69 (ddt, J= 5.9,
1.1, 0.9 Hz, 3H; H-17); 13C NMR 8 155.7 (C-3), 141.6 (C-7a), 137.5 (C-9), 131.1 (C-
aromatic), 128.5 (C-aromatic), 127.4 (C-aromatic), 127.0 (C-aromatic), 126.9 (C-
aromatic), 126.1 (C-aromatic), 120.1 (C-aromatic), 119.1 (C-aromatic), 113.1 (C-
3a), 108.8 (C-15), 69.6 (C-16), 52.3 (C-14), 17.9 (C-17) ; LR MS (ES+) m/z: 301; HR
MS (ES+) calcd for C,8Hi8N2ONa [M+Na]+: 301.1317, found: 301.1316; IR (thin film,
cm-1) 3060 m, 3030 m, 2937 m, 1615 stg (C=C), 1530 stg (C=N), 1496 m (C=N), 1436
m, 1351 m, 1185 m, 968 m, 739 stg (C=C), 696 m.
207
Synthesis ofN1 -benzyl 3-cinnamyloxyindazole 165
To a solution of 164 (53.0 mg, 0.21 mmol, 1.0
22 equiv.) in dry THF (10 mL) was added potassium t-
butoxide (32.0 mg, 0.25 mmol, 1.2 equiv.) and the
solution was stirred 30 minutes. To that solution was
added benzyl bromide (30 pL, 0.25 mmol, 1.2
equiv.) and the reaction was stirred at room
temperature under an inert atmosphere for 16 hours. The reaction was quenched by
addition of ammonium chloride (10 mL) and extracted with ethyl acetate (3x15 mL).
The combined organic extracts were dried (MgSCL) and concentrated in vacuo. The
crude material was purified by flash chromatography eluting with 5% ethyl
acetate/hexane to afford 165 as a colourless oil (66.0 mg, 91%); Rf (20% ethyl
acetate/petrol) 0.45; 'H NMR S 7.62 (dt, J = 8.1, 1.0 Hz, 1H; H-aromatic), 7.21 (m,
12H; H-aromatic), 6.95 (ddd, J = 7.9, 6.8, 0.8 Hz, 1H; H-aromatic), 6.71 (d, J - 16.0
Hz, 1H; H-18), 6.45 (dt, J = 15.9, 6.1 Hz, 1H; H-17), 5.32 (s, 2H; H-8), 4.99 (dd, J =
6.1, 1.3 Hz, 2H; H-16); ,3C NMR S 155.6 (C-3), 141.6 (C-aromatic), 137.4 (C-
aromatic), 136.5 (C-aromatic), 133.6 (C-18), 128.5 (C-aromatic), 127.8 (C-
aromatic), 127.42 (C-aromatic), 127.37 (C-aromatic), 127.0 (C-aromatic), 126.6 (C-
aromatic), 124.4 (C-17), 120.1 (C-aromatic), 119.2 (C-aromatic), 113.1 (C-3a),
108.8 (C-aromatic), 69.4 (C-16), 52.3 (C-8); LR MS (ES+) m/z: 363 [M+Na]+; HR MS
(ES+) calcd for C23H2oN20Na [M+Na]+: 363.1473, found: 363.1479; IR (thin film, cm"1)
3060 w, 3026 w, 2933 w, 1617 m (C=C), 1527 stg (C=N), 1496 m (C=N), 1447 m,







A solution of 165 (33.0 mg, 0.097 mmol) in dry
DMF (2 mL) was submitted to microwave
irradiations (200°C, 300W) for 10 min under a
maximum pressure of 105 psi. The crude reaction
was cooled down at room temperature. Water (10
mL) was added to the mixture and the aqueous
solution was extracted with ether (2x5 mL). The combined organic extracts were
washed with water (5 mL) and dried (MgSCL). The crude material was purified by flash
chromatography eluting with 30% ethyl acetate/hexane to afford 167 as a orange oil
(14.0 mg, 42%) as the only product of the reaction. Rf (20% ethyl acetate/petrol) 0.04;
'H NMR S 7.80 (d, J = 7.8 Hz, 1H; H-aromatic), 7.43 (ddd, J= 8.3, 7.3, 1.2 Hz, 1H;
H-aromatic), 7.13 (m, 12H; H-aromatic), 6.42 (dt, J = 15.9, 1.3 Hz, 1H; H-17), 6.07
(dt, J= 15.9, 6.3 Hz, 1H; H-16), 4.80 (s, 2H; H-8), 4.60 (dd, J= 6.3, 1.3 Hz, 2H; H-15);
13C NMR S 163.2 (C-3), 149.2 (C-aromatic), 136.1 (C-aromatic), 134.8 (C-
aromatic), 133.1 (C-17), 132.2 (C-aromatic), 128.7 (C-aromatic), 128.5 (C-
aromatic), 128.2 (C-aromatic), 127.9 (C-aromatic), 127.7 (C-aromatic), 126.5 (C-
aromatic), 124.3 (C-aromatic), 123.9 (C-16), 122.0 (C-aromatic), 111.6 (C-
aromatic), 53.6 (C-8), 44.9 (C-15); LR MS (ES+) m/z: 363 [M+Na]+; HR MS (ES+)
calcd for C23H2oN2ONa [M+Na]+: 363.1473, found: 363.1465; IR (thin film, cm"1) 2925
stg, 2853 stg, 1671 stg (C=0), 1618 w(C=C), 1484 w, 1451 m, 1254 w, 1152 w, 965 w,
752 stg (C=C), 696 stg.
209
Synthesis ofA7-benzyl-7V2-(but-3-en-2-yl) indazolinone 166
4
o ^ A solution of 163 (15.0 mg, 0.054 mmol) in dry DMF (1
12
k17 mL) was submitted to microwave irradiations (200°C,
Ha
300W) for 10 min under a maximum pressure of 96 psi. The
crude reaction was cooled down at room temperature. Water
(10 mL) was added to the mixture and the aqueous solution
was extracted with ether (2x5 mL). The combined organic
extracts were washed with water (5 mL) and dried (MgSCL). The crude material was
purified by flash chromatography eluting with 30% ethyl acetate/hexane to afford 166
as a orange oil (10.0 mg, 67%). Rf (20% ethyl acetate/petrol) 0.07 ; !H NMR S 7.76 (d,
J — 7.8 Hz, 1H; H-aromatic), 7.36 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H; H-aromatic), 7.12
(m, 3H; H-aromatic), 7.05 (m, 2H; H-aromatic), 6.89 (d, J = 8.3 Hz, 1H; H-
aromatic), 6.10 (ddd, J = 17.5, 10.6, 5.0 Hz, 1H; H-16), 5.18 (ddd, J = 12.6, 1.9, 0.9
Hz, 1H; H-17a), 5.13 (ddd, J= 5.7, 1.9, 0.9 Hz, 1H; H-17b), 5.00 (m, 1H; H-15), 4.77
(ABX system, J = 48.7, 15.9 Hz, 2H; H-8), 1.46 (d,J= 7.0 Hz, 3H; H-18); 13C NMR S
160.4 (C-3), 150.7 (C-7a), 138.0 (C-16), 132.3 (C-aromatic), 130.9 (C-aromatic),
128.7 (C-aromatic), 128.0 (C-aromatic), 127.6 (C-aromatic), 124.2 (C-aromatic),
122.1 (C-aromatic), 116.1 (C-17), 112.0 (C-aromatic), 55.0 (C-8), 53.5 (C-15), 17.3
(C-18), C-3a not observed; LR MS (ES+) m/z: 301 [M+Na]+; HR MS (ES+) calcd for
CigHi8N2ONa [M+Na]+: 301.1317, found: 301.1319 ; IR (thin film, cm"1) 2920 stg,
2852 stg, 1725 w, 1674 stg (C=0), 1615 m, 1483 w, 1457 m, 1262 m, 1075 w, 1019 w,
798 m, 751 m (C=C), 700 m.
210
Synthesis of allylbenzyl ether 229
Ha\ To a suspension of sodium hydride (10.2 g, 254 mmol,
Hb 11 eq.) in dry THF (250 mL) was added via cannula a
solution of benzyl alcohol (25.0 g, 231 mmol, 1.0 eq.) in6
dry THF (50 mL). The reaction was stirred at room temperature for two hours under an
inert atmosphere. Allyl bromide (23.0 mL, 254 mmol, 1.1 eq.) was then added
dropwise. The resulting suspension was stirred overnight at room temperature. The
solvent was partially removed in vacuo and saturated ammonium chloride solution (100
mL) was added. The aqueous phase was extracted with ethyl acetate (3x150 mL) and
the combined organic extracts were dried (MgSCL) and concentrated in vacuo. The
crude oil was purified by flash chromatography eluting with 5% ethyl acetate/hexane to
give the desired product 229 as a colourless oil (34.0 g, 229 mmol, 99%); 'H NMR S
7.39-7.27 (m, 5H; H-aromatic), 5.98 (ddt, J= 17.3, 10.4, 5.6 Hz, 1H; H-10), 5.33 (ddt,
J= 17.3, 1.6, 1.6 Hz, 1H; H-lla), 5.22 (ddt, J= 10.4, 1.4, 1.4 Hz, 1H; H-llb), 4.54 (s,
2H; H-2), 4.05 (ddd, J= 5.6, 1.4, 1.4 Hz, 2H; H-9); IR (thin film, cm"1) 2924 m, 2852
m, 1717 m, 1449 m, 1270 w, 743 stg, 709 stg (C=C), 692 m;
211
Synthesis of methyl 2-amino-5-r3-(benzyloxv)propvl"|benzoate 230 and 2-
amino-5-r3-(benzyloxy)propyllbenzoic acid 231
O Solid 9-BBN (4.38 g, 35.9 mmol, 1.65
eq.) was transferred to a 500 mL 3-neck
flask fitted with a condenser under an
inert atmosphere. Freshly distilled dry
THF (220 mL) and allylbenzyl ether 229 (5.60 g, 37.8 mmol, 1.74 eq.) were added. The
reaction mixture was then stirred for 3 hours at room temperature. The final
concentration of the allyl benzyl ether in THF is 0.16M, [136] which is the appropriate
concentration for the subsequent Suzuki coupling. To the resulting alkylborane-
containing THF solution was added methyl 5-iodoanthranilate (5.00 g, 21.7 mmol, 1.0
eq.), tetrakis(triphenylphosphine)palladium(0) (627 mg, 2.50 mol %) and NaOH
solution (2.0 M, 21.7 mL, 2.0 eq.). The reaction was then heated to reflux for 24 hours.
The presence of 9-BBN by-products made the purification of 230 difficult; for purpose
of characterisation, 230 was purified from an aliquot of the reaction by flash
chromatography eluting with 20% ethyl acetate/hexane giving an orange oil; Rf (20%
ethyl acetate/petrol) 0.23; 'H NMR S 7.59 (d, J = 2.2 Hz, 1H; H-aromatic), 7.26-7.14
(m, 5H; H-aromatic), 6.99 (dd, J= 8.4, 2.1 Hz, 1H; H-aromatic), 6.48 (d, J — 8.4 Hz,
1H; H-aromatic), 4.40 (s, 2 H; H-12), 3.75 (s, 3H; H-20), 3.37 (t, 6.3 Hz, 2H; H-
10), 2.51 (m, 2H; H-8), 1.79 (m, 2H; H-9); I3C NMR S 168.5 (C-l), 148.5 (C-
aromatic), 138.5 (C-aromatic), 134.5 (C- aromatic), 130.3 (C-aromatic), 129.5 (C-
aromatic), 128.2 (C-aromatic), 127.5 (C-aromatic), 127.4 (C-aromatic), 116.8 (C-
aromatic), 110.5 (C-aromatic), 72.8 (C-12), 69.3 (C-10), 51.3 (C-20), 31.3 (C-9), 31.1
(C-8); LRMS (Cf) m/z: 300 [M+H]+, HRMS (CI+) calcd for C18H22NO3 [M+H]+:
300.1600, found: 300.1595; IR (thin film, cm"1) 3481(N-H), 3374 br (N-H), 2950 m,
2856 m, 1691 stg (C=0), 1632 stg (C=C), 1585 m (C=C), 1496 m, 1436 w, 1291 m,




A solution of aqueous sodium hydroxide
(2.0 M, 20 mL) was added to the crude
reaction mixture and the biphasic solution
refluxed for 5 days. The mixture was then
cooled, filtered through celite, neutralised with diluted aqueous hydrochloric acid
solution to pH 7, and extracted with ethyl acetate (3x100 mL). The combined organic
extracts were dried (MgSCL) and concentrated in vacuo. The resulting oil was extracted
with hot petrol (5><200 mL) and on cooling the desired product 231 was obtained as an
off white solid (3.50 g, 60%); mp 90-91°C; !H NMR S 7.74 (d, J = 2.3 Hz, 1H, H-
aromatic), 7.36-7.25 (m, 5 H; H-aromatic), 7.16 (dd, J = 8.5, 2.3 Hz, 1H; H-
aromatic), 6.64 (d, J= 8.5 Hz, 1H; H-aromatic), 4.51 (s, 2H; H-12), 3.48 (t, J= 6.4
Hz, 2H; H-10) 2.62 (m, 2H; H-8), 1.89 (m, 2H, H-9); 13C NMR S 173.5 (C-l), 148.3
(C-quat.), 138.6 (C-quat.), 135.9 (C-aromatic), 131.4 (C-aromatic), 130.1 (C-quat.),
128.5 (C-aromatic), 127.8 (C-aromatic), 127.7 (C-aromatic), 117.2 (C-aromatic),
109.7 (C-quat.), 73.1 (C-12), 69.5 (C-10), 31.5 (C-8), 31.3 (C-9); LRMS (ES") m/z\
284 [M-H]"; HRMS (ES") calcd for Ci7Hi8N03 [M-H]": 284.1287, found 284.1279, IR
(thin film, cm"1) 3460 br (N-H), 3358 br (N-H), 2971 stg, 2869 stg, 1670 stg (C=0),
1457 m, 1249 m, 1126 m, 734 m.
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Synthesis of 2-iodo-5-r3-(benzyloxy)propyllbenzoic acid 241
17
o A solution of sodium nitrite (125 mg, 1.77
mmol, 1.03 eq.) in water/acetonitrile (1:1,
5.0 mL) was added with continuous
stirring to a solution of 231 in aqueous
hydrochloric acid solution (13%, v/v) at such a rate that the reaction temperature
remained below 5°C. After addition was complete, the solution was stirred for 15
minutes and potassium iodide (454 mg, 2.74 mmol, 1.56 eq.) in aqueous sulphuric acid
solution (10%, v/v, 5 mL) was added. The reaction was then heated for 10 minutes at
reflux and cooled to room temperature. Saturated sodium thiosulphate solution (5 mL)
was added and the reaction was extracted with ethyl acetate (3x30 mL). The combined
organic extracts were dried (MgSCb) and concentrated in vacuo. The crude oil was
purified by flash chromatography eluting with 20 to 100% ethyl acetate/hexane to give
the desired compound 241 as a viscous oil (593 mg, 85%); Rf (100% ethyl acetate) 0.54;
'H NMR <511.3 (br s, 1H; O-H), 7.83 (d, J= 7.9 Hz, 1H; H-aromatic), 7.6 (d , J= 1.8
Hz, 1H; H-aromatic), 7.28-7.17 (m, 5H; H-aromatic), 6.93 (dd, J = 7.9, 1.8 Hz, 1H;
H-aromatic), 4.44 (s, 2H; H-12), 3.41 (t, J = 6.1 Hz, 2H; H-10), 2.65 (t, J = 1A Hz,
2H; H-8), 1.81 (m, 2H; H-9); 13C NMR 8 170.9 (C-l), 142.1 (C-quat.), 141.6 (C-
aromatic), 138.0 (C-quat.), 133.8 (C-aromatic), 133.2 (C-quat.), 132.1 (C-aromatic),
128.3 (C-aromatic), 127.7 (C-aromatic), 127.6 (C-aromatic), 91.1 (C-3), 72.8 (C-12),
68.8 (C-10), 31.5 (C-8), 30.7 (C-9); LRMS (ES+) m/z: 418.96 [M+Na]+; HRMS (ES+)
calcd for Ci7Hi7I03Na [M+Na]+: 419.0120, found 419.0124; IR (thin film, cm"1) 3031
m, 2933 m, 2862 m (O-H), 1699 stg (C=0), 1462 m, 1449 m, 1262 m, 1101 m, 735 m,
700 m.
214
Synthesis of 5-r3-(benzyloxy)propyl]indazolinone 232
q A suspension of 241 (800 mg, 2.02 mmol,
(p 1.0 eq.), freshly prepared copper powder
.n,NH I169l(i15 mg; i 82 mmol, 0.90 eq.) and
^ 99% hydrazine hydrate solution (440 pL,
14.0 mmol, 7.0 eq.) in isopropanol (12 mL) was refluxed overnight. After cooling, the
solution was filtered and solid residues washed with methanol (3x20 mL). The
combined organic extracts were then concentrated in vacuo. The crude product was
purified by flash chromatography eluting with 50-100% ethyl acetate/hexane to give the
desired product 232 (270 mg, 52%) as a white solid; Rf (100% ethyl acetate) 0.23; mp
120-122°C; 'H NMR £9.64 (br s, 1H; N-H), 7.45 (s, 1H; H-4), 7.28-7.16 (m, 5H; H-
aromatic), 7.12 (dd, J = 8.6, 1.5 Hz, 1H; H-aromatic), 6.99 (d, J = 8.6 Hz, 1H; H-
aromatic), 4.39 (s, 2H; H-12), 3.37 (t, J= 6.3 Hz, 2H; H-10), 2.61 (m, 2H; H-8), 1.85-
1.76 (m, 2H; H-9); 13C NMR S 162.6 (C-3), 144.5 (C-7a), 138.4 (C-aromatic), 134.5
(C-aromatic), 132.3 (C-aromatic), 128.3 (C-aromatic), 127.6 (C-aromatic), 127.5
(C-aromatic), 121.2 (C-aromatic), 115.8 (C-aromatic), 111.6 (C-3a), 72.8 (C-12),
69.3 (C-10), 31.9 (C-8), 31.4 (C-9); LRMS (ES") m/z: 281.1590 [M-H]"; HRMS (ES")
calcd for C17Hi7N202 [M-H]": 281.1290, found 281.1290; IR (thin film, cm"1) 3062 m,
2926 m, 2864 m, 1623 stg (C=0), 1589 stg, 1492 m, 1107 m, 699 m.
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Synthesis of N1 -ethyloxycarbonyl-5-r3-(benzyloxy)propyllindazolinone
263
To a solution of 232 (120 mg, 0.42
mmol, 1.0 eq.) in THF (5 mL) was
added triethylamine (0.20 mL, 1.26
•d mmol, 3.0 eq.). The solution was
stirred at room temperature under an
inert atmosphere for 30 minutes. To the resulting solution was added ethyl
chloroformate (0.13 mL, 1.26 mmol, 3.0 eq.) and the reaction stirred at room
temperature for 16 hours. The reaction was then quenched by addition of saturated
ammonium chloride solution (20 mL) and extracted with ethyl acetate (3x50 mL). The
combined organic extracts were dried (MgSCb) and concentrated in vacuo. The crude
material was purified by flash chromatography eluting with 30% ethyl acetate/hexane to
give Nl, N2 and N1,0 acylated isomers as an off white solid (150 mg) (The two
isomers were not isolated). Morpholine (45 pL , 0.42 mmol, 1.2 eq.) was added to a
solution of the white solid (150 mg, 1.0 eq.) in dry THF (15 mL) and the mixture was
stirred 30 minutes at room temperature. The reaction was then quenched by addition of
saturated ammonium chloride solution (10 mL) and extracted with ethyl acetate (3x30
mL). The combined organic extracts were dried (MgSCL) and concentrated in vacuo.
The crude product was purified by recrystallisation in hot ethyl acetate to give 263 as
white minute needles (135 mg, 89%); mp 139-140°C, 'H NMR S 7.95 (br s, 1H; NH),
7.64 (s, 1H; H-aromatic), 7.44 (dd, J = 8.6, 1.6 Hz, 1H; H-aromatic), 7.37-7.27 (m,
6H; H-aromatic), 4.55 (q, J= 7.2 Hz, 2H; H-10), 4.51 (s, 2H; H-16), 3.5 (t, J= 6.2 Hz,
2H; H-14), 2.85 (m, 2H; H-12), 2.05-1.94 (m, 2H; H-13), 1.53 (t, J= 7.2 Hz, 3H; H-
11); 13C NMR S 160.1 (C-3), 150.1 (C-8), 138.4 (C-quat.), 137.7 (C-quat.), 132.2 (C-
aromatic), 128.3 (C-aromatic), 127.6 (C-aromatic), 127.5 (C-aromatic), 120.2 (C-
aromatic), 117.6 (C-quat.), 114.2 (C-aromatic), 72.1 (C-16), 69.1 (C-14), 63.6 (C-
10), 32.0 (C-12), 31.5 (C-13), 14.3 (C-ll); LRMS (ES") m/z: 353 [M-H]"; HRMS (ES")
calcd for C20H21N2O4 [M-H]": 353.1501, found: 353.1489; IR (thin film, cm"1) 2966 m,
2864 m, 1736 stg (C=0), 1458 m, 1373 m, 1271 m, 744 m; calculated for C20H22N2O4:
C 67.78, H 6.26, N 7.90. Found: C 67.72, H 6.36, N 8.00%.
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Synthesis ofA7-ethyloxycarbonyl-5-(3-hvdroxvpropyl)indazolinone 264
The reaction was stirred at room temperature for five days, filtered through celite and
concentrated in vacuo. The solid residues were washed with methanol (3x20 mL), the
combined organic extracts were concentrated in vacuo to give the desired product 264
as a white solid (260 mg, 86%); mp 168-170°C, JH NMR 8 7.81 (d, J = 8.4 Hz, 1H; H-
7), 7.48 (s, 1H; H-4), 7.37 (d, J= 8.4 Hz, 1H; H-6), 4.38 (q, J= 7.1 Hz, 2H; H-10), 3.50
(t, J — 6.3 Hz, 2H; H-14), 2.71 (t, .7=7.7 Hz, 2H; H-12), 1.83-1.74 (m, 2H; H-13), 1.36
(t, 7.1 Hz, 3H; H-ll); 13C NMR ([d6] DMSO) 8 152.2, 151.7, 141.6 , 129.7, 123.7,
111.7, 109.6, 105.8, 55.0, 52.3, 25.8, 23.0, 5.2; LRMS (ES+) m/z: 287 [M+Na]+; HRMS
(ES+) calcd for Ci3Hi6N204Na [M+Naf: 287.1008, found: 287.1011; IR (thin film, cm"
') 3430 br (O-H), 2977 stg, 2892 stg, 2835 m, 1725 stg (C=0), 1640 stg (C=0), 1453 m,
1379 m, 727 m.
To a solution of 263 (400 mg, 1.13 mmol, 1.0
eq.) in dry THF (15 mL) in an autoclave was
added a catalytic amount of palladium on carbon
9
11 (10%). The reaction mixture was degassed under
vacuum and charged with hydrogen (20 bars).
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Synthesis ofA7-ethyloxycarbonyl-7V2-allyl-5-(3-hydroxypropyl)
indazolinone 265 and iW-ethyloxycarbonyl-S-allyloxy-S-O-
hydroxypropyl) indazole 266
To a solution of 264 (310 mg, 1.17 mmol, 1.0 eq.), allyl alcohol (1.2 mL, 17.6 mmol, 15
eq.), and triphenylphosphine (338 mg, 1.29 mmol, 1.05 eq.) in toluene (50 mL) was
added slowly diethylazodicarboxylate (0.20 mL, 1.29 mmol, 1.05 eq.) under an inert
atmosphere. The reaction was stirred at room temperature for 16 hours. The solvent was
partially removed by evaporation, the reaction quenched by addition of saturated
ammonium chloride solution (20 mL) and extracted with ethyl acetate (3x25 mL). The
combined organic extracts were dried (MgSCb) and concentrated in vacuo. The crude
material was purified by flash chromatography eluting with 10-20% ethyl
acetate/hexane to give 265 (103 mg, 0.35 mmol, 30%) as an off white solid and 266
(208 mg, 0.70 mmol, 60%) as an off white solid.
2H; H-13), 4.47 (q, J= 7.1 Hz, 2H; H-10), 3.31 (t, J = 6.3 Hz, 2H; H-18), 2.74 (m, 2H;
H-16), 1.86 (m, 2H; H-17); 1.42 (t, .7=7.1 Hz, 3H; H-ll); ,3C NMR S 159 (C-3), 150.9
(C-8), 139.7 (C-7a), 137.3 (C-5), 132.3 (C-14), 131.0 (C-6), 118.9 (C-4), 118.7 (C-15),
117.4 (C-3a), 114.6 (C-7), 70.0 (C-13), 63.5 (C-10), 62.0 (C-18), 34.3 (C-17), 31.6 (C-
16), 14.5 (C-ll); LR MS (ES+) m/z: 327.12 [M+Naf; HR MS (ES+) calcd for
Ci6H2oN202Na [M+Na]+: 327.1321, found: 327.1319 ; IR (thin film, cm"1) 2971 m,
2882 m, 2843 w, 1457 stg (C=N), 1372 m, 717 m.
Hb (265): Rf (50% ethyl acetate/petrol) 0.25; mp
58-59°C , JH NMR d 7.92 (br s, 1H; H-7),
7.43 (m, 1H; H-4), 7.32 (dd, J = 8.7, 1.6 Hz,
1H; H-6), 6.09 (ddt, J = 17.2, 10.4, 5.7 Hz,
1H; H-14), 5.43 (ddt, J= 17.2, 1.5, 1.5 Hz,
1H; H-15a), 5.27 (ddt, J = 10.4, 1.4, 1.4 Hz,
1H; H-15b), 4.94 (ddd, J = 5.7, 1.4, 1.4 Hz,
(266): Rf (50% ethyl acetate/petrol) 0.07;
mp = 139-140°C , 'H NMR S 7.79 (dd, J =
L_|p
8.5, 0.7 Hz, 1H; H-7), 7.71 (dd, J = 1.9, 0.7
1 Hz, 1H; H-4), 7.48 (dd, J = 8.5, 1.9 Hz, 1H;
O 9 H-6), 5.72 (ddt, J = 17.1, 10.1, 6.3 Hz, 1H;
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H-13), 5.23 (ddt, J = 17.1, 1.4, 1.4 Hz, 1H; H-14a), 5.17 (ddt, J= 10.1, 1.3, 1.3 Hz, 1H;
H-14b), 4.83 (dt, J= 6.3, 1.3 Hz, 2H; H-12), 4.44 (q, J= 7.1 Hz, 2H; H-10), 3.68 (t, J =
6.3 Hz, 2H; H-17), 2.81 (m, 2H; H-15), 1.92 (m, 2H; H-16), 1.45 (t, J= 7.1 Hz, 3H; H-
11); 13C NMR S 164.8 (C-3), 151.0 (C-8), 141.6 (C-7a), 138.7 (C-5), 134.3 (C-6),
131.6 (C-4), 122.9 (C-13), 119.1 (C-14), 118.8 (C-3a), 115.3 (C-7), 63.9 (C-10), 61.7
(C-17), 49.2 (C-12), 34.0 (C-16), 31.4 (C-15), 14.4 (C-ll); LRMS (ES+) m/z: 327.12
[M+Na]+; HRMS (ES+) Calcd for C16H2oN202 [M+Na]+: 327.1321, found: 327.1321; IR




To a solution of 265 (40.0 mg, 0.13 mmol, 1.0
eq.) in dry THF (5 mL) was added
triethylamine (1.01 mL, 2.60 mmol, 20.0 eq.).
Triisopropylsilyl trifluoromethanesulfonate
(0.52 mL, 1.95 mmol, 15.0 eq.) was added and
the reaction mixture stirred for 30 minutes at
room temperature. The reaction was quenched
by addition of saturated ammonium chloride solution (10 mL) and extracted with ethyl
acetate (3x15 mL). The combined organic extracts were dried (MgS04) and
concentrated in vacuo. The crude oil was purified by flash chromatography eluting with
hexane to give the desired product 267 as a colourless oil (57 mg, 95%): Rf (20% ethyl
acetate/petrol) 0.43; 'H NMR S 7.91 (br d, 1H; H-7), 7.44 (dd, J = 1.6, 0.8 Hz, 1H; H-
4), 7.32 (dd, J= 8.7, 1.6 Hz, 1H; H-6), 6.08 (ddt, J = 17.2, 10.5, 5.8 Hz, 1H; H-14),
5.42 (ddt, J= 17.2, 1.5, 1.5 Hz, 1H; H-15a), 5.26 (ddt, J = 10.5, 1.5, 1.5 Hz, 1H; H-
15b), 4.93 (ddt, J= 5.8, 1.5, 1.5 Hz, 2H, H-13), 4.46 (q, J= 1A Hz, 2H; H-10), 3.63 (t,
J =6.1 Hz, 2H; H-18), 2.76 (m, 2H; H-16), 1.85-1.76 (m, 2H, H-17), 1.42 (t, J= 7.1
Hz, 3H; H-ll), 0.99 (m, 21H; H-20, H-21, H-22); ,3C NMR S 159.3 (C-3), 150.9 (C-8),
139.8 (C-7a), 137.8 (C-5), 132.3 (C-14), 131.2 (C-6), 118.9 (C-4), 118.5 (C-15), 117.3
(C-3a), 114.5 (C-7), 69.9 (C-13), 63.4 (C-10), 62.2 (C-18), 34.8 (C-17), 31.7 (C-16),
18.0 (C-21 and C-22), 14.5 (C-ll), 12.0 (C-20); LRMS (ES+) m/z: 461 [M+H]+, 483
[M+Na]+; HRMS (ES+) calcd for C25H4iN204Si [M+H]+: 461.2836, found: 461.2856;
TIPSO
219
Calcd for C25H4iN204Si [M+Na]+: 483.2648, found: 483.2655; IR (thin film, cm"1) 2937
m, 2860 m, 1755 stg (C=0), 1725 stg (CO), 1547 stg (C=N), 1487 stg, 1444 m, 1406
w, 1377 m, 1342 w, 1240 m, 1206 m, 1096 m, 1041 m, 973 m, 879 w, 751 m, 675 stg;
Synthesis of 3-allyloxy-5-[3-(triisopropylsilyloxv)propyll indazole 268
removed in vacuo. The reaction was then neutralised with diluted hydrochloric acid
solution (10%) to pH 7 and extracted with ethyl acetate (3x25 mL). The combined
organic extracts were dried (MgS04) and concentrated in vacuo. The crude material was
purified by flash chromatography eluting with 10% ethyl acetate/hexane to give the
desired product 268 as a colourless oil (36 mg, 75%): Rf (20% ethyl acetate/hexane)
0.19 ; *H NMR <5 8.74 (br s, 1 H; NH), 7.34 (s, 1H; H-aromatic), 7.07 (d, J = 1.5 Hz,
1H; H-aromatic), 7.06 (d, J= 0.9 Hz, 1H; H-aromatic), 6.00 (ddt, J= 17.2, 10.5, 5.4
Hz, 1H; H-10), 5.31 (ddt, J= 17.2, 1.5, 1.5 Hz, 1H; H-15a), 5.14 (ddt, J= 10.5, 1.5,
1.5 Hz, 1H; H-15b), 4.75 (dt, J = 5.4, 1.5 Hz, 2H; H-9), 3.55 (t, J= 6.2 Hz, 2H; H-14),
2.63 (m, 2H; H-12), 1.72 (m, 2H; H-13), 0.92-0.88 (m, 21H; H-16 and H-17); 13C
NMR S 157.3 (C-3), 141.9 (C-quat.), 134.5 (C-quat.), 133.6 (C-10), 129.9 (C-
aromatic), 118.9 (C-aromatic), 118.2 (C-ll), 109.9 (C-aromatic), 69.9 (C-9), 62.9
(C-14), 32.3 (C-13), 35.5 (C-12), 18.5 and 12.4 (C-16 and C-17); LR MS (CI+) m/z:
389.26 [M+H]+; HR MS (CI+) calcd for C22H37N202Si [M+H]+: 389.2624, found:
389.2615; IR (thin film, cm"1) 3205 br (N-H), 2941 m, 2860 m, 1525 stg (C=N), 1496 m
(C=N), 1461 stg, 1321 m, 1249 m, 1202 m, 1100 m, 981 w, 883 w;
Aqueous lithium hydroxide (2 M, 2.0 mL)
was added to a solution of 267 (57.0 mg,
0.12 mmol, 1.0 eq.) in THF (5 mL) and the
reaction stirred vigorously for 16 hours at
room temperature. The solvent was partially
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Synthesis of 3-allvloxy-5-r3-hydroxypropyll indazole 271
To a solution of 268 (23.0 mg, 0.059 mmol, 1.0
Is
1 equiv.) in THF (5 mL) was added tetrabutyl
Hb ammonium fluoride (TBAF) (30 mg, 0.12 mmol,
2.00 equiv.) and the mixture was stirred at room
1 'i temperature for 16 hours. The reaction mixture
was then quenched by addition of ammonium chloride (5 mL) and extracted with ethyl
acetate (3x5 mL). The combined organic extracts were dried (MgSCL), concentrated in
vacuo. The crude material was purified by flash chromatography eluting with 40% ethyl
acetate/hexane to give the desired product 271 as a yellow oil (9.00 mg, 66%); Rf (50%
ethyl acetate/petrol) 0.16; 'H NMR d 8.90 (br s, 1H; NH), 7.44 (s, 1H; H-4), 7.16 (d, J
= 1.6 Hz, 2H; H-6, H-7), 6.11 (ddt, J = 17.2, 16.0, 5.5 Hz, 1H; H-10), 5.41 (dq, J =
17.2, 1.6 Hz, 1H; H-lla), 5.25 (dq, J= 10.5, 1.3 Hz, 1H; H-llb), 4.84 (dt, 5.5, 1.4
Hz, 2H; H-9), 3.62 (t, 6.4 Hz, 2H; H-14), 2.73 (m, 2H; H-12), 1.86 (m, 2H; H-13),
1.63 (br s, 1H; OH); 13C NMR S 157.0 (C-3), 141.5 (C-7a), 133.4 (C-10), 133.1 (C-5),
128.2 (C-6), 118.5 (C-4), 117.9 (C-ll), 112.9 (C-3a), 109.6 (C-7), 69.5 (C-9), 62.1 (C-
14), 34.5 (C-12), 31.8 (C-13); LR MS (ES+) m/z: 255 [M+Na]+, HR MS (ES+) calcd for
Ci3Hi6N202Na [M+Naf: 255.1109, found 255.1105; IR (thin film, cm"1) 3256 br, 2928





15 16 |-|a To a solution of 268 (36.0 mg, 0.09 mmol,
TIPSO
"is^Hb 1-0 ecf) in dry THF (5 mL) was added
potassium /-butoxide (20.0 mg, 0.18 mmol,
11 2.0 eq.) and benzyl bromide (0.02 mL, 0.14
12 mmol, 1.50 eq.) under an inert atmosphere.
The solution was stirred at room temperature
for 30 minutes. The reaction was quenched by addition of saturated ammonium chloride
solution (10 mL) and extracted with ethyl acetate (3x15 mL). The combined organic
extracts were dried (MgSCL) and concentrated in vacuo. The crude material was
purified by flash chromatography eluting with 0-10% ethyl acetate/hexane to give the
desired product 269 as a colourless oil (28.0 mg, 67%); Rf (20% ethyl acetate/petrol)
0.57; 'H NMR d 7.42-7.41 (m, 1H; H-aromatic), 7.23-7.07 (m, 6 H; H-aromatic), 7.00
(dd, J = 8.7, 0.8 Hz, 1H; H-aromatic), 6.09 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H; H-17),
5.40 (ddt, J = 17.2, 1.6, 1.6 Hz, 1H; H-18a), 5.23 (s, 2H; H-8), 5.22 (ddt, J= 10.5, 1.6,
1.3 Hz, 1H, H-18b), 4.83 (m, 2H; H-16), 3.64 (t, J= 6.3 Hz, 2H; H-21), 2.69 (m, 2H;
H-19), 1.79 (m, 2H; H-20), 0.99 (m, 21H; H-23, H-24); 13C NMR S 155.3 (C-3), 140.6
(C-quat.), 137.5 (C-quat.), 133.3 (C-17), 129.0 (C-aromatic), 128.5 (C-aromatic),
127.4 (C-aromatic), 127.0 (C-aromatic), 118.6 (C-aromatic), 117.8 (C-18), 113.2 (C-
3a), 108.7 (C-aromatic), 69.6 (C-16), 62.5 (C-21), 52.3 (C-8), 35.0 (C-20), 31.8 (C-
19), 18.0 and 12.0 (C-23 and C-24); LR MS (Cf) m/z: 479 [M+H]+, HR MS (CI+) calcd
for C29H43N202Si [M+H]+: 479.3092, found: 479.3094; IR (thin film, cm'1) 2945 m,
2865 m, 1534 stg (C=N), 1491 m (C=N), 1453 m, 1338, 1211, 1100 m, 981 w, 883 m,
798 stg (Si-C), 683 w;
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Synthesis ofA^7-benzyl-i-allyloxy-5-[3-(hydroxy)propyll indazole 270
To a solution of 269 (47.0 mg, 0.10 mmol, 1.0
eq.) in dry THF (5 mL) was added
tetrabutylammonium fluoride (55 mg, 0.20
mmol, 2.0 eq.) and the reaction mixture was
stirred at room temperature for 16 hours. The
reaction was quenched by addition of saturated
ammonium chloride solution (10 mL) and extracted with ethyl acetate (3x15 mL). The
combined organic extracts were dried (MgS04) and concentrated in vacuo. The crude
material was purified by flash chromatography eluting with 20-100% ethyl
acetate/hexane to give the desired product 270 as a colourless oil (30 mg, 89%); Rf
(50% ethyl acetate/petrol) 0.3 ; !H NMR 5 7.41 (br s, 1H; OH), 7.23-7.07 (m, 7H; H-
aromatic), 7.00 (br d, 1H; H-aromatic), 6.09 (ddt, J = 17.2, 10.4, 5.6 Hz, 1H; H-17),
5.40 (ddt, J= 17.2, 1.6, 1.6 Hz, 1H; H-18a), 5.29 (s, 2H, H-8), 5.22 (ddt, J- 10.4, 1.4,
1.4 Hz, 1H; H-18b), 4.83 (ddd, J= 5.6, 1.4, 1.4 Hz, 2H; H-16), 3.60 (t, 6.4 Hz, 2H;
H-21), 2.73-2.68 (m, 2H; H-19), 1.88-1.79 (m, 2H; H-20); 13C NMR S 155.4 (C-3),
140.8 (C-7a), 137.7 (C-quat.), 133.4 (C-aromatic), 132.8 (C-quat.), 128.9 (C-
aromatic), 128.7 (C-aromatic), 127.6 (C-aromatic), 127.2 (C-aromatic), 118.8 (C-
aromatic), 118.0 (C-17), 113.4 (C-18), 109.0 (C-aromatic), 69.8 (C-16), 62.4 (C-21),
52.6 (C-8), 34.7 (C-20), 61.9 (C-19); LR MS (CI+) m/z: 232.18 [M+H]+; HR MS (CI+)
Calcd for C20H22N2O2 [M+H]+: 323.1760, found: 323.1752; IR (thin film, cm"1) 2920 m,
2853 m, 1526 stg (C=N), 1492 m (C=N), 1334 m, 1209 m, 1039 stg , 977 m;
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Synthesis ofN1 -ethyloxycarbonyl-/V.2-ally1-5-["3 -(triisopropylsilyloxy)
propyl"! indazolinone 272
To a solution of 266 (52.0 mg, 0.17 mmol,
1.0 eq.) in dry THF (5 ml) was added
triethylamine (0.12 mL, 0.85 mmol, 5.0
eq.) and triisopropylsilyl
trifluoromethanesulfonate (0.09 mL, 0.34
mmol, 2.0 eq.) under an inert atmosphere. The solution was stirred at room temperature
for 30 minutes. The reaction mixture was quenched by addition of saturated ammonium
chloride solution (15 mL) and extracted with ethyl acetate (3x15 mL). The combined
organic extracts were dried (MgSCfi) and concentrated in vacuo. The crude material was
purified by flash chromatography eluting with 10% ethyl acetate/hexane to give the
desired product 272 as a colourless oil (80 mg, 99%): Rf (20% ethyl acetate/ petrol)
0.34; 'H NMR 8 7.71 (d,J = 8.5 Hz, 1H; H-aromatic), 7.63 (d, J = 1.7 Hz, 1H; H-
aromatic), 7.40 (dd, J = 8.5, 1.7 Hz, 1H; H-aromatic), 5.65 (ddt, J = 16.5, 10.1, 6.2
Hz, 1H; H-13), 5.12 (m, 2H; H-14), 4.76 (m, 2H; H-12), 4.36 (q,J= 7.1 Hz, 2H; H-10),
3.64 (t, J= 6.1 Hz, 2H; H-17), 2.73 (m, 2H; H-15), 1.80 (m, 2H; H-16), 1.38 (t, J= 7.1
Hz, 3H; H-ll), 0.99 (m, 21H; H-19 and H-20); 13C NMR 8 164.8 (C-3), 151 (C-8),
141.5 (C-7a), 139.2 (C-5), 134.3 (C-6), 131.6 (C-13), 122.9 (C-4), 118.9 (C-14), 118.7
(C-3a), 115.1 (C-7), 63.7 (C-10), 62.1 (C-17), 49.1 (C-12), 34.6 (C-16), 31.5 (C-15),
18.0 (C-20), 14.3 (C-ll), 11.9 (C-19); LR MS (ES+) m/z: 461.27 [M+H]+; 483.25
[M+Na]+; HR MS (ES+) Calcd for C25H40N2O4 [M+Na]+: 483.2655, found: 483.2651 ;
IR (thin film, cm'1) 2937 m, 2860 m, 1742 stg (C=0), 1700 stg (C=0), 1487 m, 1283 m,
1211 m, 1104 m, 879 w, 679 w;
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Synthesis of 272 usinR the Claisen rearrangement
To a solution of 267 (5 mg, 0.0106 mmol, 1.0 eq.) in dry THF (5 mL) was added a
catalytic amount of tetrakis(triphenylphosphine)palladium(0) (5% mol.). The reaction
was stirred at room temperature for 16 hours under nitrogen. The solvent was removed
in vacuo and the crude solid was purified by flash chromatography eluting with 0-10%
ethyl acetate/petrol to give the desired product 272 as a colourless oil; 'H NMR
identical to the product obtained by reaction of 266 with tri(isopropyl)silyl
trifluromethanesulfonate.
Synthesis of7V2-allyl-5-r3-(triisopropylsilyloxy)propyl1indazolinol 273
stirred vigorously at room temperature for 16 hours. The reaction was then neutralised
with diluted hydrochloric acid solution (10%) to pH 7 and extracted with ethyl acetate
(3x15 mL). The combined organic extracts were dried (MgSCL) and concentrated in
vacuo. The crude material was purified by flash chromatography eluting with 30% ethyl
acetate/hexane to give the desired product 273 as a white solid (44 mg, 65%); Rf (20%
ethyl acetate/hexane) 0.13; mp 63-65°C; 'H NMR S 7.56 (br s, 1H; H-aromatic), 7.39
(s, 1H; H-OH), 7.29 (dd, J= 8.4, 1.7 Hz, 1H; H-aromatic), 7.06 (d, J= 8.4 Hz, 1H; H-
aromatic), 5.82 (m, 1H; H-9), 5.27-5.18 (m, 2H, H-10), 4.40 (m, 2H; H-8), 3.63 (t, J =
6.2 Hz, 2H; H-13), 2.69 (m, 2H; H-ll), 1.78 (m, 2H, H-12), 0.98 (m, 21H; H-15 and
H-16); ,3C NMR S 162.5 (C-3), 145.4 (C-7a), 137.1 (C-5), 133.0 (C-6), 131.9 (C-9),
122.8 (C-4), 119.5 (C-3a), 119.3 (C-10), 112.3 (C-7), 62.3 (C-13), 46.7 (C-8), 34.8 (C-
11), 31.7 (C-12), 18.0 and 11.9 (C-15 and C-16); LR MS (ES') m/z: 387 [M-H]", HR
MS (ES") Calcd for C22H35N202Si [M-H]": 387.2468, found: 387.2460; IR (thin film,
cm"1) 2945 m, 2865 m, 1632 m, 1500 stg (C=N), 1461 m (C=N), 1104 m, 883 m, 679
To a solution of 272 (80.0 mg, 0.17 mmol, 1.0
eq.) in THF (10 mL) was added an aqueous
lithium hydroxide solution (2 M, 2.0 mL, 4.0
mmol, 4.0 eq.). The reaction mixture was
m.
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Synthesis ofA^2-allyl-5-r3-hydroxy propyl!indazolinone 276
OH
To a solution of 273 (20.0 mg, 0.052 mmol) in
THF (5 mL) was added tetrabutylammonium
fluoride (27.0 mg, 0.10 mmol, 2.0 equiv.). The
HO' 10 reaction mixture was stirred for 16 hours at room
temperature. The reaction was quenched by addition of saturated solution of ammonium
chloride and extracted with ethyl acetate (3><10 mL). The combined organic extracts
were dried (MgS04), concentrated in vacuo. The crude product was purified by flash
chromatography eluting with ethyl acetate to afford the desired compound 276 as a
yellow oil (7 mg, 60%); Rf (100% ethyl acetate) 0.06; 'H NMR d 7.57 (s, 1H; H-4),
7.30 (dd, J= 8.5, 1.3 Hz, 1H; H-6), 7.08 (d, J= 8.3 Hz, 1H; H-7), 5.86 (ddt, J= 16.3,
10.1, 6.2 Hz, 1H; H-9), 5.29 (br d,J = 11.8 Hz, 1H; H-10), 5.25 (br d,J= 5.4 Hz, 1H;
H-10), 4.44 (d,J= 6.0 Hz, 2H; H-8), 3.59 (t, J= 6.3 Hz, 2H; H-13), 2.71 (t, J= 7.6 Hz,
2H; H-ll), 1.82 (m, 2H; H-12), 1.72 (br s, 2H; NH and OH); ,3C NMR S 145.5 (C-3),
136.8 (C-5), 132.9 (C-6), 131.8 (C-9), 122.9 (C-4), 119.6 (C-10), 112.5 (C-7), 100.2
(C-quat.), 61.8 (C-13), 46.8 (C-8), 34.2 (C-12), 31.5 (C-ll), one C-quat. too weak to
observe; LR MS (CI+) m/z: 233 [M+H]+, HR MS (CI+) calcd for Ci3H17N202 [M+H]+:
233.1290, found 233.1288; IR (thin film, cm"1) 2928 stg, 2856 stg, 1627 stg (C=N),




O -IC Hb To a solution of 269 (20.0 mg, 0.04 mmol,
i7 1.0 eq.) in dry THF (5 mL) was added
Ha
TIPSO' tetrakis(triphenylphosphine)palladium (0)
(10.0 mg , 8.66 pmol, 20% mol.). The
13
2 solution was stirred in the dark at room
temperature under an inert atmosphere for 16
hours. The reaction was quenched with addition of ammonium chloride (5 mL) and
extracted with ethyl acetate (3x15 mL). The combined organic extracts were dried
(MgSCL) and concentrated in vacuo. The product was purified by flash chromatography
eluting with hexane to afford 274 as a colourless oil (18.0 mg, 90%); Rf (20% ethyl
acetate/petrol) 0.1 ; NMR 8 7.58 (s, 1H; H-aromatic), 7.29-6.94 (m, 7H; H-
aromatic), 5.73 (m, 1H; H-16); 5.14 (m, 1H; H-17a); 5.10 (m, 1H; H-17b); 4.71 (s,
2H; H-8); 4.43 (dt, J= 5.7, 1.4 Hz, 2H; H-15); 3.63 (t, J= 6.2 Hz, 2H; H-20); 2.69 (m,
2H; H-18); 1.79 (m, 2H; H-19); 0.99 (m, 21H; H-22 and H-23); 13C NMR S 163.5 (C-
3), 148.1 (C-quat.), 136.4 (C-quat.), 134.8 (C-quat.), 133.2 (C-aromatic), 132.6 (C-
16), 128.6 (C-aromatic), 128.1 (C-aromatic), 127.8 (C-aromatic), 123.0 (C-4), 118.7
(C-3a), 117.9 (C-17), 111.7 (C-aromatic), 62.4 (C-20), 53.7 (C-8), 45.1 (C-15), 34.7
(C-19), 31.6 (C-18), 18.03 and 12.0 (C-22 and C-23); LR MS (ES+) m/z: 501 [M+Na]+;
HRMS (CI+) Calcd for C29H43N202Si [M+H]+: 479.3094, found: 479.3092; IR (thin




To a solution of 274 (2.00 mg, 0.0042 mmol, 1.0
eq.) in dry THF (10 mL) was added
tetrabutylammonium fluoride solid (5 mg, 0.023
mmol, 5.0 eq.). The reaction mixture was stirred
at room temperature under an inert atmosphere
for 16 hours. The reaction was quenched by
addition of ammonium chloride (3 mL) and extracted with ethyl acetate (3x2 mL). The
combined organic extracts were dried (MgSCL) and concentrated in vacuo. The product
was purified by flash chromatography eluting with ethyl acetate to give 275 as a
colourless oil (1.00 mg, 74%); Rf (ethyl acetate) 0.19; !H NMR 5 7.59 (s, 1H; H-4),
7.27 (dd, J = 8.5, 1.7 Hz, 1H; H-6), 7.21-7.16 (m, 3H; H-aromatic), 7.03 (m, 2H; H-
aromatic), 6.96 (d, J= 8.4 Hz, 1H; H-7), 5.75 (m, 1H; H-16), 5.12 (m, 2H; H-17), 4.71
(s, 2H; H-8), 4.44 (d, J= 5.6 Hz, 2H; H-15), 3.60 (t, J= 6.3 Hz, 2H; H-20), 2.70 (t, J =
7.6 Hz, 2H; H-18), 1.91 (br s, 1H; OH), 1.83 (m, 2H; H-19); 13C NMR S 163.5 (C-3),
148.2 (C-quat.), 136.1 (C-quat.), 134.9 (C-quat.), 133.3 (C-6), 132.7 (C-16), 128.8
(C-aromatic), 128.4 (C-aromatic), 127.9 (C-aromatic), 123.2 (C-4), 118.7 (C-quat.),
118.1 (C-17), 111.7 (C-7), 62.0 (C-20), 53.7 (C-8), 45.3 (C-15), 34.3 (C-19), 31.6 (C-
18); LR MS (ES+) m/z: 345 [M+Na]+; HR MS (ES+) Calcd for CzoHzaNzOaNa [M+Na]+:
345.1579, found: 345.1580; IR (thin film, cm"1) 3362 br (O-H), 2941 m, 2852 m, 1661
stg (C=0), 1491 m, 700 m.
13
228
The loading procedure for solid-supported synthesis
Activation: Silicon functionalised resin (1.43 mequiv. Si/g) that had been dried under
high vacuum for 12 hours was weighed (260 for O-allylated isomer and 226 mg for N-
allylated isomer, 1 equiv.) into a 10 mL polypropylene PD-10 column fitted with a
Teflon stopcock and swollen in DCM (2.0 mL, 10 mL of solvent/g of resin) under N2
atmosphere for 30 min. The solvent was then drained under positive N2 pressure and 5,2
and 4.5 mL of a 4% trifluoromethanesulfonic acid/DCM solution (6 equiv. of TfOH
relative to Si) respectively was added by syringe. The resin turned bright red/orange
upon acid treatment and was then gently agitated for 30 min. while still under N2
atmosphere. Once activation was completed, two DCM washes remoed excess acid.
Loading: Treatment of the silicon-based resin with 2,6-lutidine (450 and 420 pL
respectively, 8.0 equiv. relative to Si) for 15 minutes followed by addition of 0.5 mL of
an azeotropically dried 1.0 M solution of 265 (147 mg)/ 266 (137 mg) (2.0 equiv.)
resulted in a colorless resin. The beads are then gently agitated for an additional 10 hour
under N2 atmosphere. The beads were drained, exposed to atmosphere, and subjected to
the following wash protocol : CH2CI2 (2x3 mL for 45 minutes), THF (2x3 mL for 30
minutes), THF/IPA (3:1, 2x3 mL for 30 minutes), THF/H20 (3:1, 2x3 mL for 30
minutes), THF/IPA (3:1, 2x3 mL for 30 minutes), THF/IPA (3:1, 2x3 mL for 30
minutes), DMF (2x3 mL for 30 minutes), THF (2x3 mL for 30 minutes). The resin was
air-dried for 3 h and then placed under high vacuum for 24 h to remove trace of solvent
and H2O. The mass of the loaded and dried resin indicated an apparent loading
efficiency of 35% and 28% respectively based on weight gain and recovered starting
material.
The cleavage procedure from the solid support
Vacuum-dried resin was weighed (>5 mg) out into a solvent resistant scintillation vial
and allowed to swell in 1.0 mL of THF for 30 min. The THF solution was removed and
replaced with a fresh 0.95 mL of THF and 0.05 mL of HF/pyridine solution (7:3 ratio
HF/pyridine, available from Aldrich Co.) The vial was sealed and agitated for 3 h at
which time 0.1 mL of methoxytrimethylsilane was added to quench unreacted HF.
(Note : quench is mildly exothermic therefore use caution). The beads are further
agitated for 30 minutes to ensure complete quenching. The solution was removed and
the beads washed twice with additional 1.0 mL portions of fresh THF. All solvents were
229
combined and concentrated in vacuo. The material recovered from the cleavage was
then analysed by LC/MS and compared with the traces of authentic materials.
Synthesis ofyV2-allyl 3-benzyloxycarbonyloxyindazole 170
To a solution of 23 (250 mg, 1.44 mmol, 1.0 equiv.) in
dry THF (15 mL) was added triethylamine (241 pL, 1.73
mmol, 1.20 equiv.) and the solution was stirred at room
temperature under an inert atmosphere for 30 minutes.
Benzyl chloroformate (225 pL, 1.58 mmol, 1.10 equiv.)
was added and the solution was stirred under the same
conditions for 1 hour. The reaction was quenched by addition of saturated ammonium
chloride solution (20 mL) and extracted with ethyl acetate (3x30 mL). The combined
organic extracts were dried (MgSCL) and concentrated in vacuo. The crude material was
purified by flash chromatography eluting with 20% ethyl acetate/hexane to afford 170
as an orange oil (431 mg, 97%); Rf (20% ethyl acetate/petrol) 0.15 ; 'H NMR S 7.61 (d,
J= 8.8 Hz, 1H; H-7), 7.44 (m, 6H; H-aromatic), 7.25 (m, 1H; H-6), 7.05 (m, 1H; H-5),
5.98 (m, 1H; H-), 5.33 (s, 2H; H-14), 5.18 (d, J= 5.9 Hz, 1H; H-10), 5.13 (d, J= 12.7
Hz, 1H; H-10), 4.89 (d, J= 5.9 Hz, 2H; H-8) ; 13C NMR S 151.2 (C-12), 147.1 (C-7a),
136.8 (C-3), 133.9 (C-15), 131.3 (C-9), 129.3 (C-aromatic), 128.8 (C-aromatic),
126.6 (C-6), 121.9 (C-5), 118.9 (C-10), 118.6 (C-4), 117.8 (C-7), 110.4 (C-3a), 71.8
(C-14), 52.0 (C-8); LR MS (EI+) m/z: 308 [M]+; HR MS (EI+) calcd for CI8Hi6N203
[M]+: 308.1161, found: 308.1157; IR (thin film, cnf1) 3037 w, 2925 w, 1750 stg (C=0),
1700 stg, 1615 w, 1457 stg, 1389 m, 1280 stg, 752 stg;
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Synthesis ofN2-dX\y\ 3-chloroindazole 197
7
CI
23 (100 mg, 0.57 mmol) were introduced in a flask
'10 containing phosphorus oxychloride (3.00 mL). The
Ha solution was refluxed for 16 hours under an inert
atmosphere. The excess of phosphorus oxychloride was
removed by co-distillation using toluene (4x6 mL). The crude oil was purified by flash
chromatography eluting with 20% ethyl acetate/petrol to afford 197 as a brown oil (60.0
mg , 54%); Rf (20% ethyl acetate/petrol) 0.33; ]H NMR 8 7.58 (dt,J= 8.8, 0.9 Hz, 1H;
H-7), 7.49 (dt, J = 8.5, 1.0 Hz, 1H; H-4), 7.23 (ddd, J = 8.8, 6.6, 1.1 Hz, 1H; H-6), 7.04
(ddd, J = 8.4, 6.6, 0.8 Hz, 1H; H-5), 5.98 (ddt, J= 17.0, 10.3, 5.7 Hz, 1H; H-9), 5.23
(ddd, J = 10.2, 2.3, 1.3 Hz, 1H; H-lOb), 5.12 (ddd, J= 17.0, 2.5, 1.5 Hz, 1H; H-lOa),
4.99 (dt, J= 5.8, 1.5 Hz, 2H; H-8); 13C NMR 8 148.0 (C-7a), 131.2 (C-9), 126.9 (C-6),
122.2 (C-5), 118.9 (C-10, C-3 overlapping), 118.6 (C-4, C-3a overlapping), 117.9 (C-
7), 52.9 (C-8); LR MS (Cf) m/z: 193 [M+H]+, HR MS (CI+) calcd for Ci0Hi0N2C1
[M+H]+: 193.0533, found: 193.0534; IR (thin film, cm"1) 3056 w, 2937 w, 1627 m
(C=C), 1504 m (C=N), 1461 m, 1364 stg, 1287 m, 1245 m, 1053 stg, 985 m, 921 m,
862 w, 739 stg;
Synthesis of 2-azido benzoic acid 206
remained below 5°C. After completion of sodium nitrite addition, the diazonium
solution was filtered and added dropwise to a stirred solution of sodium azide (2.05 g,
30.0 mmol, 1.00 equiv.) and sodium acetate (30.10 g, 0.36 mol, 12 equiv.) in water (60
mL). The yellow solution was stirred for 15 minutes. The white precipitate was filtered
and recrystallised from toluene as white needles, 206 (1.90 g, 43%), mp 145-146°C (lit.
155°C), IR (nujol, cm"1) 2946 stg, 2926 stg, 2893 stg, 2101m (N=N), 1694 m, 1595 w,
1578 w, 1459 m (nujol), 1377 m (nujol), 1270 m.
To a solution of 2-amino benzoic acid (4.11 g, 30.0 mmol) in
fl concentrated hydrochloric acid (60 mL) and water (60 mL) was added
^OH
dropwise a solution of sodium nitrite (2.32 g, 33.6 mmol) in water (30
N3 mL) at a rate such that the temperature of the reaction mixture
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Synthesis of 2-azido /V-phenyl benzamide 207
To a solution of 206 (1.80 g, 11.0 mmol) in dichloromethane
(50 mL) was added oxalyl chloride (1.07 mL, 12.0 mmol, 1.10
equiv.) and a catalytic amount of DMF. The reaction was
stirred for 2 hours at room temperature under an inert
atmosphere. The resulting solution was added via cannula to a solution of aniline (1.20
mL, 13.2 mmol, 1.20 equiv.) and Hunig's base (2.30 mL, 13.0 mmol, 1.20 equiv.) in
DCM (50 mL). The reaction mixture was stirred for 30 min at room temperature,
quenched by addition of saturated ammonium chloride (50 mL) then extracted with
ethyl acetate (3x30 mL). The combined organic extracts were dried (MgSCL) and
concentrated in vacuo. The crude product was purified by flash chromatography eluting
with 10% ethyl acetate/hexane to afford 207 as a brown solid (2.20 g, 84%); mp 128°C
(lit. [156]136°C), 'HNMR 9.24 (s, 1H; NH), 8.19 (dd, J = 7.9, 1.6 Hz, 1H; H-aromatic),
7.62 (app. dd, J= 8.5, 0.9 Hz, 2H; H-aromatic), 7.49 (ddd, J = 8.0, 7.4, 1.7 Hz, 1H; H-
aromatic), 7.31 (m, 2H, H-aromatic), 7.22 (m, 2H; H-aromatic), 7.09 (app. tt, J = 1A,
1.3 Hz, 1H; H-aromatic) ; IR (thin film, cm"1) 3293 w, 3060 w, 3030 w, 2925 w, 2127
stg, 1656 stg, 1597 stg, 1542 stg, 1497 stg, 1441 stg, 1322 stg, 1277 m, 751 stg, 690 m;
Synthesis of 3-chloro-2-phenvl-2//-indazole 208
11 inert atmosphere. The excess of thionyl chloride was
crude oil was purified by flash chromatography eluting with 10% ethyl acetate/hexane
to afford the desired compound 208 (1.53 g, 80%) as a white solid; mp 36-37°C (lit. [156]
34°C); 'H NMR 5 7.65-7.59 (m, 3H; H-aromatic), 7.54 (dt, J = 8.5, 1.0 Hz, 1H; H-
aromatic), 7.49-7.40 (m, 3H; H-aromatic), 7.27 (ddd, J= 8.8, 6.6, 1.1 Hz, 1H; H-6),
7.07 (ddd, J= 8.5, 6.6, 0.8 Hz, 1H; H-5) ;13C NMR S 148.5, 138.4, 129.1, 127.5, 125.7,
122.7, 119.8, 119.4, 118.9, 118.2 (one carbon missing due to overlapping); LR MS
(CI+) m/z: 229 [M+H]+; HR MS (CI+) calcd for Ci3Hi0N235C1 [M+H]+: 229.0533, found:
229.0538 ; IR (thin film, cm"1) 3063 w, 3040 w, 1627 m, 1596 m, 1516 stg, 1497 stg,
1454 m, 1369 stg, 1263 w, 1108 w, 1016 m, 824 w, 760 stg, 742 stg, 692 stg;
2-azido /V-phenyl benzamide 207 (2.00 g, 8.40 mmol) was
refluxed in thionyl chloride (10 mL) for 16 hours under an
7 removed by co-distillation with toluene (3x30 mL). The
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Synthesis of 2-phenyl-2//-indazole 210
To a solution of 208 (200 mg, 0.88 mmol) in glacial acetic
acid (5 mL) was added zinc dust (340 mg, 5.28 mmol, 6.00
equiv.). The stirred reaction was heated under reflux for 2
7 1 hours. The reaction was cooled down to room temperature,
the solvent was removed in vacuo. The oily residue was solubilised in dichloromethane
(20 mL) and the excess of acetic acid was removed by washing the organic phase with
water (2x10 mL) and saturated sodium bicarbonate solution (1x10 mL). The combined
organic extracts were dried (MgS04) and concentrated in vacuo. The crude product was
purified by flash chromatography eluting with 10% ethyl acetate/hexane to afford 210
(130 mg, 76%) as an offwhite solid; Rf (20% ethyl acetate/petrol) 0.36; 'HNMR S 8.31
(s, 1H, H-3), 7.81 (m, 2H; H-aromatic), 7.72 (dd, J = 8.8, 0.8 Hz, 1H; H-aromatic),
7.62 (d, J= 8.5 Hz, 1H; H-aromatic), 7.43 (t,J= 7.8 Hz, 2H; H-aromatic), 7.31 (t,J =
7.4 Hz, 1H; H-ll), 7.24 (ddd, J= 8.7, 6.6, 1.0 Hz, 1H; H-aromatic), 7.03 (dd, J= 8.2,
6.8 Hz, 1H; H-aromatic); LR (ES+) m/r. 195 [M+H]+; HR (ES+) calcd for Ci3H,iN2
[M+H]+: 195.0922, found: 195.0918;
Synthesis of 3-methoxy-2-phenyl-2//-indazole 209
208 (200 g, 0.88 mmol) was heated under reflux for 24 h
with a solution of sodium methoxide [sodium (200 mg) in
methanol (10 mL)]. The reaction mixture was cooled and
the solvent was removed in vacuo. The residue was
adsorbed onto silica and purified by flash chromatography
eluting with 10% ethyl acetate/hexane to afford 209 as an brown oil (22.0 mg, 11%); Rf
(20% ethyl acetate/petrol) 0.29; *H NMR S 7.72 (m, 2H; H-aromatic), 7.62 (dt, J= 8.6,
1.0 Hz, 1H; H-6), 7.49 (dt, J = 8.9, 0.9 Hz, 1H; H-5), 7.39 (m, 2H; H-aromatic), 7.28
(m, 1H; H-ll), 7.14 (ddd, J= 8.9, 6.6, 1.0 Hz, 1H; H-4), 6.84 (ddd, J= 8.6, 6.6, 0.8 Hz,
1H; H-7), 4.17 (s, 3H; H-15); 13C NMR S 147.9 (C-7a), 146.7 (C-3), 138.5 (C-
aromatic), 128.9 (C-aromatic), 127.7 (C-ll), 126.9 (C-4), 123.9 (C-aromatic), 120.1
(C-7), 119.7 (C-6), 117.9 (C-5), 107.7 (C-3a), 60.6 (C-15); LR (ES+) m/z: 225 [M+H]+;
HR (ES+) calcd for Ci4Hi3N20 [M+H]+: 225.1028, found: 225.1032; IR (thin film, cm"1)
3063 w, 2925 m, 2853 w, 1625 stg, 1596 stg, 1551 stg, 1523 stg, 1513 stg, 1490 m,
1460 m, 1414 stg, 1382 stg, 1285 m, 1159 m, 1143 m, 1127 stg, 1076 stg, 762 stg, 740
stg, 692 stg;
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Synthesis of 2-benzyl-3-chloro-2//-indazole 203
202 (2.00 g, 8.93 mmol) was refluxed in phosphorus
oxychloride (3 mL, 3.60 equiv.) for 16 hours under an inert
atmosphere. The excess of phosphorus oxychloride was
removed by co-distillation with toluene (4^10 mL). The crude
12 product was then transferred onto silica and purified by flash
chormatography eluting with 20% ethyl acetate/petrol to afford 203 as an off-white
solid (700 mg, 33%); Rf (20% ethyl acetate/petrol) 0.51, lU NMR S 7.59 (dt,J = 8.8,
0.9 Hz, 1H; H-4), 7.47 (dt, J= 8.5, 1.0 Hz, 1H; H-7), 7.26-7.16 (m, 6H; H-aromatic),
7.03 (ddd, J = 8.4, 6.6, 0.8 Hz, 1H; H-6), 5.55 (s, 2H; H-8); 13C NMR S 148.0, 135.2,
128.8, 128.2, 127.6, 126.9, 122.3, 119.3, 119.1, 118.7, 118.0, 54.2 ; LR (ES+) m/z: 265
[M+Na]+; IR (thin film, cm"1) 3063 w, 3037 w, 2945 w, 1628 m, 1507 m, 1496 m, 1468
m, 1455 m, 1368 s, 1291 m, 1246 m, 1175 w, 1147 w, 1058 m, 880 w, 758 m, 742 stg,
705 stg;
Synthesis of 2-benzyl-2//-indazole 204
To a solution of 203 (297 mg, 1.23 mmol) in glacial acetic
acid (5 mL) was added zinc dust (160 mg, 2 equiv.). The
reaction was stirred under reflux for 16 hours, filtered whilst
hot, and the residue washed with methanol (2x10 mL). The
solvent was removed in vacuo. The product was solubilised in
dichloromethane (20 mL) and the excess of acetic acid was
removed by washing the organic phase with water (2x10 mL) and saturated sodium
bicarbonate solution (1x10 mL). The combined organic extracts were dried (MgSCL)
and concentrated in vacuo. The crude product was purified by flash chromatography
eluting with 10% ethyl acetate/hexane to afford 204 as a yellow oil (199 mg, 78%); Rf
(20% ethyl acetate/petrol) 0.19; !H NMR <5 7.80 (d, J= 0.8 Hz, 1H; H-3), 7.66 (ddd, J =
8.7, 1.8, 0.9 Hz, 1H; H-4), 7.54 (dt, J = 8.4, 1.0 Hz, 1H; H-7), 7.32-7.17 (m, 6H; H-
aromatic), 7.00 (ddd, J = 8.4, 6.6, 0.9 Hz, 1H; H-aromatic), 5.52 (s, 2H; H-8); LR
(CI+) m/z: 209 [M+H]+; HR (CI+) calcd for CI4Hi3N2 [M+H]+: 209.1079, found:
209.1081; IR (thin film, cm"1) 3063 m, 3033 m, 2932 m, 1628 m, 1515 m, 1496 m, 1470
m, 1455 m, 1390 m, 1310 m, 1156 m, 1135 m, 1029 w, 1009 w, 981 w, 906 w, 839 w,
784 m, 758 stg, 705 w, 644 w;
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Synthesis of 4-phenvl-l-(2-phenyl-27/-indazol-3-yl)-l,2,4-triazolidine-3,5-
dione 215 and 4-phenyl-l,2-bis(2-phenyl-2H-indazol-3-yl)-1,2,4-
triazolidine-3,5-dione 216
To a solution of 210 (83.0 mg, 0.43 mmol) in chloroform (8 mL) was added 4-phenyl-
3H-l,2,4-triazoline-3,5-dione (75.0 mg, 0.43 mmol, 1.00 equiv.). The reaction was
refluxed until the bright red colour faded to a colourless solution (16 hours). The crude
reaction mixture was evaporated in vacuo and purified by flash chromatography eluting
with 20-50% ethyl acetate petrol to afford 215 as a white solid (118 mg, 75%) and 216
as a white crystalline solid (15 mg, 6%);
cm"1) 3468 br (N-H), 3060 w, 2954 m, 2924 m, 2852 w, 1785 w, 1725 stg (C=0), 1634
w, 1597 w, 1526 w, 1501 m, 1411 m, 1376 w, 1240 w, 1139 w, 833 w, 762 m, 691 m,
633 w, 615 w.
129.6 (C-aromatic), 129.4 (C-aromatic), 129.0 (C-aromatic), 127.5 (C-aromatic),
127.0 (C-aromatic), 126.1 (C-aromatic), 125.9 (C-aromatic), 125.4 (C-aromatic),
125.2 (C-aromatic), 124.7 (C-aromatic), 124.5 (C-aromatic), 119.8 (C-quat.), 119.2
(C-aromatic), 118.8 (C-aromatic), 118.4 (C-quat.), 117.2 (C-aromatic), 116.9 (C-
(215) : Rf (50% ethyl acetate/petrol) 0.29; mp 184-185°C; !H
NMR [Methanol-d4] S 7.36-7.32 (m, 13H; H-aromatic), 7.23
(m, 1H; H-aromatic); 13C NMR [Methanol-cf] d 154.4,
153.5, 149.5, 139.7, 132.5, 131.0, 130.6, 130.3, 129.8, 127.4,
126.6, 126.4, 125.5, 120.2, 119.7, 119.1, one C missing due to
overlapping; LR (ES") m/z: 368 [M-H]"; HR (ES") calcd for
C21H14N5O2 [M-H]": 368.1147, found: 368.1148; IR (thin film,
(216) : Rf (50% ethyl acetate/petrol) 0.45; mp 220°C; 'H
NMR <7 7.69 (m, 2H; H-aromatic), 7.55 (m, 2H; H-
aromatic), 7.47-7.24 (m, 7H; H-aromatic), 7.19-7.04
(m, 9H; H-aromatic), 6.93 (d, J = 8.5 Hz, 1H; H-
aromatic), 6.87 (dd, J = 8.2, 1.3 Hz, 1H; H-aromatic),
6.80 (m, 1H; H-aromatic); 13C NMR ^ 151.6 (C=0.),
148.2 (C=0), 147.9 (C-quat.), 138.0 (C-quat.), 137.2
(C-quat.), 130.0 (C-aromatic), 129.7 (C-aromatic),
235
aromatic), 114.6 (C-quat.); LR (ES+) m/z: 584 [M+Na]+ ; HR (ES+) calcd for
C34H24N7O2 [M+H]+: 562.1991, found: 562.1989; IR (thin film, cm"1) 2924 stg, 2852 m,
1788 w, 1734 stg (C=0), 1596 w, 1524 w, 1499 m, 1454 w, 1404 m, 1377 w, 760 m,
735 m, 690 m.
Synthesis of 1 -(2-benzyl-2H-indazol-3-yl)-4-phenvl-1,2,4-triazolidine-3,5-
dione 214
To a solution of 204 (20.0 mg, 0.096 mmol) in chloroform (3
mL) was added 4-phenyl-3//-l,2,4-triazoline-3,5-dione (16.8
mg, 0.096 mmol, 1.0 equiv.). The solution was refluxed for 16
hours until the bright red colour disapeared. The crude mixture
was concentrated in vacuo and purified by flash
chromatography eluting with 20-50% ethyl acetate/petrol to
afford 214 as an pale orange oil (30 mg, 82%); Rf (100% ethyl
acetate) 0.52; 'H NMR <5 7.56 (d, J = 8.8 Hz, 1H; H-aromatic), 7.47-7.05 (m, 13H; H-
aromatic), 5.49 (s, 2H; H-8); 13C NMR 8 154.6 (C=0), 153.1 (C=0), 151.0 (C-quat.),
147.4 (C-quat.), 135.0 (C-quat.), 130.5 (C-quat.), 129.3 (C-aromatic), 129.0 (C-
aromatic), 128.8 (C-aromatic), 128.5 (C-aromatic), 127.4 (C-aromatic), 126.9 (C-
aromatic), 125.5 (C-aromatic), 124.6 (C-quat.), 123.8 (C-aromatic), 118.3 (C-
aromatic), 118.0 (C-aromatic), 117.2 (C-quat.), 54.8 (C-8); LR (CI+) m/z: 384
[M+H]+; HR (CI+) calcd for C22H18N502 [M+H]+: 384.1461, found: 384.1457; IR (thin
film, cm"1) 3494 br (NH), 3069 m, 2958 m, 2928 m, 2856 w, 1788 m, 1726 stg (C=0),
1634 w, 1601 w, 1501 m, 1419 stg, 1277 m, 1142 w, 762 m, 733 m, 710 m, 690 m, 631
w.
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Synthesis of 2-nitro-Ar-benzylbenzamide 201
O A solution of 2-nitrobenzoic acid (5 g, 19.5 mmol) in
thionyl chloride (10 mL) was re fluxed for 2 h under an
5 13 inert atmosphere. The excess of thionyl chloride was
distilled off and the traces of SOCh were removed by
azeotropic distillations with toluene (2x20 mL). The acid chloride was redissolved in
DCM (20 mL) and cannulated onto a solution of benzylamine (3.27 mL, 31.1 mmol,
1.60 equiv.) and Hunigs base (5.2 mL, 54.2 mmol, 2.78 equiv.) in DCM (50 mL). The
solution was stirred at room temperature under an inert atmosphere for 16 hours. The
reaction was quenched by addition of saturated ammonium chloride (30 mL) and
extracted with ethyl acetate (3x30 mL). The combined organic extracts were dried
(MgSCL) and concentrated in vacuo. The crude material was recrystallised from hot
ethyl acetate to afford 201 as an orange solid (7.65 g, 99%); mp 125°C (lit. 126-
127°C[179] ); 'H NMR S 7.97 (dd, J = 8.1, 1.1 Hz, 1H; H-aromatic), 7.58 (dt, J = 7.5,
1.3 Hz, 1H; H-aromatic), 7.48 (ddd, J= 8.1, 7.6, 1.6 Hz, 1H; H-aromatic), 7.43 (dd, J
= 7.4, 1.4 Hz, 1H; H-aromatic), 7.32-7.20 (m, 5H; H-aromatic), 6.14 (br s, 1H; NH),
4.55 (d, J = 5.7 Hz, 2H; H-9); LR (ES") m/z\ 255 [M-H]'; HR (ES") calcd for
C14H11N2O3 [M-H]~: 255.0770, found: 255.0772.
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Synthesis of -/V2-benzyl indazolinone 202
12 To a solution of 201 (7.67 g, 29.9 mmol, 1.0 equiv.) in
methanol (72 mL) and sodium hydroxide (4.93 g in 96 mL
of water, 4.10 equiv.) was added solid zinc (5.92 g, 91
7 H mmol, 3.0 equiv) and the solution was refluxed for 24 h.
1
The reaction was then cooled down at room temperature;
the zinc solid was removed by filtration. The product was precipitated out of the
solution by neutralisation with dilute hydrochloric acid. The collected precipitate was
further purified by flash chromatography eluting with ethyl acetate to afford the desired
product 202 as an off-white solid (4.73 g, 72%); mp 169°C (lit. 168°C [140]); Rf(50%
ethyl acetate/petrol) 0.08; 'H NMR S 7.90 (app. dt, J = 7.9, 0.9 Hz, 1H; H-4), 7.50
(ddd, J = 8.3, 7.2, 1.2 Hz, 1H; H-6), 7.38-7.31 (m, 5H; H-aromatic), 7.20 (m, 2H; H-
aromatic), 5.06 (s, 2H; H-8); LR (ES") m/z\ 223 [M-H]; HR (ES") calcd for Ci4H,iN20
[M-H]+: 223.0871, found: 223.0869; IR (thin film, cm"1) 3063 w, 3033 w, 2935 w, 1624
s, 1456 m, 1422 m, 1325 m, 1274 w, 1252 w, 746 m, 700 stg, 678 m;
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Synthesis of 7V7-allyl A(2-benzyl indazolinone 262
To a solution of 202 (100 mg, 0.46 mmol, 1.0 equiv.) in
dry THF (10 mL) was added potassium /-butoxide (60 mg,
0.54 mmol, 1.20 equiv.) and the solution was stirred at
room temperature under an inert atmosphere for 30
minutes. Allyl bromide (50 pL, 0.54 mmol, 1.20 equiv.)
was added and the solution was stirred under the same conditions for 2 hours before the
solvent was removed in vacuo. The reaction was quenched by addition of saturated
ammonium chloride solution (20 mL) and extracted with ethyl acetate (3x30 mL). The
combined organic extracts were dried (MgSCL) and concentrated in vacuo. The crude
material was purified by flash chromatography eluting with 30% ethyl acetate/hexane to
afford the desired compound 262 as an orange oil (117 mg, 99%); Rf (20% ethyl
acetate/petrol) 0.06; !H NMR £7.83 (dt, J = 7.8, 0.9 Hz, 1H; H-4), 7.43 (ddd, J= 8.3,
7.2, 1.2 Hz, 1H; H-6), 7.19 (m, 5H; H-aromatic), 7.08 (m, 2H; H-aromatic), 5.35 (ddt,
J= 16.3, 10.1, 6.2 Hz, 1H; H-9), 5.05 (dq, J= 12.8, 1.3 Hz, 1H; H-lOa), 5.02 (s, 2H; H-
11), 5.00 (ddd, J= 5.7,2.3, 1.1 Hz, 1H; H-lOb), 4.17 (dt, J=6.2, 1.1 Hz, 2H; H-8); 13C
NMR S 163.7 (C-3), 149.0 (C-7a), 136.3 (C-12), 132.1 (C-aromatic), 130.2 (C-9),
128.7 (C-aromatic), 127.9 (C-aromatic), 127.7 (C-aromatic), 124.3 (C-aromatic),
122.2 (C-aromatic), 120.1 (C-10), 118.9 (C-3a), 111.9 (C-aromatic), 52.0 (C-8), 46.0
(C-ll); LR MS (CI+) m/z: 265 [M+H]+; HR MS (CI+) calcd for CnHnNzO [M+H]+:
265.1341, found: 265.1342; IR (thin film, cm"1) 3064 w, 3030 w, 2933 w, 1670 stg
(C=0), 1619 m, 1482 m, 1464 m, 1352 w, 1327 w, 1259 m, 1152 w, 1134 w, 992 m,
928 m, 755 m, 698 m, 683 m;
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Synthesis of 5-methyl indazolinone 244
4 O A solution of sodium nitrite (2.55 g, 37.0 mmol) in water (5.5 mL)
After stirring for 30 minutes, a solution of sodium sulfite (12.8 g, 102 mmol) in water
(33.5 mL) was added. After 2 hours, concentrated hydrochloric acid (11 mL) was added
and the mixture was stirred for 12 hours. The mixture was then heated to 70°C for 16
hours. After cooling to room temperature, the pH was adjusted to 5-5.5 with dilute
sodium hydroxide (2 M). The resulting yellow/brown precipitate was filtered under
vacuum, washed with water (3><50 mL) and dried under vacuum to give 244 (4.23 g,
86%); mp 235-237°C (lit. 240-242°C [180]); 'H NMR (DMSO-d6) 811.28 (br s, 1H; NH),
10.60 (br s, 1H; NH), 7.55 (s, 1H; H-4), 7.32 (m, 2H; H-6 and H-7), 2.50 (s, 3H; H-8);
13C NMR 8 156.3 (C-3), 141.7 (C-7a), 129.6 (C-4), 127.8 (C-5), 119.5 (C-6), 113.3
(C-3a), 110.5 (C-7), 21.2 (C-8); LR MS (ES~) m/z: 147 [M-H]".
was added dropwise with continuous stirring to a mixture of 5-
methylanthranilic acid (5.00 g, 33.1 mmol), water (33.5 mL) and
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Unit cell dimensions a = 11.652(8) A a= 90°.
b = 4.850(3) A (3=105.10(2)°.
c= 17.171(10) A y = 90°.
Volume 937.0(10) A3
Z 4
Density (calculated) 1.235 Mg/m3
Absorption coefficient 0.082 mm1
F(000)368
Crystal size .1 x .1 x .05 mm3
Theta range for data collection 2.44 to 24.71 °.
Index ranges -13<=h<= 13, -5<=k<=4, -20<=1<=13
Reflections collected 3371
Independent reflections 1463 [R(int) = 0.0699]
Completeness to theta = 24.71° 91.4%
Absorption correctionMultiscan
Max. and min. transmission 1.00000 and 0.5445
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 1463 / 1 / 123
Goodncss-of-fit on F2 0.903
Final R indices [I>2sigma(I)]Rl = 0.0637, wR2 = 0.1194
R indices (all data) R1 = 0.2000, wR2 = 0.1591
Extinction coefficient 0.009(3)
Largest diff. peak and hole 0.131 and -0.143 e.A"3
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement
parameters (A2x 103) for ninw4. U(eq) is defined as one third of the trace of the
orthogonalized U'i tensor.
x y z U(eq)
N(l) 3314(3) 2536(8) 7159(3) 70(1)
N(2) 3818(3) 4459(7) 7754(2) 65(1)
C(3A) 5226(4) 2828(8) 7156(3) 53(1)
C(3) 4938(4) 4601(9) 7728(3) 58(1)
C(4) 6225(4) 2218(9) 6898(3) 66(1)
C(5) 6138(4) 272(10) 6317(3) 78(2)
C(6) 5062(6) -1095(9) 5974(3) 80(2)
C(7A) 4137(4) 1483(8) 6812(3) 59(1)
C(7) 4064(5) -498(10) 6219(3) 75(1)
0(8) 5740(2) 6305(6) 8208(2) 68(1)
C(9) 5309(4) 7865(9) 8786(3) 68(1)
C(10) 6307(5) 9600(12) 9226(4) 106(2)
C(ll) 6664(6) 10000(13) 9946(4) 133(2)
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Symmetry transformations used to generate equivalent atoms:
Table 4. Anisotropic displacement parameters (A2x 103) for ninw4. The
anisotropic displacement factor exponent takes the form: -27t2[ h2 a*2Uu + ... + 2 h k a*
b* U12]
U11 U22 U33 U23 U13 IP2
N(l) 37(3) 76(3) 96(3) -1(2) 16(2) -5(2)
N(2) 39(2) 72(2) 84(3) 1(2) 16(2) 2(2)
C(3A) 36(3) 56(2) 64(3) 7(2) 8(3) 1(2)
C(3) 34(3) 62(3) 74(3) 11(3) 6(3) 0(2)
C(4) 54(3) 74(3) 69(3) -3(3) 16(3) -3(3)
C(5) 55(3) 95(4) 86(4) 2(3) 22(3) 7(3)
C(6) 97(5) 79(3) 60(4) -5(2) 15(4) 16(3)
C(7A) 54(3) 54(3) 63(3) 8(2) 7(3) 7(2)
C(7) 68(4) 76(3) 73(4) 14(3) 6(3) -7(3)
0(8) 41(2) 75(2) 85(2) -5(2) 14(2) -3(2)
C(9) 46(3) 84(3) 70(3) -4(3) 10(3) 2(3)
C(10) 82(5) 133(4) 95(5) -35(4) 10(4) 12(4)
C(ll) 93(5) 165(5) 127(6) -44(5) 2(5) 29(4)
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x
10 3) for ninw4.
x y z U(eq)
H(l) 2534(16) 1850(70) 719i
H(4A) 6941 3120 7117 79
H(5A) 6807 -167 6141 93
H(6A) 5028 -2419 5577 96
H(7A) 3351 -1400 5992 90
H(9A) 5055 6640 9155 81
H(9B) 4641 9005 8514 81
H(10A) 6721 10515 8908 127
H(11A) 6291 9149 10300 160
H(11B) 7310 11158 10145 160
100(16)
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Table 6. Torsion angles [°] for ninw4.
C(7A)-N(1)-N(2)-C(3) 2.5(5)
N(l)-N(2)-C(3)-0(8) 178.7(3)






















Symmetry transformations used to generate equivalent atoms:
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Table 7. Hydrogen bonds for ninw4 [A and °].
D-H...A d(D-H)d(H...A) d(D...A) <(DHA)
N(1)-H(1)...N(2)#1 0.9800(13) 1.981(11) 2.935(5) 164(3)





Table 1. Crystal data and structure refinement for ninw2.
Identification code ninw2






Unit cell dimensions a =12.691(4) A a= 90°.
b = 6.1123(17) A p= 102.673(5)°.
c= 11.694(3) A y = 90°.
Volume 885.1(4) A3
Z 4
Density (calculated) 1.307 Mg/m3
Absorption coefficient 0.087 mm-1
F(000)368
Crystal size .12 x .03 x .03 mm3
Theta range for data collection 1.64 to 23.25°.
Index ranges -14<=h<=14, -4<=k<=6, -13<=1<=12
Reflections collected 3466
Independent reflections 1216 [R(int) = 0.0392]
Completeness to theta = 23.25° 95.8 %
Absorption correctionSADABS
Max. and min. transmission 1.00000 and 0.434168
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 1216 / 1 / 123
Goodncss-of-fit on F71.003
Final R indices [I>2sigma(I)]Rl = 0.0362, wR2 = 0.0888
R indices (all data) R1 = 0.0446, wR2 = 0.0921
Extinction coefficient 0.020(4)
Largest diff. peak and hole 0.184 and -0.137 e.A"3
259
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement
parameters (A2x 103) for ninw2. U(eq) is defined as one third of the trace of the
orthogonalized U'J tensor.
x y z U(eq)
N(l) 7392(1) 2102(2) 1394(1) 22(1)
N(2) 8002(1) 1285(2) 2458(1) 22(1)
C(3) 7756(1) 2302(3) 3402(1) 21(1)
0(3) 8111(1) 1710(2) 4440(1) 27(1)
C(3A) 7032(1) 4071(2) 2916(1) 21(1)
C(4) 6545(1) 5747(3) 3435(1) 25(1)
C(5) 5915(1) 7251(3) 2707(2) 27(1)
C(6) 5781(1) 7099(3) 1487(2) 28(1)
C(7) 6250(1) 5454(3) 962(1) 25(1)
C(1A) 6868(1) 3918(3) 1701(1) 21(1)
C(8) 8577(1) -775(3) 2467(1) 25(1)
C(9) 9344(1) -762(3) 1661(1) 25(1)
C(10) 9297(1) -2142(3) 798(2) 31(1)
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Symmetry transformations used to generate equivalent atoms:
262
Table 4. Anisotropic displacement parameters (A2x 103) for ninw2. The
anisotropic displacement factor exponent takes the form: -2n2[ h2 a*2Uu + ... + 2 h k a*
b* U12 ]
U11 U22 U33 U23 U13 U12
N(l) 29(1) 24(1) 16(1) 0(1) 10(1) 2(1)
N(2) 29(1) 23(1) 17(1) 2(1) 10(1) 2(1)
C(3) 24(1) 25(1) 17(1) 1(1) 11(1) -4(1)
0(3) 35(1) 32(1) 18(1) 2(1) 12(1) 5(1)
C(3A) 22(1) 22(1) 23(1) 0(1) 12(1) -5(1)
C(4) 27(1) 28(1) 23(1) -4(1) 13(1) -3(1)
0(5) 26(1) 27(1) 32(1) -1(1) 13(1) 4(1)
0(6) 25(1) 29(1) 31(1) 5(1) 7(1) 2(1)
0(7) 25(1) 30(1) 21(1) 3(1) 7(1) -4(1)
C(1 A) 22(1) 21(1) 22(1) 1(1) 10(1) -5(1)
0(8) 31(1) 21(1) 24(1) 2(1) 10(1) 3(1)
0(9) 26(1) 24(1) 27(1) -2(1) 10(1) -1(1)
C(10) 31(1) 32(1) 32(1) -3(1) 12(1) 1(1)
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x
10 3) for ninw2.
x y z U(eq)
H(1N) 7746(13) 2240(30)
H(4A) 6646 5846 4263 30
H(5A) 5570 8396 3036 32
H(6A) 5352 8165 1005 34
H(7A) 6157 5371 135 30
H(8A) 8046 -1969 2233 30
H(8B) 8984 -1080 3275 30
H(9A) 9897 314 1783 30
H(10A) 8753 -3237 653













N(2)-C(3)-C(3A)-C( 1 A) 2.27(16)
0(3)-C(3)-C(3A)-C(4) 4.0(3)
N(2)-C(3)-C(3A)-C(4) -176.52(15)





N(2)-N( 1 )-C( 1 A)-C(3A) -7.35(16)
N(2)-N( 1 )-C( 1 A)-C(7) 172.65(14)
C(4)-C(3A)-C( 1 A)-N( 1) -177.73(13)
C(3)-C(3A)-C(lA)-N( 1) 3.31(17)





N( 1 )-N(2)-C(8)-C(9) 56.67(17)
N(2)-C(8)-C(9)-C(10) -121.56(18)
Symmetry transformations used to generate equivalent atoms:
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Table 7. Hydrogen bonds for ninw2 [A and °].
D-H...A d(D-H)d(H...A) d(D...A) <(DHA)
N(1)-H(1N)...0(3)#10.979(5) 1.796(8) 2.7386(17) 160.6(17)
























Completeness to theta = 25.35°
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)j
R indices (all data)
Extinction coefficient
Largest diff. peak and hole
refinement for ninw6.
ninw6






a = 16.062(4) A a= 90°.
b = 11.3230(18) A (3=114.113(8)°.






0.1000 x 0.0300 x 0.0300 mm3
1.80 to 25.35°.
-14<=h<= 19, -13<=k<= 13, -19<=1<=17
14698




Full-matrix least-squares on F2
4791 /0/ 175
1.101
R1 =0.2586, wR2 = 0.5255
R1 = 0.2797, wR2 = 0.5347
0.0001(8)
1.037 and -0.881 e.A-3
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x
103)
for ninw6. U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
X y z U(eq)
N(l) 6363(8) -1213(10) 587(8) 18(2)
N(2) 7001(7) -381(10) 994(7) 13(2)
C(3) 6768(10) 382(13) 1512(10) 23(3)
N(3) 7358(8) 1307(11) 2018(8) 23(3)
C(4) 5938(8) 30(12) 1472(8) 13(3)
C(5) 5344(9) 471(13) 1884(9) 19(3)
C(6) 4552(9) -96(13) 1653(9) 20(3)
C(7) 4315(11) -1086(14) 1029(11) 29(3)
C(8) 4872(10) -1521(14) 642(10) 23(3)
C(9) 5704(9) -928(12) 880(9) 18(3)
C(10) 7851(9) -455(12) 878(9) 18(3)
C(ll) 8232(10) -1545(15) 965(10) 28(3)
C(12) 9082(12) -1705(17) 937(12) 36(4)
C(13) 9537(10) -709(14) 834(10) 26(3)
C(14) 9144(10) 414(13) 738(10) 23(3)
C(15) 8282(9) 522(13) 768(9) 21(3)
C(16) 7192(10) 2452(13) 1750(10) 21(3)
0(16) 6888(7) 2794(10) 939(7) 30(3)
N(16) 7500 3121(14) 2500 15(3)
C(17) 7500 4463(16) 2500 11(4)
C( 18) 8332(9) 5006(12) 2796(9) 17(3)
C( 19) 8332(10) 6212(14) 2818(10) 25(3)
C(20) 7500 6826(18) 2500 19(4)
N(21) 10598(8) 5778(11) 1489(8) 21(3)
N(22) 10995(7) 4850(10) 2032(7) 15(2)
C(23) 11555(9) 4242(12) 1748(9) 17(3)
N(23) 12033(8) 3268(11) 2249(8) 23(3)
C(24) 11496(9) 4766(12) 935(9) 18(3)
C(25) 11877(10) 4551(14) 330(10) 27(3)
C(26) 11666(9) 5230(13) -424(10) 21(3)
C(27) 11045(10) 6208(14) -591(10) 25(3)
C(28) 10658(10) 6443(13) 40(10) 22(3)
C(29) 10901(9) 5739(12) 808(9) 18(3)
C(30) 10876(9) 4640(13) 2850(9) 19(3)
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C(31) 10927(10) 5592(14) 3417(10) 26(3)
C(32) 10872(10) 5382(14) 4248(11) 28(3)
C(33) 10721(11) 4272(15) 4482(12) 33(4)
C(34) 10676(12) 3288(16) 3923(12) 36(4)
C(35) 10714(10) 3480(14) 3079(10) 27(3)
C(36) 11736(10) 2087(14) 2035(10) 24(3)
0(36) 10981(8) 1752(10) 1494(8) 34(3)
N(36) 12500 1392(14) 2500 14(3)
C(37) 12500 155(17) 2500 14(4)
C(38) 12747(9) -458(13) 3314(9) 19(3)
C(39) 12747(10) -1672(14) 3305(11) 26(3)
C(40) 12500 -2270(20) 2500 24(5)




















































































































C(12)-C(l 1)-H(11 A) 119.3
C(13)-C(12)-C(l 1) 117.9(16)















C( 16)# 1 -N( 16)-C( 17) 124.6(8)
C(16)-N(16)-C(17) 124.6(8)




C( 17)-C( 18)-H( 18A) 121.7
C( 19)-C( 18)-H( 18A) 121.7
C(18)-C(19)-C(20) 119.6(15)
C( 18)-C( 19)-H( 19A) 120.2
C(20)-C(19)-H(19A) 120.2
C( 19)# 1 -C(20)-C(19) 120.7( 19)


































































Symmetry transformations used to generate equivalent atoms:
#1 -x+3/2,y,-z+l/2 #2-x+5/2,y,-z+l/2
Table 4. Hydrogen coordinates (x 104) and isotropic displacement parameters (A2x 10 3)
for ninw6.
x y z U(eq)
H(5A) 5510 1122 2294 23
H(6A) 4137 155 1902 24
H(7A) 3741 -1456 879 34
H(8A) 4705 -2179 239 27
H(11A) 7914 -2211 1047 33
H(12A) 9341 -2470 987 44
H(13A) 10124 -791 829 31
H(14A) 9452 1090 654 27
H(15A) 8005 1276 711 25
H(18A) 8882 4566 2977 20
H(19A) 8893 6634 3047 30
H(20A) 7500 7665 2500 23
H(25A) 12296 3917 439 32
H(26A) 11929 5060 -844 25
H(27A) 10897 6688 -1117 30
H(28A) 10237 7073 -62 26
H(31A) 10999 6373 3240 31
H(32A) 10941 6019 4656 34
H(33A) 10645 4157 5032 39
H(34A) 10621 2511 4118 43
H(35A) 10632 2844 2667 32
H(38A) 12915 -42 3873 23
H(39A) 12920 -2097 3861 31
H(40A) 12500 -3106 2500 29
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Table 5. Torsion angles [°] for ninw6.
C(9)-N( 1 )-N(2)-C(3) 0.1(14)
C(9)-N(l)-N(2)-C(10) 176.2(11)
N( 1 )-N(2)-C(3)-C(4) 1.5(16)
C( 10)-N(2)-C(3)-C(4) -174.0(12)















N(2)-N( 1 )-C(9)-C(4) -1.7(15)











C( 15)-C( 10)-C( 11 )-C( 12) -1(2)
N(2)-C(10)-C(l 1)-C(12) -175.0(14)
C(10)-C(l 1)-C(12)-C(13) 1(2)
C( 11 )-C( 12)-C( 13)-C( 14) -2(2)
C( 12)-C( 13)-C( 14)-C( 15) 1(2)
C( 11 )-C( 10)-C( 15)-C( 14) 0(2)
N(2)-C( 10)-C( 15)-C( 14) 174.5(12)
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C( 13)-C( 14)-C( 15)-C( 10) -1(2)
N(3)# 1 -N(3)-C( 16)-0( 16) -176.6(14)
C(3)-N(3)-C( 16)-0( 16) -38(2)
N(3)#l-N(3)-C(16)-N(16) 9.8(17)
C(3)-N(3)-C( 16)-N( 16) 148.0(11)
0( 16)-C( 16)-N( 16)-C( 16)# 1 -177.3(18)
N(3)-C( 16)-N( 16)-C( 16)# 1 -4.0(7)
0(16)-C( 16)-N( 16)-C( 17) 2.7(18)
N(3)-C( 16)-N( 16)-C( 17) 176.0(7)
C( 16)# 1 -N( 16)-C( 17)-C( 18) 69.1(10)
C( 16)-N( 16)-C( 17)-C( 18) -110.9(10)
C( 16)# 1 -N( 16)-C( 17)-C( 18)# 1 -110.9(10)
C( 16)-N( 16)-C( 17)-C( 18)# 1 69.1(10)
C( 18)# 1 -C( 17)-C( 18)-C( 19) 1.6(10)
N(16)-C( 17)-C( 18)-C( 19) -178.4(10)
C( 17)-C( 18)-C( 19)-C(20) -3.2(19)
























































Symmetry transformations used to generate equivalent atoms:
#1 -x+3/2,y,-z+l/2 #2 -x+5/2,y,-z+l/2
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Appendix D



















Completeness to theta = 24.70°
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)J
R indices (all data)
Absolute structure parameter
Extinction coefficient









a= 11.736(6) A a= 90°.
b = 25.753(13) A p= 90°.














Full-matrix least-squares on F2
1991 121177
0.893
R1 =0.0619, wR2 = 0.0819
R1 = 0.1901, wR2 = 0.1089
1(3)
0.0040(11)
0.138 and -0.126 e.A"3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x
103)
for ninw3. U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
X y z U(eq)
N(l) 9051(4) 4749(2) 6464(10) 61(1)
N(2) 8782(4) 5182(2) 4695(11) 60(1)
C(3) 7662(5) 5171(2) 4680(14) 50(1)
C(3A) 7169(4) 4769(2) 6383(13) 47(2)
C(4) 6059(5) 4594(2) 7036(14) 68(2)
C(5) 5952(5) 4176(3) 8875(14) 75(2)
C(6) 6912(5) 3924(2) 10054(13) 69(2)
C(7) 8001(5) 4082(2) 9452(12) 62(2)
C(7A) 8110(5) 4510(2) 7547(12) 52(2)
0(8) 7036(3) 5536(2) 3195(8) 61(1)
C(9) 7687(4) 5935(2) 1677(14) 60(2)
C(10) 6869(4) 6315(2) 383(12) 63(2)
C(ll) 6850(5) 6809(3) 1065(12) 68(2)
C(12) 6096(5) 7223(2) -116(14) 57(2)
C( 13) 5163(5) 7113(2) -1821(15) 82(2)
C(14) 4460(6) 7502(3) -2871(16) 101(3)
C(15) 4673(6) 8007(3) -2209(18) 88(2)
C(16) 5593(7) 8120(2) -437(16) 86(2)
C(17) 6307(5) 7734(3) 525(17) 86(2)
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Symmetry transformations used to generate equivalent atoms:
Table 4. Anisotropic displacement parameters (A2x 103) for ninw3. The anisotropic
displacement factor exponent takes the form: -2n2[ h2 a*2U" + ... + 2 h k a* b* U12 ]
U" U22 U33 U23 U13 U12
N( 1)27(3) 76(4) 80(4) 1(3) -6(3) 2(3)
N(2)34(3) 61(4) 85(3) 4(3) 4(3) -5(3)
C(3)46(4) 42(4) 61(4) -10(3) 0(4) 11(3)
C(3A) 46(4) 45(4) 51(4) -6(3) -7(3)
C(4)54(4) 66(5) 84(5) 2(4) 4(3) -7(4)
C(5)44(4) 89(5) 90(6) -9(5) -5(4) -4(4)
C(6)72(4) 55(4) 81(5) 12(4) -2(4) -12(4)
C(7)53(4) 65(4) 68(4) 8(4) -15(4) 12(3)
C(7A) 40(4) 52(4) 62(4) -5(4) -8(4)
3(4)
0(8)40(2) 55(3) 89(3) 7(2) 13(2) -11(2)
C(9)41 (4) 58(4) 83(4) -5(4) -5(3) 2(3)
C(10)66(4) 63(4) 59(4) -1(4) -5(4) -12(4)
C(11)58(4) 64(4) 82(5) -1(4) -6(3) -9(4)
0(12)48(4) 55(5) 68(4) 3(4) -2(3) -11(4)
0(13)61(5) 50(5) 134(5) -7(5) -12(5) -7(4)
0(14)78(5) 86(5) 139(7) -2(7) -30(5) 9(5)
0(15)80(6) 87(7) 97(6) 15(5) 1(5) 16(5)
0(16)131(7) 52(5) 75(5) 12(5) 10(5) 21(5)
0(17)85(5) 57(5) 117(6) 4(4) -26(4) -8(4)
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Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (A2x 10 3)
for ninw3.
x y z U(eq)
H(1N) 9835(13) 4716(14) 7200(90) 52(15)
H(4A) 5422 4759 6233 81
H(5A) 5229 4055 9365 89
H(6A) 6805 3636 11298 83
H(7A) 8631 3914 10268 74
H(9A) 8146 5784 79 73
H(9B) 8190 6106 3105 73
H(10A) 6336 6193 -1004 75
H(11A) 7385 6914 2492 82
H(13A) 4997 6769 -2288 98
H(14A) 3830 7417 -4050 122
H(15A) 4205 8269 -2944 106
H(16A) 5734 8462 121 103
H(17A) 6952 7821 1641 103
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Table 6. Torsion angles [°] for ninw3.
C(7A)-N( 1 )-N(2)-C(3) -2.7(6)
N(l)-N(2)-C(3)-0(8) 179.5(5)























C( 10)-C( 11 )-C( 12)-C( 13) 10.9(10)
C( 10)-C( 11 )-C( 12)-C( 17) -170.3(6)
C( 17)-C( 12)-C( 13)-C( 14) 0.2(10)
C( 11 )-C( 12)-C( 13 )-C( 14) 179.1(6)
C( 12)-C( 13)-C( 14)-C( 15) -0.6(12)
C( 13)-C( 14)-C( 15)-C(l 6) -1.0(12)
C( 14)-C( 15)-C( 16)-C( 17) 2.9(11)
C( 15)-C( 16)-C( 17)-C( 12) -3.4(10)
C( 13 )-C( 12)-C( 17)-C( 16) 1.8(9)
C( 11 )-C( 12)-C( 17)-C( 16) -177.1(6)
Symmetry transformations used to generate equivalent atoms:
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Table 7. Hydrogen bonds for ninw3 [A and °].
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
N( 1 )-H( IN).. .N(2)# 10.9799(12) 1.979(13) 2.922(6) 161(3)
Symmetry transformations used to generate equivalent atoms:
#1 -x+2,-y+l,z+l/2
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